id	sid	tid	token	lemma	pos
dpc-500	1	1	dermatology	dermatology	NOUN
dpc-500	1	2	:	:	PUNCT
dpc-500	1	3	practical	practical	ADJ
dpc-500	1	4	and	and	CCONJ
dpc-500	1	5	conceptual	conceptual	ADJ
dpc-500	1	6	262	262	NUM
dpc-500	1	7	research	research	NOUN
dpc-500	1	8	|	|	ADV
dpc-500	1	9	dermatol	dermatol	NOUN
dpc-500	1	10	pract	pract	NOUN
dpc-500	1	11	concept	concept	NOUN
dpc-500	1	12	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	1	13	dermatology	dermatology	NOUN
dpc-500	1	14	practical	practical	ADJ
dpc-500	1	15	&	&	CCONJ
dpc-500	1	16	conceptual	conceptual	ADJ
dpc-500	1	17	www.derm101.com	www.derm101.com	X
dpc-500	1	18	the	the	DET
dpc-500	1	19	potential	potential	ADJ
dpc-500	1	20	roles	role	NOUN
dpc-500	1	21	of	of	ADP
dpc-500	1	22	herpesvirus	herpesvirus	NOUN
dpc-500	1	23	and	and	CCONJ
dpc-500	1	24	cytomegalovirus	cytomegalovirus	NOUN
dpc-500	1	25	in	in	ADP
dpc-500	1	26	the	the	DET
dpc-500	1	27	exacerbation	exacerbation	NOUN
dpc-500	1	28	of	of	ADP
dpc-500	1	29	pemphigus	pemphigus	NOUN
dpc-500	1	30	vulgaris	vulgaris	NOUN
dpc-500	1	31	fariba	fariba	PROPN
dpc-500	1	32	mohammadi1	mohammadi1	PROPN
dpc-500	1	33	,	,	PUNCT
dpc-500	1	34	zahra	zahra	PROPN
dpc-500	1	35	khalili1	khalili1	PROPN
dpc-500	1	36	,	,	PUNCT
dpc-500	1	37	sayed	say	VERB
dpc-500	1	38	mahdi	mahdi	PROPN
dpc-500	1	39	marashi2	marashi2	PROPN
dpc-500	1	40	,	,	PUNCT
dpc-500	1	41	amirhoushang	amirhoushang	PROPN
dpc-500	1	42	ehsani1	ehsani1	PROPN
dpc-500	1	43	,	,	PUNCT
dpc-500	1	44	maryam	maryam	PROPN
dpc-500	1	45	daneshpazhooh1	daneshpazhooh1	PROPN
dpc-500	1	46	,	,	PUNCT
dpc-500	1	47	majid	majid	PROPN
dpc-500	1	48	teymoori	teymoori	PROPN
dpc-500	1	49	-	-	PUNCT
dpc-500	1	50	rad2	rad2	PROPN
dpc-500	1	51	,	,	PUNCT
dpc-500	1	52	kamran	kamran	PROPN
dpc-500	1	53	balighi1	balighi1	PROPN
dpc-500	1	54	,	,	PUNCT
dpc-500	1	55	ahmad	ahmad	PROPN
dpc-500	1	56	nejati2	nejati2	PROPN
dpc-500	1	57	,	,	PUNCT
dpc-500	1	58	shohreh	shohreh	NOUN
dpc-500	1	59	shahmahmoodi2	shahmahmoodi2	VERB
dpc-500	1	60	,	,	PUNCT
dpc-500	1	61	shima	shima	PROPN
dpc-500	1	62	izadidakhrabadi2	izadidakhrabadi2	PROPN
dpc-500	1	63	,	,	PUNCT
dpc-500	1	64	hamidreza	hamidreza	PROPN
dpc-500	1	65	mahmoudi1	mahmoudi1	NOUN
dpc-500	1	66	,	,	PUNCT
dpc-500	1	67	pedarm	pedarm	NOUN
dpc-500	1	68	noormohammadpour1	noormohammadpour1	NOUN
dpc-500	1	69	1	1	NUM
dpc-500	1	70	 	 	SPACE
dpc-500	1	71	autoimmune	autoimmune	ADJ
dpc-500	1	72	bullous	bullous	ADJ
dpc-500	1	73	disease	disease	NOUN
dpc-500	1	74	research	research	NOUN
dpc-500	1	75	center	center	NOUN
dpc-500	1	76	,	,	PUNCT
dpc-500	1	77	department	department	NOUN
dpc-500	1	78	of	of	ADP
dpc-500	1	79	dermatology	dermatology	NOUN
dpc-500	1	80	,	,	PUNCT
dpc-500	1	81	razi	razi	PROPN
dpc-500	1	82	hospital	hospital	PROPN
dpc-500	1	83	,	,	PUNCT
dpc-500	1	84	tehran	tehran	PROPN
dpc-500	1	85	university	university	PROPN
dpc-500	1	86	of	of	ADP
dpc-500	1	87	medical	medical	ADJ
dpc-500	1	88	sciences	sciences	PROPN
dpc-500	1	89	,	,	PUNCT
dpc-500	1	90	tehran	tehran	PROPN
dpc-500	1	91	,	,	PUNCT
dpc-500	1	92	iran	iran	PROPN
dpc-500	1	93	2	2	NUM
dpc-500	1	94	 	 	SPACE
dpc-500	1	95	virology	virology	NOUN
dpc-500	1	96	department	department	NOUN
dpc-500	1	97	,	,	PUNCT
dpc-500	1	98	school	school	NOUN
dpc-500	1	99	of	of	ADP
dpc-500	1	100	public	public	ADJ
dpc-500	1	101	health	health	NOUN
dpc-500	1	102	(	(	PUNCT
dpc-500	1	103	sph	sph	PROPN
dpc-500	1	104	)	)	PUNCT
dpc-500	1	105	,	,	PUNCT
dpc-500	1	106	tehran	tehran	PROPN
dpc-500	1	107	university	university	PROPN
dpc-500	1	108	of	of	ADP
dpc-500	1	109	medical	medical	PROPN
dpc-500	1	110	sciences	sciences	PROPN
dpc-500	1	111	(	(	PUNCT
dpc-500	1	112	tums	tums	PROPN
dpc-500	1	113	)	)	PUNCT
dpc-500	1	114	,	,	PUNCT
dpc-500	1	115	tehran	tehran	PROPN
dpc-500	1	116	,	,	PUNCT
dpc-500	1	117	iran	iran	PROPN
dpc-500	1	118	key	key	ADJ
dpc-500	1	119	words	word	NOUN
dpc-500	1	120	:	:	PUNCT
dpc-500	1	121	pemphigus	pemphigus	NOUN
dpc-500	1	122	vulgaris	vulgaris	NOUN
dpc-500	1	123	,	,	PUNCT
dpc-500	1	124	herpesvirus	herpesvirus	NOUN
dpc-500	1	125	,	,	PUNCT
dpc-500	1	126	cytomegalovirus	cytomegalovirus	NOUN
dpc-500	1	127	citation	citation	NOUN
dpc-500	1	128	:	:	PUNCT
dpc-500	1	129	mohammadi	mohammadi	PROPN
dpc-500	1	130	f	f	PROPN
dpc-500	1	131	,	,	PUNCT
dpc-500	1	132	khalili	khalili	PROPN
dpc-500	1	133	z	z	PROPN
dpc-500	1	134	,	,	PUNCT
dpc-500	1	135	mahdi	mahdi	PROPN
dpc-500	1	136	marashi	marashi	PROPN
dpc-500	1	137	s	s	PROPN
dpc-500	1	138	,	,	PUNCT
dpc-500	1	139	ehsani	ehsani	NOUN
dpc-500	1	140	a	a	X
dpc-500	1	141	,	,	PUNCT
dpc-500	1	142	daneshpazhooh	daneshpazhooh	NOUN
dpc-500	1	143	m	m	PROPN
dpc-500	1	144	,	,	PUNCT
dpc-500	1	145	teymoori	teymoori	NOUN
dpc-500	1	146	-	-	PUNCT
dpc-500	1	147	rad	rad	NOUN
dpc-500	1	148	m	m	PROPN
dpc-500	1	149	,	,	PUNCT
dpc-500	1	150	balighi	balighi	PROPN
dpc-500	1	151	k	k	PROPN
dpc-500	1	152	,	,	PUNCT
dpc-500	1	153	nejati	nejati	PROPN
dpc-500	1	154	a	a	NOUN
dpc-500	1	155	,	,	PUNCT
dpc-500	1	156	shahmahmoodi	shahmahmoodi	PROPN
dpc-500	1	157	s	s	PART
dpc-500	1	158	,	,	PUNCT
dpc-500	1	159	izadidakhrabadi	izadidakhrabadi	PROPN
dpc-500	1	160	s	s	PART
dpc-500	1	161	,	,	PUNCT
dpc-500	1	162	mahmoudi	mahmoudi	ADJ
dpc-500	1	163	h	h	NOUN
dpc-500	1	164	,	,	PUNCT
dpc-500	2	1	noormohammadpour	noormohammadpour	ADJ
dpc-500	3	1	p.	p.	NOUN
dpc-500	3	2	the	the	DET
dpc-500	3	3	potential	potential	ADJ
dpc-500	3	4	roles	role	NOUN
dpc-500	3	5	of	of	ADP
dpc-500	3	6	herpesvirus	herpesvirus	NOUN
dpc-500	3	7	and	and	CCONJ
dpc-500	3	8	cytomegalovirus	cytomegalovirus	NOUN
dpc-500	3	9	in	in	ADP
dpc-500	3	10	the	the	DET
dpc-500	3	11	exacerbation	exacerbation	NOUN
dpc-500	3	12	of	of	ADP
dpc-500	3	13	pemphigus	pemphigus	NOUN
dpc-500	3	14	vulgaris	vulgaris	NOUN
dpc-500	3	15	.	.	PUNCT
dpc-500	4	1	dermatol	dermatol	NOUN
dpc-500	4	2	pract	pract	PROPN
dpc-500	4	3	concept	concept	NOUN
dpc-500	4	4	.	.	PUNCT
dpc-500	5	1	2018;8(4):262	2018;8(4):262	X
dpc-500	5	2	-	-	PUNCT
dpc-500	5	3	271	271	NUM
dpc-500	5	4	.	.	PUNCT
dpc-500	5	5	doi	doi	NOUN
dpc-500	5	6	:	:	PUNCT
dpc-500	5	7	https://doi.org/10.5826/dpc.0804a03	https://doi.org/10.5826/dpc.0804a03	ADJ
dpc-500	5	8	received	receive	VERB
dpc-500	5	9	:	:	PUNCT
dpc-500	5	10	march	march	PROPN
dpc-500	5	11	 	 	SPACE
dpc-500	5	12	19	19	NUM
dpc-500	5	13	,	,	PUNCT
dpc-500	5	14	2018	2018	NUM
dpc-500	5	15	;	;	PUNCT
dpc-500	5	16	accepted	accept	VERB
dpc-500	5	17	:	:	PUNCT
dpc-500	5	18	july	july	PROPN
dpc-500	5	19	 	 	SPACE
dpc-500	5	20	18	18	NUM
dpc-500	5	21	,	,	PUNCT
dpc-500	5	22	2018	2018	NUM
dpc-500	5	23	;	;	PUNCT
dpc-500	5	24	published	publish	VERB
dpc-500	5	25	:	:	PUNCT
dpc-500	5	26	october	october	PROPN
dpc-500	5	27	 	 	SPACE
dpc-500	5	28	31	31	NUM
dpc-500	5	29	,	,	PUNCT
dpc-500	5	30	2018	2018	NUM
dpc-500	5	31	copyright	copyright	NOUN
dpc-500	5	32	:	:	PUNCT
dpc-500	5	33	©	©	PROPN
dpc-500	5	34	2018	2018	NUM
dpc-500	5	35	 	 	SPACE
dpc-500	5	36	mohammadi	mohammadi	NOUN
dpc-500	5	37	et	et	PROPN
dpc-500	5	38	 	 	SPACE
dpc-500	5	39	al	al	PROPN
dpc-500	5	40	.	.	PUNCT
dpc-500	6	1	this	this	PRON
dpc-500	6	2	is	be	AUX
dpc-500	6	3	an	an	DET
dpc-500	6	4	open	open	ADJ
dpc-500	6	5	-	-	PUNCT
dpc-500	6	6	access	access	NOUN
dpc-500	6	7	article	article	NOUN
dpc-500	6	8	distributed	distribute	VERB
dpc-500	6	9	under	under	ADP
dpc-500	6	10	the	the	DET
dpc-500	6	11	terms	term	NOUN
dpc-500	6	12	of	of	ADP
dpc-500	6	13	the	the	DET
dpc-500	6	14	creative	creative	ADJ
dpc-500	6	15	commons	common	NOUN
dpc-500	6	16	attribution	attribution	NOUN
dpc-500	6	17	license	license	NOUN
dpc-500	6	18	,	,	PUNCT
dpc-500	6	19	which	which	PRON
dpc-500	6	20	permits	permit	VERB
dpc-500	6	21	unrestricted	unrestricted	ADJ
dpc-500	6	22	use	use	NOUN
dpc-500	6	23	,	,	PUNCT
dpc-500	6	24	distribution	distribution	NOUN
dpc-500	6	25	,	,	PUNCT
dpc-500	6	26	and	and	CCONJ
dpc-500	6	27	reproduction	reproduction	NOUN
dpc-500	6	28	in	in	ADP
dpc-500	6	29	any	any	DET
dpc-500	6	30	medium	medium	NOUN
dpc-500	6	31	,	,	PUNCT
dpc-500	6	32	provided	provide	VERB
dpc-500	6	33	the	the	DET
dpc-500	6	34	original	original	ADJ
dpc-500	6	35	author	author	NOUN
dpc-500	6	36	and	and	CCONJ
dpc-500	6	37	source	source	NOUN
dpc-500	6	38	are	be	AUX
dpc-500	6	39	credited	credit	VERB
dpc-500	6	40	.	.	PUNCT
dpc-500	7	1	funding	funding	NOUN
dpc-500	7	2	:	:	PUNCT
dpc-500	7	3	this	this	DET
dpc-500	7	4	research	research	NOUN
dpc-500	7	5	was	be	AUX
dpc-500	7	6	supported	support	VERB
dpc-500	7	7	by	by	ADP
dpc-500	7	8	tehran	tehran	PROPN
dpc-500	7	9	university	university	PROPN
dpc-500	7	10	of	of	ADP
dpc-500	7	11	medical	medical	PROPN
dpc-500	7	12	sciences	sciences	PROPN
dpc-500	7	13	(	(	PUNCT
dpc-500	7	14	tums	tum	NOUN
dpc-500	7	15	)	)	PUNCT
dpc-500	7	16	,	,	PUNCT
dpc-500	7	17	grant	grant	VERB
dpc-500	7	18	numbers	number	NOUN
dpc-500	7	19	 	 	SPACE
dpc-500	7	20	32855	32855	NUM
dpc-500	7	21	-	-	SYM
dpc-500	7	22	30	30	NUM
dpc-500	7	23	-	-	PUNCT
dpc-500	7	24	03	03	NUM
dpc-500	7	25	-	-	PUNCT
dpc-500	7	26	95	95	NUM
dpc-500	7	27	 	 	SPACE
dpc-500	7	28	and	and	CCONJ
dpc-500	7	29	 	 	SPACE
dpc-500	7	30	30976101	30976101	NUM
dpc-500	7	31	-	-	PUNCT
dpc-500	7	32	04	04	NUM
dpc-500	7	33	-	-	PUNCT
dpc-500	7	34	94	94	NUM
dpc-500	7	35	.	.	PUNCT
dpc-500	8	1	competing	compete	VERB
dpc-500	8	2	interests	interest	NOUN
dpc-500	8	3	:	:	PUNCT
dpc-500	8	4	the	the	DET
dpc-500	8	5	authors	author	NOUN
dpc-500	8	6	have	have	VERB
dpc-500	8	7	no	no	DET
dpc-500	8	8	conflicts	conflict	NOUN
dpc-500	8	9	of	of	ADP
dpc-500	8	10	interest	interest	NOUN
dpc-500	8	11	to	to	PART
dpc-500	8	12	disclose	disclose	VERB
dpc-500	8	13	.	.	PUNCT
dpc-500	9	1	all	all	DET
dpc-500	9	2	authors	author	NOUN
dpc-500	9	3	have	have	AUX
dpc-500	9	4	contributed	contribute	VERB
dpc-500	9	5	significantly	significantly	ADV
dpc-500	9	6	to	to	ADP
dpc-500	9	7	this	this	DET
dpc-500	9	8	publication	publication	NOUN
dpc-500	9	9	.	.	PUNCT
dpc-500	10	1	corresponding	correspond	VERB
dpc-500	10	2	author	author	NOUN
dpc-500	10	3	:	:	PUNCT
dpc-500	10	4	pedarm	pedarm	PROPN
dpc-500	10	5	noormohammadpour	noormohammadpour	PROPN
dpc-500	10	6	,	,	PUNCT
dpc-500	10	7	md	md	PROPN
dpc-500	10	8	,	,	PUNCT
dpc-500	10	9	autoimmune	autoimmune	ADJ
dpc-500	10	10	bullous	bullous	ADJ
dpc-500	10	11	disease	disease	NOUN
dpc-500	10	12	research	research	NOUN
dpc-500	10	13	center	center	NOUN
dpc-500	10	14	,	,	PUNCT
dpc-500	10	15	razi	razi	PROPN
dpc-500	10	16	hospital	hospital	PROPN
dpc-500	10	17	,	,	PUNCT
dpc-500	10	18	vahdate	vahdate	ADJ
dpc-500	10	19	-	-	PUNCT
dpc-500	10	20	eslami	eslami	NOUN
dpc-500	10	21	square	square	NOUN
dpc-500	10	22	,	,	PUNCT
dpc-500	10	23	11996	11996	NUM
dpc-500	10	24	,	,	PUNCT
dpc-500	10	25	tehran	tehran	PROPN
dpc-500	10	26	,	,	PUNCT
dpc-500	10	27	iran	iran	PROPN
dpc-500	10	28	.	.	PUNCT
dpc-500	11	1	email	email	NOUN
dpc-500	11	2	:	:	PUNCT
dpc-500	11	3	normohamad@razi.tums.ac.ir	normohamad@razi.tums.ac.ir	ADJ
dpc-500	11	4	background	background	NOUN
dpc-500	11	5	:	:	PUNCT
dpc-500	11	6	among	among	ADP
dpc-500	11	7	exogenous	exogenous	ADJ
dpc-500	11	8	etiologies	etiology	NOUN
dpc-500	11	9	,	,	PUNCT
dpc-500	11	10	the	the	DET
dpc-500	11	11	critical	critical	ADJ
dpc-500	11	12	role	role	NOUN
dpc-500	11	13	of	of	ADP
dpc-500	11	14	microbial	microbial	ADJ
dpc-500	11	15	agents	agent	NOUN
dpc-500	11	16	such	such	ADJ
dpc-500	11	17	as	as	ADP
dpc-500	11	18	herpesviruses	herpesviruse	NOUN
dpc-500	11	19	(	(	PUNCT
dpc-500	11	20	hsv1/2	hsv1/2	NUM
dpc-500	11	21	)	)	PUNCT
dpc-500	11	22	and	and	CCONJ
dpc-500	11	23	cytomegalovirus	cytomegalovirus	NOUN
dpc-500	11	24	(	(	PUNCT
dpc-500	11	25	cmv	cmv	NOUN
dpc-500	11	26	)	)	PUNCT
dpc-500	11	27	in	in	ADP
dpc-500	11	28	triggering	trigger	VERB
dpc-500	11	29	and	and	CCONJ
dpc-500	11	30	flaring	flare	VERB
dpc-500	11	31	autoimmune	autoimmune	ADJ
dpc-500	11	32	conditions	condition	NOUN
dpc-500	11	33	such	such	ADJ
dpc-500	11	34	as	as	ADP
dpc-500	11	35	pemphigus	pemphigus	NOUN
dpc-500	11	36	vulgaris	vulgaris	NOUN
dpc-500	11	37	(	(	PUNCT
dpc-500	11	38	pv	pv	NOUN
dpc-500	11	39	)	)	PUNCT
dpc-500	11	40	has	have	AUX
dpc-500	11	41	been	be	AUX
dpc-500	11	42	recently	recently	ADV
dpc-500	11	43	discovered	discover	VERB
dpc-500	11	44	.	.	PUNCT
dpc-500	12	1	objectives	objective	NOUN
dpc-500	12	2	:	:	PUNCT
dpc-500	12	3	the	the	DET
dpc-500	12	4	present	present	ADJ
dpc-500	12	5	study	study	NOUN
dpc-500	12	6	aimed	aim	VERB
dpc-500	12	7	to	to	PART
dpc-500	12	8	investigate	investigate	VERB
dpc-500	12	9	the	the	DET
dpc-500	12	10	plausible	plausible	ADJ
dpc-500	12	11	role	role	NOUN
dpc-500	12	12	of	of	ADP
dpc-500	12	13	these	these	DET
dpc-500	12	14	viruses	virus	NOUN
dpc-500	12	15	in	in	ADP
dpc-500	12	16	the	the	DET
dpc-500	12	17	exacerbation	exacerbation	NOUN
dpc-500	12	18	of	of	ADP
dpc-500	12	19	pv	pv	NOUN
dpc-500	12	20	using	use	VERB
dpc-500	12	21	serological	serological	ADJ
dpc-500	12	22	and	and	CCONJ
dpc-500	12	23	molecular	molecular	ADJ
dpc-500	12	24	methods	method	NOUN
dpc-500	12	25	.	.	PUNCT
dpc-500	13	1	patients	patient	NOUN
dpc-500	13	2	/	/	SYM
dpc-500	13	3	methods	method	NOUN
dpc-500	13	4	:	:	PUNCT
dpc-500	13	5	sixty	sixty	NUM
dpc-500	13	6	patients	patient	NOUN
dpc-500	13	7	with	with	ADP
dpc-500	13	8	pv	pv	PROPN
dpc-500	13	9	(	(	PUNCT
dpc-500	13	10	30	30	NUM
dpc-500	13	11	 	 	SPACE
dpc-500	13	12	with	with	ADP
dpc-500	13	13	relapse	relapse	NOUN
dpc-500	13	14	type	type	NOUN
dpc-500	13	15	and	and	CCONJ
dpc-500	13	16	 	 	SPACE
dpc-500	13	17	30	30	NUM
dpc-500	13	18	 	 	SPACE
dpc-500	13	19	with	with	ADP
dpc-500	13	20	remission	remission	NOUN
dpc-500	13	21	type	type	NOUN
dpc-500	13	22	)	)	PUNCT
dpc-500	13	23	were	be	AUX
dpc-500	13	24	recruited	recruit	VERB
dpc-500	13	25	for	for	ADP
dpc-500	13	26	the	the	DET
dpc-500	13	27	purpose	purpose	NOUN
dpc-500	13	28	of	of	ADP
dpc-500	13	29	this	this	DET
dpc-500	13	30	case	case	NOUN
dpc-500	13	31	-	-	PUNCT
dpc-500	13	32	control	control	NOUN
dpc-500	13	33	study	study	NOUN
dpc-500	13	34	.	.	PUNCT
dpc-500	14	1	skin	skin	NOUN
dpc-500	14	2	,	,	PUNCT
dpc-500	14	3	mucosal	mucosal	NOUN
dpc-500	14	4	,	,	PUNCT
dpc-500	14	5	and	and	CCONJ
dpc-500	14	6	throat	throat	NOUN
dpc-500	14	7	specimens	specimen	NOUN
dpc-500	14	8	were	be	AUX
dpc-500	14	9	obtained	obtain	VERB
dpc-500	14	10	and	and	CCONJ
dpc-500	14	11	examined	examine	VERB
dpc-500	14	12	for	for	ADP
dpc-500	14	13	viruses	virus	NOUN
dpc-500	14	14	by	by	ADP
dpc-500	14	15	reverse	reverse	ADJ
dpc-500	14	16	transcriptase	transcriptase	NOUN
dpc-500	14	17	polymerase	polymerase	NOUN
dpc-500	14	18	chain	chain	NOUN
dpc-500	14	19	reaction	reaction	NOUN
dpc-500	14	20	.	.	PUNCT
dpc-500	15	1	to	to	PART
dpc-500	15	2	determine	determine	VERB
dpc-500	15	3	the	the	DET
dpc-500	15	4	immunoglobulin	immunoglobulin	NOUN
dpc-500	15	5	g	g	PROPN
dpc-500	15	6	(	(	PUNCT
dpc-500	15	7	igg	igg	PROPN
dpc-500	15	8	)	)	PUNCT
dpc-500	15	9	titer	titer	NOUN
dpc-500	15	10	,	,	PUNCT
dpc-500	15	11	enzyme	enzyme	NOUN
dpc-500	15	12	-	-	PUNCT
dpc-500	15	13	linked	link	VERB
dpc-500	15	14	immunosorbent	immunosorbent	NOUN
dpc-500	15	15	assay	assay	NOUN
dpc-500	15	16	was	be	AUX
dpc-500	15	17	used	use	VERB
dpc-500	15	18	.	.	PUNCT
dpc-500	16	1	results	result	NOUN
dpc-500	16	2	:	:	PUNCT
dpc-500	16	3	desmoglein1	desmoglein1	ADJ
dpc-500	16	4	-	-	PUNCT
dpc-500	16	5	specific	specific	ADJ
dpc-500	16	6	igg	igg	NOUN
dpc-500	16	7	was	be	AUX
dpc-500	16	8	positive	positive	ADJ
dpc-500	16	9	in	in	ADP
dpc-500	16	10	  	  	SPACE
dpc-500	16	11	56.7	56.7	NUM
dpc-500	16	12	%	%	NOUN
dpc-500	16	13	of	of	ADP
dpc-500	16	14	patients	patient	NOUN
dpc-500	16	15	with	with	ADP
dpc-500	16	16	the	the	DET
dpc-500	16	17	relapse	relapse	NOUN
dpc-500	16	18	form	form	NOUN
dpc-500	16	19	and	and	CCONJ
dpc-500	16	20	in	in	ADP
dpc-500	16	21	 	 	SPACE
dpc-500	16	22	20.0	20.0	NUM
dpc-500	16	23	%	%	NOUN
dpc-500	16	24	of	of	ADP
dpc-500	16	25	those	those	PRON
dpc-500	16	26	with	with	ADP
dpc-500	16	27	the	the	DET
dpc-500	16	28	remission	remission	NOUN
dpc-500	16	29	form	form	NOUN
dpc-500	16	30	indicating	indicate	VERB
dpc-500	16	31	a	a	DET
dpc-500	16	32	significant	significant	ADJ
dpc-500	16	33	difference	difference	NOUN
dpc-500	16	34	across	across	ADP
dpc-500	16	35	the	the	DET
dpc-500	16	36	 	 	SPACE
dpc-500	16	37	2	2	NUM
dpc-500	16	38	  	  	SPACE
dpc-500	16	39	groups	group	NOUN
dpc-500	16	40	(	(	PUNCT
dpc-500	16	41	p	p	X
dpc-500	16	42	 	 	SPACE
dpc-500	16	43	=	=	NOUN
dpc-500	16	44	0.003	0.003	NUM
dpc-500	16	45	)	)	PUNCT
dpc-500	16	46	,	,	PUNCT
dpc-500	16	47	but	but	CCONJ
dpc-500	16	48	the	the	DET
dpc-500	16	49	rate	rate	NOUN
dpc-500	16	50	of	of	ADP
dpc-500	16	51	positivity	positivity	NOUN
dpc-500	16	52	for	for	ADP
dpc-500	16	53	desmoglein3	desmoglein3	NOUN
dpc-500	16	54	-	-	PUNCT
dpc-500	16	55	specific	specific	ADJ
dpc-500	16	56	igg	igg	NOUN
dpc-500	16	57	in	in	ADP
dpc-500	16	58	the	the	DET
dpc-500	16	59	relapse	relapse	NOUN
dpc-500	16	60	and	and	CCONJ
dpc-500	16	61	remission	remission	NOUN
dpc-500	16	62	types	type	NOUN
dpc-500	16	63	was	be	AUX
dpc-500	16	64	 	 	SPACE
dpc-500	16	65	76.7	76.7	NUM
dpc-500	16	66	%	%	NOUN
dpc-500	16	67	and	and	CCONJ
dpc-500	16	68	 	 	SPACE
dpc-500	16	69	63.3	63.3	NUM
dpc-500	16	70	%	%	NOUN
dpc-500	16	71	,	,	PUNCT
dpc-500	16	72	respectively	respectively	ADV
dpc-500	16	73	,	,	PUNCT
dpc-500	16	74	with	with	ADP
dpc-500	16	75	no	no	DET
dpc-500	16	76	significant	significant	ADJ
dpc-500	16	77	difference	difference	NOUN
dpc-500	16	78	(	(	PUNCT
dpc-500	16	79	p	p	NOUN
dpc-500	16	80	=	=	NOUN
dpc-500	16	81	0.260	0.260	NUM
dpc-500	16	82	)	)	PUNCT
dpc-500	16	83	.	.	PUNCT
dpc-500	17	1	there	there	PRON
dpc-500	17	2	was	be	VERB
dpc-500	17	3	no	no	DET
dpc-500	17	4	difference	difference	NOUN
dpc-500	17	5	in	in	ADP
dpc-500	17	6	the	the	DET
dpc-500	17	7	mean	mean	ADJ
dpc-500	17	8	levels	level	NOUN
dpc-500	17	9	of	of	ADP
dpc-500	17	10	hsv	hsv	PROPN
dpc-500	17	11	-	-	PUNCT
dpc-500	17	12	igg	igg	PROPN
dpc-500	17	13	and	and	CCONJ
dpc-500	17	14	cmv	cmv	NOUN
dpc-500	17	15	-	-	PUNCT
dpc-500	17	16	igg	igg	PROPN
dpc-500	17	17	in	in	ADP
dpc-500	17	18	the	the	DET
dpc-500	17	19	relapse	relapse	NOUN
dpc-500	17	20	and	and	CCONJ
dpc-500	17	21	remission	remission	NOUN
dpc-500	17	22	groups	group	NOUN
dpc-500	17	23	.	.	PUNCT
dpc-500	18	1	hsv	hsv	NOUN
dpc-500	18	2	and	and	CCONJ
dpc-500	18	3	abstract	abstract	ADJ
dpc-500	18	4	research	research	NOUN
dpc-500	18	5	|	|	ADV
dpc-500	18	6	dermatol	dermatol	NOUN
dpc-500	18	7	pract	pract	NOUN
dpc-500	18	8	concept	concept	NOUN
dpc-500	18	9	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	18	10	263	263	NUM
dpc-500	18	11	atypical	atypical	ADJ
dpc-500	18	12	hsv	hsv	NOUN
dpc-500	18	13	infections	infection	NOUN
dpc-500	18	14	have	have	AUX
dpc-500	18	15	been	be	AUX
dpc-500	18	16	described	describe	VERB
dpc-500	18	17	in	in	ADP
dpc-500	18	18	immunosuppressed	immunosuppressed	ADJ
dpc-500	18	19	patients	patient	NOUN
dpc-500	18	20	[	[	X
dpc-500	18	21	16	16	NUM
dpc-500	18	22	]	]	PUNCT
dpc-500	18	23	.	.	PUNCT
dpc-500	19	1	several	several	ADJ
dpc-500	19	2	studies	study	NOUN
dpc-500	19	3	have	have	AUX
dpc-500	19	4	suggested	suggest	VERB
dpc-500	19	5	the	the	DET
dpc-500	19	6	activation	activation	NOUN
dpc-500	19	7	or	or	CCONJ
dpc-500	19	8	exacerbation	exacerbation	NOUN
dpc-500	19	9	of	of	ADP
dpc-500	19	10	pemphigus	pemphigus	NOUN
dpc-500	19	11	after	after	ADP
dpc-500	19	12	hsv	hsv	NOUN
dpc-500	19	13	or	or	CCONJ
dpc-500	19	14	cmv	cmv	NOUN
dpc-500	19	15	infections	infection	NOUN
dpc-500	19	16	[	[	X
dpc-500	19	17	17	17	NUM
dpc-500	19	18	]	]	PUNCT
dpc-500	19	19	.	.	PUNCT
dpc-500	20	1	more	more	ADV
dpc-500	20	2	recently	recently	ADV
dpc-500	20	3	,	,	PUNCT
dpc-500	20	4	japanese	japanese	ADJ
dpc-500	20	5	researchers	researcher	NOUN
dpc-500	20	6	have	have	AUX
dpc-500	20	7	detected	detect	VERB
dpc-500	20	8	high	high	ADJ
dpc-500	20	9	levels	level	NOUN
dpc-500	20	10	of	of	ADP
dpc-500	20	11	hsv	hsv	PROPN
dpc-500	20	12	in	in	ADP
dpc-500	20	13	the	the	DET
dpc-500	20	14	saliva	saliva	NOUN
dpc-500	20	15	samples	sample	NOUN
dpc-500	20	16	of	of	ADP
dpc-500	20	17	pv	pv	NOUN
dpc-500	20	18	patients	patient	NOUN
dpc-500	20	19	[	[	X
dpc-500	20	20	18	18	NUM
dpc-500	20	21	]	]	PUNCT
dpc-500	20	22	.	.	PUNCT
dpc-500	21	1	in	in	ADP
dpc-500	21	2	this	this	DET
dpc-500	21	3	regard	regard	NOUN
dpc-500	21	4	,	,	PUNCT
dpc-500	21	5	several	several	ADJ
dpc-500	21	6	studies	study	NOUN
dpc-500	21	7	have	have	AUX
dpc-500	21	8	shown	show	VERB
dpc-500	21	9	the	the	DET
dpc-500	21	10	benefits	benefit	NOUN
dpc-500	21	11	of	of	ADP
dpc-500	21	12	adding	add	VERB
dpc-500	21	13	antiviral	antiviral	ADJ
dpc-500	21	14	therapies	therapy	NOUN
dpc-500	21	15	to	to	ADP
dpc-500	21	16	an	an	DET
dpc-500	21	17	immunosuppressive	immunosuppressive	ADJ
dpc-500	21	18	therapy	therapy	NOUN
dpc-500	21	19	in	in	ADP
dpc-500	21	20	recalcitrant	recalcitrant	ADJ
dpc-500	21	21	disease	disease	NOUN
dpc-500	21	22	[	[	X
dpc-500	21	23	19,20	19,20	X
dpc-500	21	24	]	]	PUNCT
dpc-500	21	25	.	.	PUNCT
dpc-500	22	1	several	several	ADJ
dpc-500	22	2	studies	study	NOUN
dpc-500	22	3	also	also	ADV
dpc-500	22	4	failed	fail	VERB
dpc-500	22	5	to	to	PART
dpc-500	22	6	detect	detect	VERB
dpc-500	22	7	herpesviruses	herpesviruse	NOUN
dpc-500	22	8	in	in	ADP
dpc-500	22	9	pemphigus	pemphigus	ADJ
dpc-500	22	10	patient	patient	ADJ
dpc-500	22	11	specimens	specimen	NOUN
dpc-500	23	1	[	[	X
dpc-500	23	2	21,22	21,22	X
dpc-500	23	3	]	]	PUNCT
dpc-500	23	4	,	,	PUNCT
dpc-500	23	5	suggesting	suggest	VERB
dpc-500	23	6	that	that	SCONJ
dpc-500	23	7	viruses	virus	NOUN
dpc-500	23	8	may	may	AUX
dpc-500	23	9	have	have	VERB
dpc-500	23	10	only	only	ADV
dpc-500	23	11	a	a	DET
dpc-500	23	12	transient	transient	ADJ
dpc-500	23	13	role	role	NOUN
dpc-500	23	14	for	for	ADP
dpc-500	23	15	exacerbation	exacerbation	NOUN
dpc-500	23	16	of	of	ADP
dpc-500	23	17	pemphigus	pemphigus	NOUN
dpc-500	23	18	disease	disease	NOUN
dpc-500	23	19	,	,	PUNCT
dpc-500	23	20	although	although	SCONJ
dpc-500	23	21	yet	yet	ADV
dpc-500	23	22	to	to	PART
dpc-500	23	23	be	be	AUX
dpc-500	23	24	further	far	ADV
dpc-500	23	25	defined	define	VERB
dpc-500	23	26	.	.	PUNCT
dpc-500	24	1	the	the	DET
dpc-500	24	2	number	number	NOUN
dpc-500	24	3	of	of	ADP
dpc-500	24	4	patients	patient	NOUN
dpc-500	24	5	with	with	ADP
dpc-500	24	6	pv	pv	NOUN
dpc-500	24	7	in	in	ADP
dpc-500	24	8	iran	iran	PROPN
dpc-500	24	9	appears	appear	VERB
dpc-500	24	10	to	to	PART
dpc-500	24	11	be	be	AUX
dpc-500	24	12	increasing	increase	VERB
dpc-500	24	13	,	,	PUNCT
dpc-500	24	14	and	and	CCONJ
dpc-500	24	15	little	little	ADJ
dpc-500	24	16	information	information	NOUN
dpc-500	24	17	is	be	AUX
dpc-500	24	18	available	available	ADJ
dpc-500	24	19	with	with	ADP
dpc-500	24	20	regard	regard	NOUN
dpc-500	24	21	to	to	ADP
dpc-500	24	22	the	the	DET
dpc-500	24	23	role	role	NOUN
dpc-500	24	24	of	of	ADP
dpc-500	24	25	hsv1/2	hsv1/2	PRON
dpc-500	24	26	 	 	SPACE
dpc-500	24	27	and	and	CCONJ
dpc-500	24	28	cmv	cmv	NOUN
dpc-500	24	29	in	in	ADP
dpc-500	24	30	triggering	trigger	VERB
dpc-500	24	31	pv	pv	INTJ
dpc-500	24	32	among	among	ADP
dpc-500	24	33	the	the	DET
dpc-500	24	34	iranian	iranian	ADJ
dpc-500	24	35	population	population	NOUN
dpc-500	24	36	.	.	PUNCT
dpc-500	25	1	the	the	DET
dpc-500	25	2	present	present	ADJ
dpc-500	25	3	study	study	NOUN
dpc-500	25	4	aimed	aim	VERB
dpc-500	25	5	to	to	PART
dpc-500	25	6	investigate	investigate	VERB
dpc-500	25	7	the	the	DET
dpc-500	25	8	plausible	plausible	ADJ
dpc-500	25	9	role	role	NOUN
dpc-500	25	10	of	of	ADP
dpc-500	25	11	these	these	DET
dpc-500	25	12	viruses	virus	NOUN
dpc-500	25	13	(	(	PUNCT
dpc-500	25	14	hsv1/2	hsv1/2	NOUN
dpc-500	25	15	 	 	SPACE
dpc-500	25	16	and	and	CCONJ
dpc-500	25	17	cmv	cmv	NOUN
dpc-500	25	18	)	)	PUNCT
dpc-500	25	19	in	in	ADP
dpc-500	25	20	the	the	DET
dpc-500	25	21	exacerbation	exacerbation	NOUN
dpc-500	25	22	of	of	ADP
dpc-500	25	23	pv	pv	NOUN
dpc-500	25	24	using	use	VERB
dpc-500	25	25	serological	serological	ADJ
dpc-500	25	26	and	and	CCONJ
dpc-500	25	27	molecular	molecular	ADJ
dpc-500	25	28	methods	method	NOUN
dpc-500	25	29	.	.	PUNCT
dpc-500	26	1	materials	material	NOUN
dpc-500	26	2	and	and	CCONJ
dpc-500	26	3	methods	method	NOUN
dpc-500	26	4	disease	disease	NOUN
dpc-500	26	5	definitions	definition	VERB
dpc-500	26	6	in	in	ADP
dpc-500	26	7	pv	pv	NOUN
dpc-500	26	8	patients	patient	NOUN
dpc-500	26	9	pv	pv	PRON
dpc-500	26	10	patients	patient	NOUN
dpc-500	26	11	were	be	AUX
dpc-500	26	12	categorized	categorize	VERB
dpc-500	26	13	as	as	SCONJ
dpc-500	26	14	follows	follow	VERB
dpc-500	26	15	:	:	PUNCT
dpc-500	26	16	relapse	relapse	NOUN
dpc-500	26	17	(	(	PUNCT
dpc-500	26	18	development	development	NOUN
dpc-500	26	19	of	of	ADP
dpc-500	26	20	more	more	ADJ
dpc-500	26	21	than	than	ADP
dpc-500	26	22	 	 	SPACE
dpc-500	26	23	3	3	NUM
dpc-500	26	24	 	 	SPACE
dpc-500	26	25	new	new	ADJ
dpc-500	26	26	lesions	lesion	NOUN
dpc-500	26	27	/	/	SYM
dpc-500	26	28	month	month	NOUN
dpc-500	26	29	that	that	PRON
dpc-500	26	30	do	do	AUX
dpc-500	26	31	not	not	PART
dpc-500	26	32	heal	heal	VERB
dpc-500	26	33	within	within	ADP
dpc-500	26	34	a	a	DET
dpc-500	26	35	week	week	NOUN
dpc-500	26	36	without	without	ADP
dpc-500	26	37	treatment	treatment	NOUN
dpc-500	26	38	,	,	PUNCT
dpc-500	26	39	or	or	CCONJ
dpc-500	26	40	development	development	NOUN
dpc-500	26	41	of	of	ADP
dpc-500	26	42	established	establish	VERB
dpc-500	26	43	lesions	lesion	NOUN
dpc-500	26	44	in	in	ADP
dpc-500	26	45	a	a	DET
dpc-500	26	46	patient	patient	NOUN
dpc-500	26	47	whose	whose	DET
dpc-500	26	48	disease	disease	NOUN
dpc-500	26	49	was	be	AUX
dpc-500	26	50	controlled	control	VERB
dpc-500	26	51	)	)	PUNCT
dpc-500	26	52	and	and	CCONJ
dpc-500	26	53	complete	complete	ADJ
dpc-500	26	54	remission	remission	NOUN
dpc-500	26	55	(	(	PUNCT
dpc-500	26	56	absence	absence	NOUN
dpc-500	26	57	of	of	ADP
dpc-500	26	58	new	new	ADJ
dpc-500	26	59	or	or	CCONJ
dpc-500	26	60	established	establish	VERB
dpc-500	26	61	lesions	lesion	NOUN
dpc-500	26	62	in	in	ADP
dpc-500	26	63	a	a	DET
dpc-500	26	64	patient	patient	NOUN
dpc-500	26	65	whose	whose	DET
dpc-500	26	66	all	all	ADV
dpc-500	26	67	-	-	PUNCT
dpc-500	26	68	systemic	systemic	ADJ
dpc-500	26	69	therapy	therapy	NOUN
dpc-500	26	70	is	be	AUX
dpc-500	26	71	discontinued	discontinue	VERB
dpc-500	26	72	for	for	ADP
dpc-500	26	73	≥2	≥2	NUM
dpc-500	26	74	 	 	SPACE
dpc-500	26	75	months	month	NOUN
dpc-500	26	76	,	,	PUNCT
dpc-500	26	77	or	or	CCONJ
dpc-500	26	78	while	while	SCONJ
dpc-500	26	79	the	the	DET
dpc-500	26	80	patient	patient	NOUN
dpc-500	26	81	is	be	AUX
dpc-500	26	82	receiving	receive	VERB
dpc-500	26	83	minimal	minimal	ADJ
dpc-500	26	84	therapy	therapy	NOUN
dpc-500	26	85	)	)	PUNCT
dpc-500	27	1	[	[	X
dpc-500	27	2	23	23	NUM
dpc-500	27	3	]	]	PUNCT
dpc-500	27	4	.	.	PUNCT
dpc-500	28	1	scoring	scoring	NOUN
dpc-500	28	2	of	of	ADP
dpc-500	28	3	disease	disease	NOUN
dpc-500	28	4	was	be	AUX
dpc-500	28	5	recorded	record	VERB
dpc-500	28	6	based	base	VERB
dpc-500	28	7	on	on	ADP
dpc-500	28	8	the	the	DET
dpc-500	28	9	pemphigus	pemphigus	PROPN
dpc-500	28	10	disease	disease	PROPN
dpc-500	28	11	area	area	PROPN
dpc-500	28	12	index	index	PROPN
dpc-500	28	13	.	.	PUNCT
dpc-500	29	1	study	study	NOUN
dpc-500	29	2	population	population	NOUN
dpc-500	29	3	sixty	sixty	NUM
dpc-500	29	4	patients	patient	NOUN
dpc-500	29	5	with	with	ADP
dpc-500	29	6	pv	pv	PROPN
dpc-500	29	7	(	(	PUNCT
dpc-500	29	8	27	27	NUM
dpc-500	29	9	 	 	SPACE
dpc-500	29	10	male	male	NOUN
dpc-500	29	11	,	,	PUNCT
dpc-500	29	12	33	33	NUM
dpc-500	29	13	 	 	SPACE
dpc-500	29	14	female	female	NOUN
dpc-500	29	15	;	;	PUNCT
dpc-500	29	16	mean	mean	VERB
dpc-500	29	17	age	age	NOUN
dpc-500	29	18	 	 	SPACE
dpc-500	29	19	46.3	46.3	NUM
dpc-500	29	20	 	 	SPACE
dpc-500	29	21	±	±	NUM
dpc-500	29	22	12.7	12.7	NUM
dpc-500	29	23	 	 	SPACE
dpc-500	29	24	years	year	NOUN
dpc-500	29	25	)	)	PUNCT
dpc-500	29	26	were	be	AUX
dpc-500	29	27	recruited	recruit	VERB
dpc-500	29	28	for	for	ADP
dpc-500	29	29	the	the	DET
dpc-500	29	30	purpose	purpose	NOUN
dpc-500	29	31	of	of	ADP
dpc-500	29	32	this	this	DET
dpc-500	29	33	case	case	NOUN
dpc-500	29	34	-	-	PUNCT
dpc-500	29	35	control	control	NOUN
dpc-500	29	36	study	study	NOUN
dpc-500	29	37	.	.	PUNCT
dpc-500	30	1	patients	patient	NOUN
dpc-500	30	2	were	be	AUX
dpc-500	30	3	selected	select	VERB
dpc-500	30	4	among	among	ADP
dpc-500	30	5	inpatients	inpatient	NOUN
dpc-500	30	6	and	and	CCONJ
dpc-500	30	7	outpatients	outpatient	NOUN
dpc-500	30	8	who	who	PRON
dpc-500	30	9	were	be	AUX
dpc-500	30	10	referred	refer	VERB
dpc-500	30	11	to	to	ADP
dpc-500	30	12	the	the	DET
dpc-500	30	13	pemphigus	pemphigus	PROPN
dpc-500	30	14	clinic	clinic	PROPN
dpc-500	30	15	of	of	ADP
dpc-500	30	16	razi	razi	PROPN
dpc-500	30	17	hospital	hospital	PROPN
dpc-500	30	18	(	(	PUNCT
dpc-500	30	19	tehran	tehran	PROPN
dpc-500	30	20	,	,	PUNCT
dpc-500	30	21	iran	iran	PROPN
dpc-500	30	22	)	)	PUNCT
dpc-500	30	23	.	.	PUNCT
dpc-500	31	1	the	the	DET
dpc-500	31	2	diagnosis	diagnosis	NOUN
dpc-500	31	3	of	of	ADP
dpc-500	31	4	pemphigus	pemphigus	NOUN
dpc-500	31	5	had	have	AUX
dpc-500	31	6	been	be	AUX
dpc-500	31	7	confirmed	confirm	VERB
dpc-500	31	8	by	by	ADP
dpc-500	31	9	histology	histology	NOUN
dpc-500	31	10	and	and	CCONJ
dpc-500	31	11	direct	direct	ADJ
dpc-500	31	12	immunofluorescence	immunofluorescence	NOUN
dpc-500	31	13	.	.	PUNCT
dpc-500	32	1	among	among	ADP
dpc-500	32	2	patient	patient	ADJ
dpc-500	32	3	subjects	subject	NOUN
dpc-500	32	4	,	,	PUNCT
dpc-500	32	5	30	30	NUM
dpc-500	32	6	 	 	SPACE
dpc-500	32	7	were	be	AUX
dpc-500	32	8	in	in	ADP
dpc-500	32	9	complete	complete	ADJ
dpc-500	32	10	remission	remission	NOUN
dpc-500	32	11	as	as	ADP
dpc-500	32	12	in	in	ADP
dpc-500	32	13	the	the	DET
dpc-500	32	14	control	control	NOUN
dpc-500	32	15	group	group	NOUN
dpc-500	32	16	,	,	PUNCT
dpc-500	32	17	whereas	whereas	SCONJ
dpc-500	32	18	the	the	DET
dpc-500	32	19	rest	rest	NOUN
dpc-500	32	20	(	(	PUNCT
dpc-500	32	21	n	n	NOUN
dpc-500	32	22	=	=	SYM
dpc-500	32	23	30	30	NUM
dpc-500	32	24	)	)	PUNCT
dpc-500	32	25	were	be	AUX
dpc-500	32	26	in	in	ADP
dpc-500	32	27	relapse	relapse	NOUN
dpc-500	32	28	as	as	ADP
dpc-500	32	29	in	in	ADP
dpc-500	32	30	the	the	DET
dpc-500	32	31	case	case	NOUN
dpc-500	32	32	group	group	NOUN
dpc-500	32	33	.	.	PUNCT
dpc-500	33	1	none	none	NOUN
dpc-500	33	2	of	of	ADP
dpc-500	33	3	the	the	DET
dpc-500	33	4	patients	patient	NOUN
dpc-500	33	5	had	have	VERB
dpc-500	33	6	overt	overt	ADJ
dpc-500	33	7	labial	labial	ADJ
dpc-500	33	8	herpetic	herpetic	ADJ
dpc-500	33	9	lesions	lesion	NOUN
dpc-500	33	10	at	at	ADP
dpc-500	33	11	the	the	DET
dpc-500	33	12	time	time	NOUN
dpc-500	33	13	of	of	ADP
dpc-500	33	14	sampling	sample	VERB
dpc-500	33	15	.	.	PUNCT
dpc-500	34	1	all	all	DET
dpc-500	34	2	study	study	NOUN
dpc-500	34	3	participants	participant	NOUN
dpc-500	34	4	introduction	introduction	NOUN
dpc-500	34	5	pemphigus	pemphigus	NOUN
dpc-500	34	6	disease	disease	NOUN
dpc-500	34	7	is	be	AUX
dpc-500	34	8	an	an	DET
dpc-500	34	9	autoimmune	autoimmune	ADJ
dpc-500	34	10	disease	disease	NOUN
dpc-500	34	11	that	that	PRON
dpc-500	34	12	is	be	AUX
dpc-500	34	13	characterized	characterize	VERB
dpc-500	34	14	by	by	ADP
dpc-500	34	15	secretion	secretion	NOUN
dpc-500	34	16	of	of	ADP
dpc-500	34	17	autoantibodies	autoantibody	NOUN
dpc-500	34	18	that	that	PRON
dpc-500	34	19	act	act	VERB
dpc-500	34	20	against	against	ADP
dpc-500	34	21	surface	surface	NOUN
dpc-500	34	22	glycoproteins	glycoprotein	NOUN
dpc-500	34	23	of	of	ADP
dpc-500	34	24	epithelial	epithelial	ADJ
dpc-500	34	25	cells	cell	NOUN
dpc-500	34	26	[	[	X
dpc-500	34	27	1	1	NUM
dpc-500	34	28	]	]	PUNCT
dpc-500	34	29	.	.	PUNCT
dpc-500	35	1	the	the	DET
dpc-500	35	2	immunological	immunological	ADJ
dpc-500	35	3	basis	basis	NOUN
dpc-500	35	4	for	for	ADP
dpc-500	35	5	pemphigus	pemphigus	NOUN
dpc-500	35	6	disease	disease	NOUN
dpc-500	35	7	includes	include	VERB
dpc-500	35	8	autoantibodies	autoantibody	NOUN
dpc-500	35	9	targeted	target	VERB
dpc-500	35	10	against	against	ADP
dpc-500	35	11	keratinocyte	keratinocyte	NOUN
dpc-500	35	12	surface	surface	NOUN
dpc-500	35	13	antigens	antigen	NOUN
dpc-500	35	14	desmoglein1	desmoglein1	VERB
dpc-500	35	15	 	 	SPACE
dpc-500	35	16	and	and	CCONJ
dpc-500	35	17	desmoglein3	desmoglein3	NOUN
dpc-500	35	18	(	(	PUNCT
dpc-500	35	19	dsg1	dsg1	NOUN
dpc-500	35	20	,	,	PUNCT
dpc-500	35	21	dsg3	dsg3	PROPN
dpc-500	35	22	)	)	PUNCT
dpc-500	36	1	[	[	X
dpc-500	36	2	2	2	NUM
dpc-500	36	3	]	]	PUNCT
dpc-500	36	4	.	.	PUNCT
dpc-500	37	1	these	these	DET
dpc-500	37	2	proteins	protein	NOUN
dpc-500	37	3	are	be	AUX
dpc-500	37	4	primarily	primarily	ADV
dpc-500	37	5	involved	involve	VERB
dpc-500	37	6	in	in	ADP
dpc-500	37	7	intercellular	intercellular	ADJ
dpc-500	37	8	cell	cell	NOUN
dpc-500	37	9	-	-	PUNCT
dpc-500	37	10	to	to	ADP
dpc-500	37	11	-	-	PUNCT
dpc-500	37	12	cell	cell	NOUN
dpc-500	37	13	adhesion	adhesion	NOUN
dpc-500	37	14	structures	structure	NOUN
dpc-500	37	15	.	.	PUNCT
dpc-500	38	1	pemphigus	pemphigus	PROPN
dpc-500	38	2	vulgaris	vulgaris	NOUN
dpc-500	38	3	(	(	PUNCT
dpc-500	38	4	pv	pv	NOUN
dpc-500	38	5	)	)	PUNCT
dpc-500	38	6	is	be	AUX
dpc-500	38	7	a	a	DET
dpc-500	38	8	common	common	ADJ
dpc-500	38	9	type	type	NOUN
dpc-500	38	10	of	of	ADP
dpc-500	38	11	pemphigus	pemphigus	NOUN
dpc-500	38	12	disease	disease	NOUN
dpc-500	38	13	with	with	ADP
dpc-500	38	14	painful	painful	ADJ
dpc-500	38	15	blistering	blistering	NOUN
dpc-500	38	16	on	on	ADP
dpc-500	38	17	the	the	DET
dpc-500	38	18	skin	skin	NOUN
dpc-500	38	19	and	and	CCONJ
dpc-500	38	20	mucous	mucous	ADJ
dpc-500	38	21	membranes	membrane	NOUN
dpc-500	38	22	[	[	X
dpc-500	38	23	3	3	NUM
dpc-500	38	24	]	]	PUNCT
dpc-500	38	25	.	.	PUNCT
dpc-500	39	1	overall	overall	ADV
dpc-500	39	2	,	,	PUNCT
dpc-500	39	3	the	the	DET
dpc-500	39	4	close	close	ADJ
dpc-500	39	5	link	link	NOUN
dpc-500	39	6	between	between	ADP
dpc-500	39	7	autoimmune	autoimmune	ADJ
dpc-500	39	8	diseases	disease	NOUN
dpc-500	39	9	and	and	CCONJ
dpc-500	39	10	both	both	CCONJ
dpc-500	39	11	endogenous	endogenous	ADJ
dpc-500	39	12	(	(	PUNCT
dpc-500	39	13	genetic	genetic	ADJ
dpc-500	39	14	)	)	PUNCT
dpc-500	39	15	and	and	CCONJ
dpc-500	39	16	exogenous	exogenous	ADJ
dpc-500	39	17	(	(	PUNCT
dpc-500	39	18	environmental	environmental	ADJ
dpc-500	39	19	)	)	PUNCT
dpc-500	39	20	factors	factor	NOUN
dpc-500	39	21	has	have	AUX
dpc-500	39	22	been	be	AUX
dpc-500	39	23	clearly	clearly	ADV
dpc-500	39	24	understood	understand	VERB
dpc-500	39	25	.	.	PUNCT
dpc-500	40	1	exogenous	exogenous	ADJ
dpc-500	40	2	factors	factor	NOUN
dpc-500	40	3	include	include	VERB
dpc-500	40	4	thiol	thiol	ADJ
dpc-500	40	5	drugs	drug	NOUN
dpc-500	40	6	,	,	PUNCT
dpc-500	40	7	physical	physical	ADJ
dpc-500	40	8	trauma	trauma	NOUN
dpc-500	40	9	such	such	ADJ
dpc-500	40	10	as	as	ADP
dpc-500	40	11	burn	burn	NOUN
dpc-500	40	12	,	,	PUNCT
dpc-500	40	13	ultraviolet	ultraviolet	ADJ
dpc-500	40	14	exposure	exposure	NOUN
dpc-500	40	15	,	,	PUNCT
dpc-500	40	16	x	x	NOUN
dpc-500	40	17	-	-	NOUN
dpc-500	40	18	ray	ray	NOUN
dpc-500	40	19	,	,	PUNCT
dpc-500	40	20	neoplasm	neoplasm	NOUN
dpc-500	40	21	,	,	PUNCT
dpc-500	40	22	hormones	hormone	NOUN
dpc-500	40	23	and	and	CCONJ
dpc-500	40	24	pregnancy	pregnancy	NOUN
dpc-500	40	25	,	,	PUNCT
dpc-500	40	26	nutritional	nutritional	ADJ
dpc-500	40	27	factors	factor	NOUN
dpc-500	40	28	,	,	PUNCT
dpc-500	40	29	and	and	CCONJ
dpc-500	40	30	emotional	emotional	ADJ
dpc-500	40	31	stress	stress	NOUN
dpc-500	40	32	[	[	X
dpc-500	40	33	4	4	NUM
dpc-500	40	34	-	-	SYM
dpc-500	40	35	7	7	NUM
dpc-500	40	36	]	]	PUNCT
dpc-500	40	37	.	.	PUNCT
dpc-500	41	1	among	among	ADP
dpc-500	41	2	exogenous	exogenous	ADJ
dpc-500	41	3	etiologies	etiology	NOUN
dpc-500	41	4	,	,	PUNCT
dpc-500	41	5	the	the	DET
dpc-500	41	6	critical	critical	ADJ
dpc-500	41	7	role	role	NOUN
dpc-500	41	8	of	of	ADP
dpc-500	41	9	microbial	microbial	ADJ
dpc-500	41	10	agents	agent	NOUN
dpc-500	41	11	such	such	ADJ
dpc-500	41	12	as	as	ADP
dpc-500	41	13	viruses	virus	NOUN
dpc-500	41	14	in	in	ADP
dpc-500	41	15	triggering	trigger	VERB
dpc-500	41	16	and	and	CCONJ
dpc-500	41	17	flaring	flaring	ADJ
dpc-500	41	18	autoimmune	autoimmune	ADJ
dpc-500	41	19	conditions	condition	NOUN
dpc-500	41	20	has	have	AUX
dpc-500	41	21	been	be	AUX
dpc-500	41	22	recently	recently	ADV
dpc-500	41	23	discovered	discover	VERB
dpc-500	41	24	.	.	PUNCT
dpc-500	42	1	in	in	ADP
dpc-500	42	2	this	this	DET
dpc-500	42	3	regard	regard	NOUN
dpc-500	42	4	,	,	PUNCT
dpc-500	42	5	the	the	DET
dpc-500	42	6	causative	causative	ADJ
dpc-500	42	7	role	role	NOUN
dpc-500	42	8	of	of	ADP
dpc-500	42	9	herpesviruses	herpesviruse	NOUN
dpc-500	42	10	(	(	PUNCT
dpc-500	42	11	hsvs	hsvs	NOUN
dpc-500	42	12	)	)	PUNCT
dpc-500	42	13	as	as	ADP
dpc-500	42	14	the	the	DET
dpc-500	42	15	most	most	ADV
dpc-500	42	16	important	important	ADJ
dpc-500	42	17	human	human	ADJ
dpc-500	42	18	pathogens	pathogen	NOUN
dpc-500	42	19	in	in	ADP
dpc-500	42	20	the	the	DET
dpc-500	42	21	pathogenesis	pathogenesis	NOUN
dpc-500	42	22	of	of	ADP
dpc-500	42	23	pv	pv	NOUN
dpc-500	42	24	has	have	AUX
dpc-500	42	25	been	be	AUX
dpc-500	42	26	recently	recently	ADV
dpc-500	42	27	suggested	suggest	VERB
dpc-500	42	28	[	[	X
dpc-500	42	29	8	8	NUM
dpc-500	42	30	]	]	PUNCT
dpc-500	42	31	.	.	PUNCT
dpc-500	43	1	thus	thus	ADV
dpc-500	43	2	,	,	PUNCT
dpc-500	43	3	efforts	effort	NOUN
dpc-500	43	4	have	have	AUX
dpc-500	43	5	been	be	AUX
dpc-500	43	6	made	make	VERB
dpc-500	43	7	to	to	PART
dpc-500	43	8	clarify	clarify	VERB
dpc-500	43	9	viral	viral	ADJ
dpc-500	43	10	etiologies	etiology	NOUN
dpc-500	43	11	for	for	ADP
dpc-500	43	12	pv	pv	ADV
dpc-500	43	13	and	and	CCONJ
dpc-500	43	14	in	in	ADP
dpc-500	43	15	this	this	DET
dpc-500	43	16	way	way	NOUN
dpc-500	43	17	the	the	DET
dpc-500	43	18	role	role	NOUN
dpc-500	43	19	of	of	ADP
dpc-500	43	20	hsvs	hsvs	NOUN
dpc-500	43	21	and	and	CCONJ
dpc-500	43	22	cytomegalovirus	cytomegalovirus	NOUN
dpc-500	43	23	(	(	PUNCT
dpc-500	43	24	cmv	cmv	NOUN
dpc-500	43	25	)	)	PUNCT
dpc-500	43	26	is	be	AUX
dpc-500	43	27	taken	take	VERB
dpc-500	43	28	into	into	ADP
dpc-500	43	29	consideration	consideration	NOUN
dpc-500	43	30	[	[	X
dpc-500	43	31	9,10	9,10	NUM
dpc-500	43	32	]	]	X
dpc-500	43	33	.	.	PUNCT
dpc-500	44	1	the	the	DET
dpc-500	44	2	main	main	ADJ
dpc-500	44	3	common	common	ADJ
dpc-500	44	4	features	feature	NOUN
dpc-500	44	5	of	of	ADP
dpc-500	44	6	both	both	DET
dpc-500	44	7	pointed	point	VERB
dpc-500	44	8	viruses	virus	NOUN
dpc-500	44	9	include	include	VERB
dpc-500	44	10	their	their	PRON
dpc-500	44	11	ability	ability	NOUN
dpc-500	44	12	to	to	PART
dpc-500	44	13	survive	survive	VERB
dpc-500	44	14	in	in	ADP
dpc-500	44	15	the	the	DET
dpc-500	44	16	host	host	NOUN
dpc-500	44	17	body	body	NOUN
dpc-500	44	18	for	for	ADP
dpc-500	44	19	a	a	DET
dpc-500	44	20	long	long	ADJ
dpc-500	44	21	time	time	NOUN
dpc-500	44	22	as	as	ADV
dpc-500	44	23	well	well	ADV
dpc-500	44	24	as	as	ADP
dpc-500	44	25	activating	activate	VERB
dpc-500	44	26	periodically	periodically	ADV
dpc-500	44	27	[	[	X
dpc-500	44	28	11	11	NUM
dpc-500	44	29	]	]	PUNCT
dpc-500	44	30	.	.	PUNCT
dpc-500	45	1	the	the	DET
dpc-500	45	2	human	human	ADJ
dpc-500	45	3	hsvs	hsvs	NOUN
dpc-500	45	4	including	include	VERB
dpc-500	45	5	herpesviruses	herpesviruse	NOUN
dpc-500	45	6	 	 	SPACE
dpc-500	45	7	1	1	NUM
dpc-500	45	8	 	 	SPACE
dpc-500	45	9	and	and	CCONJ
dpc-500	45	10	 	 	SPACE
dpc-500	45	11	2	2	NUM
dpc-500	45	12	(	(	PUNCT
dpc-500	45	13	hsv1/2	hsv1/2	NUM
dpc-500	45	14	)	)	PUNCT
dpc-500	45	15	and	and	CCONJ
dpc-500	45	16	cmv	cmv	NOUN
dpc-500	45	17	infect	infect	NOUN
dpc-500	45	18	between	between	ADP
dpc-500	45	19	 	 	SPACE
dpc-500	45	20	60	60	NUM
dpc-500	45	21	%	%	NOUN
dpc-500	45	22	and	and	CCONJ
dpc-500	45	23	 	 	SPACE
dpc-500	45	24	90	90	NUM
dpc-500	45	25	%	%	NOUN
dpc-500	45	26	of	of	ADP
dpc-500	45	27	the	the	DET
dpc-500	45	28	adult	adult	NOUN
dpc-500	45	29	population	population	NOUN
dpc-500	45	30	worldwide	worldwide	ADV
dpc-500	46	1	[	[	X
dpc-500	46	2	12,13	12,13	NUM
dpc-500	46	3	]	]	PUNCT
dpc-500	46	4	.	.	PUNCT
dpc-500	47	1	after	after	ADP
dpc-500	47	2	primary	primary	ADJ
dpc-500	47	3	infection	infection	NOUN
dpc-500	47	4	,	,	PUNCT
dpc-500	47	5	the	the	DET
dpc-500	47	6	virus	virus	NOUN
dpc-500	47	7	establishes	establish	VERB
dpc-500	47	8	lifelong	lifelong	ADJ
dpc-500	47	9	latency	latency	NOUN
dpc-500	47	10	,	,	PUNCT
dpc-500	47	11	with	with	ADP
dpc-500	47	12	periodic	periodic	ADJ
dpc-500	47	13	reactivations	reactivation	NOUN
dpc-500	47	14	that	that	PRON
dpc-500	47	15	are	be	AUX
dpc-500	47	16	effectively	effectively	ADV
dpc-500	47	17	controlled	control	VERB
dpc-500	47	18	by	by	ADP
dpc-500	47	19	a	a	DET
dpc-500	47	20	robust	robust	ADJ
dpc-500	47	21	immune	immune	ADJ
dpc-500	47	22	response	response	NOUN
dpc-500	47	23	in	in	ADP
dpc-500	47	24	most	most	ADV
dpc-500	47	25	infected	infected	ADJ
dpc-500	47	26	individuals	individual	NOUN
dpc-500	47	27	despite	despite	SCONJ
dpc-500	47	28	the	the	DET
dpc-500	47	29	virus	virus	NOUN
dpc-500	47	30	-	-	PUNCT
dpc-500	47	31	producing	produce	VERB
dpc-500	47	32	proteins	protein	NOUN
dpc-500	47	33	that	that	PRON
dpc-500	47	34	interfere	interfere	VERB
dpc-500	47	35	with	with	ADP
dpc-500	47	36	adaptive	adaptive	ADJ
dpc-500	47	37	and	and	CCONJ
dpc-500	47	38	innate	innate	ADJ
dpc-500	47	39	immunity	immunity	NOUN
dpc-500	47	40	.	.	PUNCT
dpc-500	48	1	the	the	DET
dpc-500	48	2	activation	activation	NOUN
dpc-500	48	3	of	of	ADP
dpc-500	48	4	t	t	NOUN
dpc-500	48	5	cells	cell	NOUN
dpc-500	48	6	is	be	AUX
dpc-500	48	7	the	the	DET
dpc-500	48	8	important	important	ADJ
dpc-500	48	9	aspect	aspect	NOUN
dpc-500	48	10	of	of	ADP
dpc-500	48	11	adaptive	adaptive	ADJ
dpc-500	48	12	immunity	immunity	NOUN
dpc-500	48	13	.	.	PUNCT
dpc-500	49	1	tissue	tissue	NOUN
dpc-500	49	2	-	-	PUNCT
dpc-500	49	3	resident	resident	NOUN
dpc-500	49	4	memory	memory	NOUN
dpc-500	49	5	(	(	PUNCT
dpc-500	49	6	trm	trm	PROPN
dpc-500	49	7	)	)	PUNCT
dpc-500	49	8	t	t	NOUN
dpc-500	49	9	cells	cell	NOUN
dpc-500	49	10	are	be	AUX
dpc-500	49	11	a	a	DET
dpc-500	49	12	subtype	subtype	NOUN
dpc-500	49	13	of	of	ADP
dpc-500	49	14	memory	memory	NOUN
dpc-500	49	15	lymphocytes	lymphocyte	NOUN
dpc-500	49	16	that	that	PRON
dpc-500	49	17	enter	enter	VERB
dpc-500	49	18	nonlymphoid	nonlymphoid	ADJ
dpc-500	49	19	tissues	tissue	NOUN
dpc-500	49	20	such	such	ADJ
dpc-500	49	21	as	as	ADP
dpc-500	49	22	skin	skin	NOUN
dpc-500	49	23	and	and	CCONJ
dpc-500	49	24	become	become	VERB
dpc-500	49	25	permanently	permanently	ADV
dpc-500	49	26	established	establish	VERB
dpc-500	49	27	without	without	ADP
dpc-500	49	28	recirculating	recirculating	NOUN
dpc-500	49	29	.	.	PUNCT
dpc-500	50	1	local	local	ADJ
dpc-500	50	2	immune	immune	ADJ
dpc-500	50	3	control	control	NOUN
dpc-500	50	4	of	of	ADP
dpc-500	50	5	viruses	virus	NOUN
dpc-500	50	6	can	can	AUX
dpc-500	50	7	be	be	AUX
dpc-500	50	8	mediated	mediate	VERB
dpc-500	50	9	by	by	ADP
dpc-500	50	10	trm	trm	PROPN
dpc-500	50	11	t	t	PROPN
dpc-500	50	12	cells	cell	NOUN
dpc-500	50	13	through	through	ADP
dpc-500	50	14	direct	direct	ADJ
dpc-500	50	15	killing	killing	NOUN
dpc-500	50	16	of	of	ADP
dpc-500	50	17	infected	infected	ADJ
dpc-500	50	18	cells	cell	NOUN
dpc-500	50	19	and	and	CCONJ
dpc-500	50	20	recruiting	recruit	VERB
dpc-500	50	21	circulating	circulate	VERB
dpc-500	50	22	memory	memory	NOUN
dpc-500	50	23	cd8	cd8	PROPN
dpc-500	50	24	+	+	PROPN
dpc-500	50	25	to	to	ADP
dpc-500	50	26	the	the	DET
dpc-500	50	27	skin	skin	NOUN
dpc-500	50	28	.	.	PUNCT
dpc-500	51	1	also	also	ADV
dpc-500	51	2	,	,	PUNCT
dpc-500	51	3	trm	trm	PROPN
dpc-500	51	4	t	t	PROPN
dpc-500	51	5	cells	cell	NOUN
dpc-500	51	6	maintain	maintain	VERB
dpc-500	51	7	hsv1	hsv1	PROPN
dpc-500	51	8	 	 	SPACE
dpc-500	51	9	latency	latency	NOUN
dpc-500	51	10	by	by	ADP
dpc-500	51	11	secreting	secrete	VERB
dpc-500	51	12	granzyme	granzyme	NOUN
dpc-500	51	13	b	b	PROPN
dpc-500	51	14	,	,	PUNCT
dpc-500	51	15	which	which	PRON
dpc-500	51	16	degrades	degrade	VERB
dpc-500	51	17	the	the	DET
dpc-500	51	18	early	early	ADJ
dpc-500	51	19	protein	protein	NOUN
dpc-500	51	20	icp4	icp4	NOUN
dpc-500	51	21	 	 	SPACE
dpc-500	51	22	that	that	PRON
dpc-500	51	23	is	be	AUX
dpc-500	51	24	important	important	ADJ
dpc-500	51	25	in	in	ADP
dpc-500	51	26	viral	viral	ADJ
dpc-500	51	27	replication	replication	NOUN
dpc-500	51	28	[	[	X
dpc-500	51	29	14,15	14,15	NUM
dpc-500	51	30	]	]	PUNCT
dpc-500	51	31	.	.	PUNCT
dpc-500	52	1	cmv	cmv	NOUN
dpc-500	52	2	positivity	positivity	NOUN
dpc-500	52	3	in	in	ADP
dpc-500	52	4	pv	pv	PROPN
dpc-500	52	5	patients	patient	NOUN
dpc-500	52	6	was	be	AUX
dpc-500	52	7	independent	independent	ADJ
dpc-500	52	8	of	of	ADP
dpc-500	52	9	the	the	DET
dpc-500	52	10	site	site	NOUN
dpc-500	52	11	of	of	ADP
dpc-500	52	12	the	the	DET
dpc-500	52	13	samples	sample	NOUN
dpc-500	52	14	.	.	PUNCT
dpc-500	53	1	using	use	VERB
dpc-500	53	2	the	the	DET
dpc-500	53	3	multivariable	multivariable	ADJ
dpc-500	53	4	linear	linear	PROPN
dpc-500	53	5	regression	regression	NOUN
dpc-500	53	6	model	model	NOUN
dpc-500	53	7	,	,	PUNCT
dpc-500	53	8	the	the	DET
dpc-500	53	9	level	level	NOUN
dpc-500	53	10	of	of	ADP
dpc-500	53	11	cmv	cmv	NOUN
dpc-500	53	12	-	-	PUNCT
dpc-500	53	13	igg	igg	PROPN
dpc-500	53	14	in	in	ADP
dpc-500	53	15	pv	pv	PROPN
dpc-500	53	16	patients	patient	NOUN
dpc-500	53	17	was	be	AUX
dpc-500	53	18	directly	directly	ADV
dpc-500	53	19	affected	affect	VERB
dpc-500	53	20	by	by	ADP
dpc-500	53	21	female	female	ADJ
dpc-500	53	22	sex	sex	NOUN
dpc-500	53	23	and	and	CCONJ
dpc-500	53	24	advanced	advanced	ADJ
dpc-500	53	25	ages	age	NOUN
dpc-500	53	26	.	.	PUNCT
dpc-500	54	1	conclusions	conclusion	NOUN
dpc-500	54	2	:	:	PUNCT
dpc-500	54	3	our	our	PRON
dpc-500	54	4	study	study	NOUN
dpc-500	54	5	could	could	AUX
dpc-500	54	6	not	not	PART
dpc-500	54	7	demonstrate	demonstrate	VERB
dpc-500	54	8	the	the	DET
dpc-500	54	9	role	role	NOUN
dpc-500	54	10	of	of	ADP
dpc-500	54	11	hsv1/2	hsv1/2	PRON
dpc-500	54	12	 	 	SPACE
dpc-500	54	13	and	and	CCONJ
dpc-500	54	14	cmv	cmv	NOUN
dpc-500	54	15	as	as	ADP
dpc-500	54	16	triggering	trigger	VERB
dpc-500	54	17	factors	factor	NOUN
dpc-500	54	18	for	for	ADP
dpc-500	54	19	pv	pv	NOUN
dpc-500	54	20	exacerbation	exacerbation	NOUN
dpc-500	54	21	.	.	PUNCT
dpc-500	55	1	further	further	ADJ
dpc-500	55	2	studies	study	NOUN
dpc-500	55	3	are	be	AUX
dpc-500	55	4	needed	need	VERB
dpc-500	55	5	to	to	PART
dpc-500	55	6	evaluate	evaluate	VERB
dpc-500	55	7	the	the	DET
dpc-500	55	8	potential	potential	ADJ
dpc-500	55	9	role	role	NOUN
dpc-500	55	10	of	of	ADP
dpc-500	55	11	these	these	DET
dpc-500	55	12	viruses	virus	NOUN
dpc-500	55	13	in	in	ADP
dpc-500	55	14	pv	pv	ADJ
dpc-500	55	15	exacerbation	exacerbation	NOUN
dpc-500	55	16	especially	especially	ADV
dpc-500	55	17	considering	consider	VERB
dpc-500	55	18	demographic	demographic	ADJ
dpc-500	55	19	variables	variable	NOUN
dpc-500	55	20	.	.	PUNCT
dpc-500	56	1	abstract	abstract	ADJ
dpc-500	56	2	264	264	NUM
dpc-500	56	3	research	research	NOUN
dpc-500	56	4	|	|	ADV
dpc-500	56	5	dermatol	dermatol	NOUN
dpc-500	56	6	pract	pract	NOUN
dpc-500	56	7	concept	concept	NOUN
dpc-500	57	1	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	57	2	statistical	statistical	ADJ
dpc-500	57	3	analysis	analysis	NOUN
dpc-500	57	4	the	the	DET
dpc-500	57	5	results	result	NOUN
dpc-500	57	6	were	be	AUX
dpc-500	57	7	presented	present	VERB
dpc-500	57	8	as	as	ADP
dpc-500	57	9	mean	mean	NOUN
dpc-500	57	10	±	±	NUM
dpc-500	57	11	standard	standard	ADJ
dpc-500	57	12	deviation	deviation	NOUN
dpc-500	57	13	for	for	ADP
dpc-500	57	14	quantitative	quantitative	ADJ
dpc-500	57	15	variables	variable	NOUN
dpc-500	57	16	and	and	CCONJ
dpc-500	57	17	were	be	AUX
dpc-500	57	18	summarized	summarize	VERB
dpc-500	57	19	by	by	ADP
dpc-500	57	20	absolute	absolute	ADJ
dpc-500	57	21	frequencies	frequency	NOUN
dpc-500	57	22	and	and	CCONJ
dpc-500	57	23	percentages	percentage	NOUN
dpc-500	57	24	for	for	ADP
dpc-500	57	25	categorical	categorical	ADJ
dpc-500	57	26	variables	variable	NOUN
dpc-500	57	27	.	.	PUNCT
dpc-500	58	1	normality	normality	NOUN
dpc-500	58	2	of	of	ADP
dpc-500	58	3	data	datum	NOUN
dpc-500	58	4	was	be	AUX
dpc-500	58	5	analyzed	analyze	VERB
dpc-500	58	6	using	use	VERB
dpc-500	58	7	the	the	DET
dpc-500	58	8	kolmogorov	kolmogorov	ADJ
dpc-500	58	9	-	-	PUNCT
dpc-500	58	10	smirnoff	smirnoff	NOUN
dpc-500	58	11	test	test	NOUN
dpc-500	58	12	.	.	PUNCT
dpc-500	59	1	categorical	categorical	ADJ
dpc-500	59	2	variables	variable	NOUN
dpc-500	59	3	were	be	AUX
dpc-500	59	4	compared	compare	VERB
dpc-500	59	5	using	use	VERB
dpc-500	59	6	chi	chi	ADJ
dpc-500	59	7	-	-	PUNCT
dpc-500	59	8	squared	square	VERB
dpc-500	59	9	test	test	NOUN
dpc-500	59	10	or	or	CCONJ
dpc-500	59	11	fisher	fisher	PROPN
dpc-500	59	12	’s	’s	PART
dpc-500	59	13	exact	exact	ADJ
dpc-500	59	14	test	test	NOUN
dpc-500	59	15	when	when	SCONJ
dpc-500	59	16	more	more	ADJ
dpc-500	59	17	than	than	ADP
dpc-500	59	18	 	 	SPACE
dpc-500	59	19	20	20	NUM
dpc-500	59	20	%	%	NOUN
dpc-500	59	21	of	of	ADP
dpc-500	59	22	cells	cell	NOUN
dpc-500	59	23	with	with	ADP
dpc-500	59	24	an	an	DET
dpc-500	59	25	expected	expect	VERB
dpc-500	59	26	count	count	NOUN
dpc-500	59	27	of	of	ADP
dpc-500	59	28	less	less	ADJ
dpc-500	59	29	than	than	ADP
dpc-500	59	30	 	 	SPACE
dpc-500	59	31	5	5	NUM
dpc-500	59	32	 	 	SPACE
dpc-500	59	33	were	be	AUX
dpc-500	59	34	observed	observe	VERB
dpc-500	59	35	.	.	PUNCT
dpc-500	60	1	quantitative	quantitative	ADJ
dpc-500	60	2	variables	variable	NOUN
dpc-500	60	3	were	be	AUX
dpc-500	60	4	also	also	ADV
dpc-500	60	5	compared	compare	VERB
dpc-500	60	6	with	with	ADP
dpc-500	60	7	t	t	NOUN
dpc-500	60	8	test	test	NOUN
dpc-500	60	9	or	or	CCONJ
dpc-500	60	10	mann	mann	PROPN
dpc-500	60	11	-	-	PUNCT
dpc-500	60	12	whitney	whitney	PROPN
dpc-500	60	13	u	u	PROPN
dpc-500	60	14	test	test	NOUN
dpc-500	60	15	.	.	PUNCT
dpc-500	61	1	the	the	DET
dpc-500	61	2	association	association	NOUN
dpc-500	61	3	between	between	ADP
dpc-500	61	4	quantitative	quantitative	ADJ
dpc-500	61	5	variables	variable	NOUN
dpc-500	61	6	was	be	AUX
dpc-500	61	7	assessed	assess	VERB
dpc-500	61	8	using	use	VERB
dpc-500	61	9	the	the	DET
dpc-500	61	10	pearson	pearson	NOUN
dpc-500	61	11	correlation	correlation	NOUN
dpc-500	61	12	test	test	NOUN
dpc-500	61	13	.	.	PUNCT
dpc-500	62	1	to	to	PART
dpc-500	62	2	determine	determine	VERB
dpc-500	62	3	the	the	DET
dpc-500	62	4	main	main	ADJ
dpc-500	62	5	correlates	correlate	NOUN
dpc-500	62	6	of	of	ADP
dpc-500	62	7	igg	igg	PROPN
dpc-500	62	8	antibodies	antibodie	VERB
dpc-500	62	9	against	against	ADP
dpc-500	62	10	viruses	virus	NOUN
dpc-500	62	11	,	,	PUNCT
dpc-500	62	12	multivariable	multivariable	ADJ
dpc-500	62	13	linear	linear	PROPN
dpc-500	62	14	regression	regression	NOUN
dpc-500	62	15	analysis	analysis	NOUN
dpc-500	62	16	was	be	AUX
dpc-500	62	17	used	use	VERB
dpc-500	62	18	.	.	PUNCT
dpc-500	63	1	for	for	ADP
dpc-500	63	2	the	the	DET
dpc-500	63	3	statistical	statistical	ADJ
dpc-500	63	4	analysis	analysis	NOUN
dpc-500	63	5	,	,	PUNCT
dpc-500	63	6	the	the	DET
dpc-500	63	7	statistical	statistical	ADJ
dpc-500	63	8	software	software	NOUN
dpc-500	63	9	spss	spss	PROPN
dpc-500	63	10	version	version	PROPN
dpc-500	63	11	 	 	SPACE
dpc-500	63	12	16.0	16.0	NUM
dpc-500	63	13	 	 	SPACE
dpc-500	63	14	for	for	ADP
dpc-500	63	15	windows	window	NOUN
dpc-500	63	16	(	(	PUNCT
dpc-500	63	17	spss	spss	PROPN
dpc-500	63	18	inc	inc	PROPN
dpc-500	63	19	.	.	PROPN
dpc-500	63	20	,	,	PUNCT
dpc-500	63	21	chicago	chicago	PROPN
dpc-500	63	22	,	,	PUNCT
dpc-500	63	23	il	il	PROPN
dpc-500	63	24	)	)	PUNCT
dpc-500	63	25	was	be	AUX
dpc-500	63	26	used	use	VERB
dpc-500	63	27	.	.	PUNCT
dpc-500	64	1	p	p	NOUN
dpc-500	64	2	values	value	NOUN
dpc-500	64	3	of	of	ADP
dpc-500	64	4	 	 	SPACE
dpc-500	64	5	0.05	0.05	NUM
dpc-500	64	6	 	 	SPACE
dpc-500	64	7	or	or	CCONJ
dpc-500	64	8	less	less	ADJ
dpc-500	64	9	were	be	AUX
dpc-500	64	10	considered	consider	VERB
dpc-500	64	11	statistically	statistically	ADV
dpc-500	64	12	significant	significant	ADJ
dpc-500	64	13	.	.	PUNCT
dpc-500	65	1	we	we	PRON
dpc-500	65	2	used	use	VERB
dpc-500	65	3	graphpad	graphpad	NOUN
dpc-500	65	4	prism	prism	NOUN
dpc-500	65	5	software	software	NOUN
dpc-500	65	6	(	(	PUNCT
dpc-500	65	7	graphpad	graphpad	NOUN
dpc-500	65	8	software	software	NOUN
dpc-500	65	9	,	,	PUNCT
dpc-500	65	10	la	la	PROPN
dpc-500	65	11	jolla	jolla	PROPN
dpc-500	65	12	,	,	PUNCT
dpc-500	65	13	ca	ca	NOUN
dpc-500	65	14	)	)	PUNCT
dpc-500	65	15	for	for	ADP
dpc-500	65	16	plotting	plot	VERB
dpc-500	65	17	graphs	graph	NOUN
dpc-500	65	18	.	.	PUNCT
dpc-500	66	1	results	result	NOUN
dpc-500	66	2	in	in	ADP
dpc-500	66	3	total	total	ADJ
dpc-500	66	4	,	,	PUNCT
dpc-500	66	5	30	30	NUM
dpc-500	66	6	 	 	SPACE
dpc-500	66	7	patients	patient	NOUN
dpc-500	66	8	with	with	ADP
dpc-500	66	9	the	the	DET
dpc-500	66	10	relapse	relapse	NOUN
dpc-500	66	11	type	type	NOUN
dpc-500	66	12	of	of	ADP
dpc-500	66	13	pv	pv	NOUN
dpc-500	66	14	and	and	CCONJ
dpc-500	66	15	 	 	SPACE
dpc-500	66	16	30	30	NUM
dpc-500	66	17	 	 	SPACE
dpc-500	66	18	patients	patient	NOUN
dpc-500	66	19	with	with	ADP
dpc-500	66	20	the	the	DET
dpc-500	66	21	remission	remission	NOUN
dpc-500	66	22	type	type	NOUN
dpc-500	66	23	were	be	AUX
dpc-500	66	24	assessed	assess	VERB
dpc-500	66	25	.	.	PUNCT
dpc-500	67	1	the	the	DET
dpc-500	67	2	demographic	demographic	ADJ
dpc-500	67	3	and	and	CCONJ
dpc-500	67	4	clinical	clinical	ADJ
dpc-500	67	5	features	feature	NOUN
dpc-500	67	6	of	of	ADP
dpc-500	67	7	patients	patient	NOUN
dpc-500	67	8	are	be	AUX
dpc-500	67	9	presented	present	VERB
dpc-500	67	10	in	in	ADP
dpc-500	67	11	table	table	NOUN
dpc-500	67	12	 	 	SPACE
dpc-500	67	13	1	1	NUM
dpc-500	67	14	.	.	PUNCT
dpc-500	67	15	comparison	comparison	NOUN
dpc-500	67	16	of	of	ADP
dpc-500	67	17	the	the	DET
dpc-500	67	18	baseline	baseline	ADJ
dpc-500	67	19	characteristics	characteristic	NOUN
dpc-500	67	20	of	of	ADP
dpc-500	67	21	the	the	DET
dpc-500	67	22	 	 	SPACE
dpc-500	67	23	2	2	NUM
dpc-500	67	24	 	 	SPACE
dpc-500	67	25	groups	group	NOUN
dpc-500	67	26	(	(	PUNCT
dpc-500	67	27	table	table	NOUN
dpc-500	67	28	 	 	SPACE
dpc-500	67	29	2	2	NUM
dpc-500	67	30	)	)	PUNCT
dpc-500	67	31	showed	show	VERB
dpc-500	67	32	no	no	DET
dpc-500	67	33	difference	difference	NOUN
dpc-500	67	34	in	in	ADP
dpc-500	67	35	gender	gender	NOUN
dpc-500	67	36	,	,	PUNCT
dpc-500	67	37	mean	mean	NOUN
dpc-500	67	38	age	age	NOUN
dpc-500	67	39	,	,	PUNCT
dpc-500	67	40	subtypes	subtype	NOUN
dpc-500	67	41	of	of	ADP
dpc-500	67	42	disease	disease	NOUN
dpc-500	67	43	(	(	PUNCT
dpc-500	67	44	mucous	mucous	ADJ
dpc-500	67	45	or	or	CCONJ
dpc-500	67	46	mucocutaneous	mucocutaneous	ADJ
dpc-500	67	47	)	)	PUNCT
dpc-500	67	48	,	,	PUNCT
dpc-500	67	49	or	or	CCONJ
dpc-500	67	50	disease	disease	NOUN
dpc-500	67	51	duration	duration	NOUN
dpc-500	67	52	and	and	CCONJ
dpc-500	67	53	oral	oral	ADJ
dpc-500	67	54	medications	medication	NOUN
dpc-500	67	55	.	.	PUNCT
dpc-500	68	1	regarding	regard	VERB
dpc-500	68	2	medical	medical	ADJ
dpc-500	68	3	history	history	NOUN
dpc-500	68	4	,	,	PUNCT
dpc-500	68	5	hypertension	hypertension	NOUN
dpc-500	68	6	and	and	CCONJ
dpc-500	68	7	hyperlipidemia	hyperlipidemia	NOUN
dpc-500	68	8	were	be	AUX
dpc-500	68	9	more	more	ADV
dpc-500	68	10	prevalent	prevalent	ADJ
dpc-500	68	11	in	in	ADP
dpc-500	68	12	those	those	PRON
dpc-500	68	13	with	with	ADP
dpc-500	68	14	relapse	relapse	NOUN
dpc-500	68	15	pv	pv	ADV
dpc-500	68	16	than	than	ADP
dpc-500	68	17	in	in	ADP
dpc-500	68	18	the	the	DET
dpc-500	68	19	remission	remission	NOUN
dpc-500	68	20	group	group	NOUN
dpc-500	68	21	,	,	PUNCT
dpc-500	68	22	while	while	SCONJ
dpc-500	68	23	no	no	DET
dpc-500	68	24	difference	difference	NOUN
dpc-500	68	25	was	be	AUX
dpc-500	68	26	revealed	reveal	VERB
dpc-500	68	27	in	in	ADP
dpc-500	68	28	other	other	ADJ
dpc-500	68	29	underlying	underlying	ADJ
dpc-500	68	30	comorbidities	comorbiditie	NOUN
dpc-500	68	31	including	include	VERB
dpc-500	68	32	diabetes	diabetes	NOUN
dpc-500	68	33	mellitus	mellitus	NOUN
dpc-500	68	34	,	,	PUNCT
dpc-500	68	35	history	history	NOUN
dpc-500	68	36	of	of	ADP
dpc-500	68	37	smoking	smoking	NOUN
dpc-500	68	38	,	,	PUNCT
dpc-500	68	39	coronary	coronary	ADJ
dpc-500	68	40	artery	artery	NOUN
dpc-500	68	41	disease	disease	NOUN
dpc-500	68	42	,	,	PUNCT
dpc-500	68	43	or	or	CCONJ
dpc-500	68	44	thyroid	thyroid	NOUN
dpc-500	68	45	abnormalities	abnormality	NOUN
dpc-500	68	46	.	.	PUNCT
dpc-500	69	1	with	with	ADP
dpc-500	69	2	regard	regard	NOUN
dpc-500	69	3	to	to	ADP
dpc-500	69	4	dsg	dsg	ADJ
dpc-500	69	5	-	-	PUNCT
dpc-500	69	6	specific	specific	ADJ
dpc-500	69	7	igg	igg	NOUN
dpc-500	69	8	positivity	positivity	NOUN
dpc-500	69	9	in	in	ADP
dpc-500	69	10	the	the	DET
dpc-500	69	11	relapse	relapse	NOUN
dpc-500	69	12	and	and	CCONJ
dpc-500	69	13	remission	remission	NOUN
dpc-500	69	14	forms	form	NOUN
dpc-500	69	15	of	of	ADP
dpc-500	69	16	pv	pv	NOUN
dpc-500	69	17	,	,	PUNCT
dpc-500	69	18	dsg1	dsg1	NOUN
dpc-500	69	19	-	-	PUNCT
dpc-500	69	20	specific	specific	ADJ
dpc-500	69	21	igg	igg	NOUN
dpc-500	69	22	was	be	AUX
dpc-500	69	23	positive	positive	ADJ
dpc-500	69	24	in	in	ADP
dpc-500	69	25	 	 	SPACE
dpc-500	69	26	56.7	56.7	NUM
dpc-500	69	27	%	%	NOUN
dpc-500	69	28	of	of	ADP
dpc-500	69	29	patients	patient	NOUN
dpc-500	69	30	with	with	ADP
dpc-500	69	31	the	the	DET
dpc-500	69	32	relapse	relapse	NOUN
dpc-500	69	33	form	form	NOUN
dpc-500	69	34	and	and	CCONJ
dpc-500	69	35	in	in	ADP
dpc-500	69	36	 	 	SPACE
dpc-500	69	37	20.0	20.0	NUM
dpc-500	69	38	%	%	NOUN
dpc-500	69	39	of	of	ADP
dpc-500	69	40	those	those	PRON
dpc-500	69	41	with	with	ADP
dpc-500	69	42	the	the	DET
dpc-500	69	43	remission	remission	NOUN
dpc-500	69	44	form	form	NOUN
dpc-500	69	45	,	,	PUNCT
dpc-500	69	46	indicating	indicate	VERB
dpc-500	69	47	a	a	DET
dpc-500	69	48	significant	significant	ADJ
dpc-500	69	49	difference	difference	NOUN
dpc-500	69	50	across	across	ADP
dpc-500	69	51	the	the	DET
dpc-500	69	52	 	 	SPACE
dpc-500	69	53	2	2	NUM
dpc-500	69	54	 	 	SPACE
dpc-500	69	55	groups	group	NOUN
dpc-500	69	56	(	(	PUNCT
dpc-500	69	57	p	p	X
dpc-500	69	58	=	=	NOUN
dpc-500	69	59	0.003	0.003	NUM
dpc-500	69	60	)	)	PUNCT
dpc-500	69	61	,	,	PUNCT
dpc-500	69	62	but	but	CCONJ
dpc-500	69	63	the	the	DET
dpc-500	69	64	rate	rate	NOUN
dpc-500	69	65	of	of	ADP
dpc-500	69	66	positivity	positivity	NOUN
dpc-500	69	67	for	for	ADP
dpc-500	69	68	dsg3	dsg3	NOUN
dpc-500	69	69	-	-	PUNCT
dpc-500	69	70	specific	specific	ADJ
dpc-500	69	71	igg	igg	NOUN
dpc-500	69	72	in	in	ADP
dpc-500	69	73	the	the	DET
dpc-500	69	74	relapse	relapse	NOUN
dpc-500	69	75	and	and	CCONJ
dpc-500	69	76	remission	remission	NOUN
dpc-500	69	77	types	type	NOUN
dpc-500	69	78	was	be	AUX
dpc-500	69	79	 	 	SPACE
dpc-500	69	80	76.7	76.7	NUM
dpc-500	69	81	%	%	NOUN
dpc-500	69	82	and	and	CCONJ
dpc-500	69	83	 	 	SPACE
dpc-500	69	84	63.3	63.3	NUM
dpc-500	69	85	%	%	NOUN
dpc-500	69	86	,	,	PUNCT
dpc-500	69	87	respectively	respectively	ADV
dpc-500	69	88	,	,	PUNCT
dpc-500	69	89	with	with	ADP
dpc-500	69	90	no	no	DET
dpc-500	69	91	significant	significant	ADJ
dpc-500	69	92	difference	difference	NOUN
dpc-500	69	93	(	(	PUNCT
dpc-500	69	94	p	p	NOUN
dpc-500	69	95	=	=	NOUN
dpc-500	69	96	0.260	0.260	NUM
dpc-500	69	97	)	)	PUNCT
dpc-500	69	98	.	.	PUNCT
dpc-500	70	1	the	the	DET
dpc-500	70	2	mean	mean	ADJ
dpc-500	70	3	hsv	hsv	PROPN
dpc-500	70	4	-	-	PUNCT
dpc-500	70	5	igg	igg	PROPN
dpc-500	70	6	in	in	ADP
dpc-500	70	7	the	the	DET
dpc-500	70	8	relapse	relapse	NOUN
dpc-500	70	9	and	and	CCONJ
dpc-500	70	10	remission	remission	NOUN
dpc-500	70	11	groups	group	NOUN
dpc-500	70	12	was	be	AUX
dpc-500	70	13	 	 	SPACE
dpc-500	70	14	154.47	154.47	NUM
dpc-500	70	15	±	±	NUM
dpc-500	70	16	66.80	66.80	NUM
dpc-500	70	17	 	 	SPACE
dpc-500	70	18	and	and	CCONJ
dpc-500	70	19	 	 	SPACE
dpc-500	70	20	151.17	151.17	NUM
dpc-500	70	21	 	 	SPACE
dpc-500	70	22	±	±	NUM
dpc-500	70	23	62.73	62.73	NUM
dpc-500	70	24	,	,	PUNCT
dpc-500	70	25	respectively	respectively	ADV
dpc-500	70	26	,	,	PUNCT
dpc-500	70	27	with	with	ADP
dpc-500	70	28	no	no	DET
dpc-500	70	29	significant	significant	ADJ
dpc-500	70	30	difference	difference	NOUN
dpc-500	70	31	(	(	PUNCT
dpc-500	70	32	p	p	NOUN
dpc-500	70	33	=	=	NOUN
dpc-500	70	34	0.844	0.844	NUM
dpc-500	70	35	)	)	PUNCT
dpc-500	70	36	.	.	PUNCT
dpc-500	71	1	moreover	moreover	ADV
dpc-500	71	2	,	,	PUNCT
dpc-500	71	3	the	the	DET
dpc-500	71	4	mean	mean	ADJ
dpc-500	71	5	cmv	cmv	NOUN
dpc-500	71	6	-	-	PUNCT
dpc-500	71	7	igg	igg	PROPN
dpc-500	71	8	in	in	ADP
dpc-500	71	9	the	the	DET
dpc-500	71	10	subgroups	subgroup	NOUN
dpc-500	71	11	was	be	AUX
dpc-500	71	12	 	 	SPACE
dpc-500	71	13	130.30	130.30	NUM
dpc-500	71	14	 	 	SPACE
dpc-500	71	15	±	±	NOUN
dpc-500	71	16	47.88	47.88	NUM
dpc-500	71	17	 	 	SPACE
dpc-500	71	18	and	and	CCONJ
dpc-500	71	19	 	 	SPACE
dpc-500	71	20	127.93	127.93	NUM
dpc-500	71	21	±	±	NUM
dpc-500	71	22	53.56	53.56	NUM
dpc-500	71	23	,	,	PUNCT
dpc-500	71	24	respectively	respectively	ADV
dpc-500	71	25	,	,	PUNCT
dpc-500	71	26	with	with	ADP
dpc-500	71	27	no	no	DET
dpc-500	71	28	meaningful	meaningful	ADJ
dpc-500	71	29	difference	difference	NOUN
dpc-500	71	30	(	(	PUNCT
dpc-500	71	31	p	p	X
dpc-500	71	32	=	=	NOUN
dpc-500	71	33	0.857	0.857	NUM
dpc-500	71	34	)	)	PUNCT
dpc-500	71	35	.	.	PUNCT
dpc-500	72	1	there	there	PRON
dpc-500	72	2	was	be	VERB
dpc-500	72	3	no	no	DET
dpc-500	72	4	correlation	correlation	NOUN
dpc-500	72	5	between	between	ADP
dpc-500	72	6	prednisolone	prednisolone	PROPN
dpc-500	72	7	dose	dose	PROPN
dpc-500	72	8	and	and	CCONJ
dpc-500	72	9	hsv	hsv	PROPN
dpc-500	72	10	-	-	PUNCT
dpc-500	72	11	igg	igg	PROPN
dpc-500	72	12	(	(	PUNCT
dpc-500	72	13	p	p	NOUN
dpc-500	72	14	=	=	NOUN
dpc-500	72	15	0.373	0.373	NUM
dpc-500	72	16	)	)	PUNCT
dpc-500	72	17	or	or	CCONJ
dpc-500	72	18	cmv	cmv	NOUN
dpc-500	72	19	-	-	PUNCT
dpc-500	72	20	igg	igg	PROPN
dpc-500	72	21	(	(	PUNCT
dpc-500	72	22	p	p	X
dpc-500	72	23	 	 	SPACE
dpc-500	72	24	=	=	NOUN
dpc-500	72	25	0.647	0.647	NUM
dpc-500	72	26	)	)	PUNCT
dpc-500	72	27	.	.	PUNCT
dpc-500	73	1	as	as	SCONJ
dpc-500	73	2	shown	show	VERB
dpc-500	73	3	in	in	ADP
dpc-500	73	4	table	table	NOUN
dpc-500	73	5	 	 	SPACE
dpc-500	73	6	3	3	NUM
dpc-500	73	7	,	,	PUNCT
dpc-500	73	8	hsv	hsv	PROPN
dpc-500	73	9	and	and	CCONJ
dpc-500	73	10	cmv	cmv	NOUN
dpc-500	73	11	positivity	positivity	NOUN
dpc-500	73	12	in	in	ADP
dpc-500	73	13	pv	pv	PROPN
dpc-500	73	14	patients	patient	NOUN
dpc-500	73	15	was	be	AUX
dpc-500	73	16	independent	independent	ADJ
dpc-500	73	17	of	of	ADP
dpc-500	73	18	the	the	DET
dpc-500	73	19	source	source	NOUN
dpc-500	73	20	of	of	ADP
dpc-500	73	21	the	the	DET
dpc-500	73	22	samples	sample	NOUN
dpc-500	73	23	.	.	PUNCT
dpc-500	74	1	gave	give	VERB
dpc-500	74	2	informed	informed	ADJ
dpc-500	74	3	consent	consent	NOUN
dpc-500	74	4	to	to	PART
dpc-500	74	5	provide	provide	VERB
dpc-500	74	6	samples	sample	NOUN
dpc-500	74	7	for	for	ADP
dpc-500	74	8	the	the	DET
dpc-500	74	9	study	study	NOUN
dpc-500	74	10	,	,	PUNCT
dpc-500	74	11	which	which	PRON
dpc-500	74	12	was	be	AUX
dpc-500	74	13	approved	approve	VERB
dpc-500	74	14	by	by	ADP
dpc-500	74	15	the	the	DET
dpc-500	74	16	local	local	ADJ
dpc-500	74	17	research	research	NOUN
dpc-500	74	18	ethics	ethic	NOUN
dpc-500	74	19	committee	committee	PROPN
dpc-500	74	20	of	of	ADP
dpc-500	74	21	tehran	tehran	PROPN
dpc-500	74	22	university	university	PROPN
dpc-500	74	23	of	of	ADP
dpc-500	74	24	medical	medical	PROPN
dpc-500	74	25	sciences	sciences	PROPN
dpc-500	74	26	(	(	PUNCT
dpc-500	74	27	approval	approval	NOUN
dpc-500	74	28	number	number	NOUN
dpc-500	74	29	:	:	PUNCT
dpc-500	74	30	ir.tums.medicine.rec.1395.1017	ir.tums.medicine.rec.1395.1017	NUM
dpc-500	74	31	 	 	SPACE
dpc-500	74	32	and	and	CCONJ
dpc-500	74	33	ir.tums	ir.tum	NOUN
dpc-500	74	34	.	.	PUNCT
dpc-500	75	1	medicine.rec.1395.2472	medicine.rec.1395.2472	X
dpc-500	75	2	)	)	PUNCT
dpc-500	75	3	.	.	PUNCT
dpc-500	76	1	sample	sample	NOUN
dpc-500	76	2	preparation	preparation	NOUN
dpc-500	76	3	for	for	ADP
dpc-500	76	4	viral	viral	ADJ
dpc-500	76	5	detection	detection	NOUN
dpc-500	76	6	and	and	CCONJ
dpc-500	76	7	determination	determination	NOUN
dpc-500	76	8	of	of	ADP
dpc-500	76	9	specific	specific	ADJ
dpc-500	76	10	antibodies	antibody	NOUN
dpc-500	76	11	,	,	PUNCT
dpc-500	76	12	we	we	PRON
dpc-500	76	13	used	use	VERB
dpc-500	76	14	blood	blood	NOUN
dpc-500	76	15	,	,	PUNCT
dpc-500	76	16	skin	skin	NOUN
dpc-500	76	17	biopsy	biopsy	NOUN
dpc-500	76	18	,	,	PUNCT
dpc-500	76	19	and	and	CCONJ
dpc-500	76	20	throat	throat	NOUN
dpc-500	76	21	swab	swab	NOUN
dpc-500	76	22	samples	sample	NOUN
dpc-500	76	23	from	from	ADP
dpc-500	76	24	patients	patient	NOUN
dpc-500	76	25	.	.	PUNCT
dpc-500	77	1	after	after	SCONJ
dpc-500	77	2	patient	patient	ADJ
dpc-500	77	3	consent	consent	NOUN
dpc-500	77	4	forms	form	NOUN
dpc-500	77	5	were	be	AUX
dpc-500	77	6	obtained	obtain	VERB
dpc-500	77	7	,	,	PUNCT
dpc-500	77	8	one	one	NUM
dpc-500	77	9	skin	skin	NOUN
dpc-500	77	10	specimen	speciman	NOUN
dpc-500	77	11	or	or	CCONJ
dpc-500	77	12	mucosal	mucosal	NOUN
dpc-500	77	13	specimens	specimen	NOUN
dpc-500	77	14	were	be	AUX
dpc-500	77	15	obtained	obtain	VERB
dpc-500	77	16	by	by	ADP
dpc-500	77	17	punch	punch	NOUN
dpc-500	77	18	biopsy	biopsy	NOUN
dpc-500	77	19	(	(	PUNCT
dpc-500	77	20	3	3	NUM
dpc-500	77	21	 	 	SPACE
dpc-500	77	22	mm	mm	NOUN
dpc-500	77	23	)	)	PUNCT
dpc-500	77	24	and	and	CCONJ
dpc-500	77	25	blood	blood	NOUN
dpc-500	77	26	samples	sample	NOUN
dpc-500	77	27	were	be	AUX
dpc-500	77	28	taken	take	VERB
dpc-500	77	29	from	from	ADP
dpc-500	77	30	all	all	DET
dpc-500	77	31	patients	patient	NOUN
dpc-500	77	32	.	.	PUNCT
dpc-500	78	1	in	in	ADP
dpc-500	78	2	addition	addition	NOUN
dpc-500	78	3	,	,	PUNCT
dpc-500	78	4	a	a	DET
dpc-500	78	5	sample	sample	NOUN
dpc-500	78	6	from	from	ADP
dpc-500	78	7	the	the	DET
dpc-500	78	8	throat	throat	NOUN
dpc-500	78	9	was	be	AUX
dpc-500	78	10	collected	collect	VERB
dpc-500	78	11	by	by	ADP
dpc-500	78	12	swabbing	swab	VERB
dpc-500	78	13	.	.	PUNCT
dpc-500	79	1	all	all	DET
dpc-500	79	2	samples	sample	NOUN
dpc-500	79	3	were	be	AUX
dpc-500	79	4	transferred	transfer	VERB
dpc-500	79	5	in	in	ADP
dpc-500	79	6	cold	cold	ADJ
dpc-500	79	7	chain	chain	NOUN
dpc-500	79	8	conditions	condition	NOUN
dpc-500	79	9	to	to	ADP
dpc-500	79	10	the	the	DET
dpc-500	79	11	virology	virology	NOUN
dpc-500	79	12	laboratory	laboratory	NOUN
dpc-500	79	13	.	.	PUNCT
dpc-500	80	1	as	as	ADV
dpc-500	80	2	soon	soon	ADV
dpc-500	80	3	as	as	SCONJ
dpc-500	80	4	samples	sample	NOUN
dpc-500	80	5	were	be	AUX
dpc-500	80	6	received	receive	VERB
dpc-500	80	7	,	,	PUNCT
dpc-500	80	8	preparation	preparation	NOUN
dpc-500	80	9	and	and	CCONJ
dpc-500	80	10	storage	storage	NOUN
dpc-500	80	11	were	be	AUX
dpc-500	80	12	carried	carry	VERB
dpc-500	80	13	out	out	ADP
dpc-500	80	14	.	.	PUNCT
dpc-500	81	1	sera	sera	NOUN
dpc-500	81	2	(	(	PUNCT
dpc-500	81	3	for	for	ADP
dpc-500	81	4	serology	serology	NOUN
dpc-500	81	5	)	)	PUNCT
dpc-500	81	6	and	and	CCONJ
dpc-500	81	7	buffy	buffy	PROPN
dpc-500	81	8	coat	coat	NOUN
dpc-500	81	9	(	(	PUNCT
dpc-500	81	10	for	for	ADP
dpc-500	81	11	virus	virus	NOUN
dpc-500	81	12	detection	detection	NOUN
dpc-500	81	13	)	)	PUNCT
dpc-500	81	14	were	be	AUX
dpc-500	81	15	isolated	isolate	VERB
dpc-500	81	16	from	from	ADP
dpc-500	81	17	whole	whole	ADJ
dpc-500	81	18	blood	blood	NOUN
dpc-500	81	19	and	and	CCONJ
dpc-500	81	20	stored	store	VERB
dpc-500	81	21	at	at	ADP
dpc-500	81	22	−20	−20	NOUN
dpc-500	81	23	°	°	ADP
dpc-500	81	24	c	c	NOUN
dpc-500	81	25	.	.	PUNCT
dpc-500	82	1	dna	dna	PROPN
dpc-500	82	2	extraction	extraction	NOUN
dpc-500	82	3	from	from	ADP
dpc-500	82	4	buffy	buffy	PROPN
dpc-500	82	5	coat	coat	NOUN
dpc-500	82	6	,	,	PUNCT
dpc-500	82	7	skin	skin	NOUN
dpc-500	82	8	biopsy	biopsy	NOUN
dpc-500	82	9	,	,	PUNCT
dpc-500	82	10	and	and	CCONJ
dpc-500	82	11	throat	throat	NOUN
dpc-500	82	12	swab	swab	NOUN
dpc-500	82	13	were	be	AUX
dpc-500	82	14	performed	perform	VERB
dpc-500	82	15	using	use	VERB
dpc-500	82	16	dna	dna	PROPN
dpc-500	82	17	isolation	isolation	NOUN
dpc-500	82	18	kit	kit	NOUN
dpc-500	82	19	for	for	ADP
dpc-500	82	20	cells	cell	NOUN
dpc-500	82	21	and	and	CCONJ
dpc-500	82	22	tissues	tissue	NOUN
dpc-500	82	23	according	accord	VERB
dpc-500	82	24	to	to	ADP
dpc-500	82	25	the	the	DET
dpc-500	82	26	manufacturers	manufacturer	NOUN
dpc-500	82	27	’	’	PART
dpc-500	82	28	instructions	instruction	NOUN
dpc-500	82	29	(	(	PUNCT
dpc-500	82	30	roche	roche	PROPN
dpc-500	82	31	,	,	PUNCT
dpc-500	82	32	berlin	berlin	PROPN
dpc-500	82	33	,	,	PUNCT
dpc-500	82	34	germany	germany	PROPN
dpc-500	82	35	)	)	PUNCT
dpc-500	82	36	.	.	PUNCT
dpc-500	83	1	after	after	ADP
dpc-500	83	2	dna	dna	PROPN
dpc-500	83	3	extraction	extraction	NOUN
dpc-500	83	4	,	,	PUNCT
dpc-500	83	5	it	it	PRON
dpc-500	83	6	was	be	AUX
dpc-500	83	7	eluted	elute	VERB
dpc-500	83	8	in	in	ADP
dpc-500	83	9	 	 	SPACE
dpc-500	83	10	50	50	NUM
dpc-500	83	11	µl	µl	NOUN
dpc-500	83	12	of	of	ADP
dpc-500	83	13	buffer	buffer	NOUN
dpc-500	83	14	and	and	CCONJ
dpc-500	83	15	then	then	ADV
dpc-500	83	16	adjusted	adjust	VERB
dpc-500	83	17	to	to	ADP
dpc-500	83	18	a	a	DET
dpc-500	83	19	definitive	definitive	ADJ
dpc-500	83	20	concentration	concentration	NOUN
dpc-500	83	21	of	of	ADP
dpc-500	83	22	 	 	SPACE
dpc-500	83	23	500	500	NUM
dpc-500	83	24	 	 	SPACE
dpc-500	83	25	ng/µl	ng/µl	NUM
dpc-500	83	26	.	.	PUNCT
dpc-500	84	1	virus	virus	NOUN
dpc-500	84	2	-	-	PUNCT
dpc-500	84	3	specific	specific	ADJ
dpc-500	84	4	antibody	antibody	NOUN
dpc-500	84	5	responses	response	NOUN
dpc-500	84	6	hsv1/2and	hsv1/2and	VERB
dpc-500	84	7	cmv	cmv	NOUN
dpc-500	84	8	-	-	PUNCT
dpc-500	84	9	immunoglobulin	immunoglobulin	NOUN
dpc-500	84	10	g	g	PROPN
dpc-500	84	11	(	(	PUNCT
dpc-500	84	12	igg	igg	PROPN
dpc-500	84	13	)	)	PUNCT
dpc-500	84	14	antibodies	antibody	NOUN
dpc-500	84	15	were	be	AUX
dpc-500	84	16	determined	determine	VERB
dpc-500	84	17	using	use	VERB
dpc-500	84	18	enzyme	enzyme	NOUN
dpc-500	84	19	-	-	PUNCT
dpc-500	84	20	linked	link	VERB
dpc-500	84	21	immunosorbent	immunosorbent	NOUN
dpc-500	84	22	assay	assay	PROPN
dpc-500	84	23	(	(	PUNCT
dpc-500	84	24	elisa	elisa	NOUN
dpc-500	84	25	)	)	PUNCT
dpc-500	84	26	.	.	PUNCT
dpc-500	85	1	quantification	quantification	NOUN
dpc-500	85	2	of	of	ADP
dpc-500	85	3	igg	igg	PROPN
dpc-500	85	4	antibodies	antibody	NOUN
dpc-500	85	5	was	be	AUX
dpc-500	85	6	determined	determine	VERB
dpc-500	85	7	by	by	ADP
dpc-500	85	8	standard	standard	ADJ
dpc-500	85	9	curve	curve	NOUN
dpc-500	85	10	as	as	ADP
dpc-500	85	11	ru	ru	NOUN
dpc-500	85	12	/	/	SYM
dpc-500	85	13	ml	ml	NOUN
dpc-500	85	14	according	accord	VERB
dpc-500	85	15	to	to	ADP
dpc-500	85	16	the	the	DET
dpc-500	85	17	manufacturer	manufacturer	NOUN
dpc-500	85	18	(	(	PUNCT
dpc-500	85	19	values	value	NOUN
dpc-500	85	20	greater	great	ADJ
dpc-500	85	21	than	than	ADP
dpc-500	85	22	 	 	SPACE
dpc-500	85	23	22	22	NUM
dpc-500	85	24	 	 	SPACE
dpc-500	85	25	ru	ru	PROPN
dpc-500	85	26	/	/	SYM
dpc-500	85	27	ml	ml	NOUN
dpc-500	85	28	were	be	AUX
dpc-500	85	29	defined	define	VERB
dpc-500	85	30	as	as	ADP
dpc-500	85	31	seropositive	seropositive	ADJ
dpc-500	85	32	)	)	PUNCT
dpc-500	85	33	.	.	PUNCT
dpc-500	86	1	dsg	dsg	ADJ
dpc-500	86	2	-	-	PUNCT
dpc-500	86	3	specific	specific	ADJ
dpc-500	86	4	igg	igg	NOUN
dpc-500	86	5	the	the	DET
dpc-500	86	6	levels	level	NOUN
dpc-500	86	7	of	of	ADP
dpc-500	86	8	autoantibody	autoantibody	ADJ
dpc-500	86	9	to	to	ADP
dpc-500	86	10	dsg1	dsg1	NOUN
dpc-500	86	11	 	 	SPACE
dpc-500	86	12	and	and	CCONJ
dpc-500	86	13	dsg3	dsg3	PROPN
dpc-500	86	14	 	 	SPACE
dpc-500	86	15	were	be	AUX
dpc-500	86	16	measured	measure	VERB
dpc-500	86	17	by	by	ADP
dpc-500	86	18	elisa	elisa	PROPN
dpc-500	86	19	.	.	PUNCT
dpc-500	87	1	the	the	DET
dpc-500	87	2	cutoff	cutoff	NOUN
dpc-500	87	3	values	value	NOUN
dpc-500	87	4	were	be	AUX
dpc-500	87	5	 	 	SPACE
dpc-500	87	6	20	20	NUM
dpc-500	87	7	 	 	SPACE
dpc-500	87	8	u	u	NOUN
dpc-500	87	9	/	/	SYM
dpc-500	87	10	ml	ml	X
dpc-500	87	11	for	for	ADP
dpc-500	87	12	both	both	PRON
dpc-500	87	13	.	.	PUNCT
dpc-500	88	1	determination	determination	NOUN
dpc-500	88	2	of	of	ADP
dpc-500	88	3	viral	viral	ADJ
dpc-500	88	4	load	load	NOUN
dpc-500	88	5	the	the	DET
dpc-500	88	6	absolute	absolute	ADJ
dpc-500	88	7	quantification	quantification	NOUN
dpc-500	88	8	of	of	ADP
dpc-500	88	9	hsv1/2	hsv1/2	PRON
dpc-500	88	10	 	 	SPACE
dpc-500	88	11	and	and	CCONJ
dpc-500	88	12	cmv	cmv	NOUN
dpc-500	88	13	-	-	PUNCT
dpc-500	88	14	specific	specific	ADJ
dpc-500	88	15	dna	dna	NOUN
dpc-500	88	16	was	be	AUX
dpc-500	88	17	performed	perform	VERB
dpc-500	88	18	by	by	ADP
dpc-500	88	19	real	real	ADJ
dpc-500	88	20	-	-	PUNCT
dpc-500	88	21	time	time	NOUN
dpc-500	88	22	polymerase	polymerase	NOUN
dpc-500	88	23	chain	chain	NOUN
dpc-500	88	24	reaction	reaction	NOUN
dpc-500	88	25	(	(	PUNCT
dpc-500	88	26	pcr	pcr	NOUN
dpc-500	88	27	)	)	PUNCT
dpc-500	88	28	using	use	VERB
dpc-500	88	29	the	the	DET
dpc-500	88	30	realstar	realstar	ADJ
dpc-500	88	31	hsv	hsv	PROPN
dpc-500	88	32	pcr	pcr	PROPN
dpc-500	88	33	kit	kit	PROPN
dpc-500	88	34	 	 	SPACE
dpc-500	88	35	1.0	1.0	NUM
dpc-500	88	36	 	 	SPACE
dpc-500	88	37	and	and	CCONJ
dpc-500	88	38	realstar	realstar	ADJ
dpc-500	88	39	cmv	cmv	PROPN
dpc-500	88	40	pcr	pcr	PROPN
dpc-500	88	41	kit	kit	PROPN
dpc-500	88	42	 	 	SPACE
dpc-500	88	43	1.0	1.0	NUM
dpc-500	88	44	,	,	PUNCT
dpc-500	88	45	respectively	respectively	ADV
dpc-500	88	46	(	(	PUNCT
dpc-500	88	47	altona	altona	PROPN
dpc-500	88	48	diagnostics	diagnostic	NOUN
dpc-500	88	49	;	;	PUNCT
dpc-500	88	50	hamburg	hamburg	PROPN
dpc-500	88	51	,	,	PUNCT
dpc-500	88	52	germany	germany	PROPN
dpc-500	88	53	)	)	PUNCT
dpc-500	88	54	.	.	PUNCT
dpc-500	89	1	all	all	DET
dpc-500	89	2	stages	stage	NOUN
dpc-500	89	3	of	of	ADP
dpc-500	89	4	the	the	DET
dpc-500	89	5	amplification	amplification	NOUN
dpc-500	89	6	of	of	ADP
dpc-500	89	7	the	the	DET
dpc-500	89	8	viruses	virus	NOUN
dpc-500	89	9	’	'	PUNCT
dpc-500	89	10	specific	specific	ADJ
dpc-500	89	11	target	target	NOUN
dpc-500	89	12	sequences	sequence	NOUN
dpc-500	89	13	for	for	ADP
dpc-500	89	14	the	the	DET
dpc-500	89	15	detection	detection	NOUN
dpc-500	89	16	and	and	CCONJ
dpc-500	89	17	quantification	quantification	NOUN
dpc-500	89	18	of	of	ADP
dpc-500	89	19	the	the	DET
dpc-500	89	20	amplified	amplify	VERB
dpc-500	89	21	dna	dna	NOUN
dpc-500	89	22	were	be	AUX
dpc-500	89	23	carried	carry	VERB
dpc-500	89	24	out	out	ADP
dpc-500	89	25	according	accord	VERB
dpc-500	89	26	to	to	ADP
dpc-500	89	27	the	the	DET
dpc-500	89	28	manufacturer	manufacturer	NOUN
dpc-500	89	29	’s	’s	PART
dpc-500	89	30	instructions	instruction	NOUN
dpc-500	89	31	.	.	PUNCT
dpc-500	90	1	ten	ten	NUM
dpc-500	90	2	microliters	microliter	NOUN
dpc-500	90	3	of	of	ADP
dpc-500	90	4	the	the	DET
dpc-500	90	5	dna	dna	PROPN
dpc-500	90	6	extracted	extract	VERB
dpc-500	90	7	from	from	ADP
dpc-500	90	8	samples	sample	NOUN
dpc-500	90	9	in	in	ADP
dpc-500	90	10	distilled	distil	VERB
dpc-500	90	11	water	water	NOUN
dpc-500	90	12	,	,	PUNCT
dpc-500	90	13	and	and	CCONJ
dpc-500	90	14	the	the	DET
dpc-500	90	15	 	 	SPACE
dpc-500	90	16	4	4	NUM
dpc-500	90	17	 	 	SPACE
dpc-500	90	18	controls	control	NOUN
dpc-500	90	19	were	be	AUX
dpc-500	90	20	included	include	VERB
dpc-500	90	21	in	in	ADP
dpc-500	90	22	each	each	DET
dpc-500	90	23	experiment	experiment	NOUN
dpc-500	90	24	as	as	ADP
dpc-500	90	25	a	a	DET
dpc-500	90	26	template	template	NOUN
dpc-500	90	27	and	and	CCONJ
dpc-500	90	28	a	a	DET
dpc-500	90	29	negative	negative	ADJ
dpc-500	90	30	control	control	NOUN
dpc-500	90	31	and	and	CCONJ
dpc-500	90	32	quantification	quantification	NOUN
dpc-500	90	33	standards	standard	NOUN
dpc-500	90	34	,	,	PUNCT
dpc-500	90	35	respectively	respectively	ADV
dpc-500	90	36	.	.	PUNCT
dpc-500	91	1	moreover	moreover	ADV
dpc-500	91	2	,	,	PUNCT
dpc-500	91	3	we	we	PRON
dpc-500	91	4	performed	perform	VERB
dpc-500	91	5	internal	internal	ADJ
dpc-500	91	6	control	control	NOUN
dpc-500	91	7	to	to	PART
dpc-500	91	8	identify	identify	VERB
dpc-500	91	9	possible	possible	ADJ
dpc-500	91	10	pcr	pcr	NOUN
dpc-500	91	11	’s	’s	PART
dpc-500	91	12	inhibitor	inhibitor	NOUN
dpc-500	91	13	and	and	CCONJ
dpc-500	91	14	to	to	PART
dpc-500	91	15	confirm	confirm	VERB
dpc-500	91	16	the	the	DET
dpc-500	91	17	reliability	reliability	NOUN
dpc-500	91	18	of	of	ADP
dpc-500	91	19	all	all	DET
dpc-500	91	20	reagents	reagent	NOUN
dpc-500	91	21	of	of	ADP
dpc-500	91	22	the	the	DET
dpc-500	91	23	kit	kit	NOUN
dpc-500	91	24	used	use	VERB
dpc-500	91	25	for	for	ADP
dpc-500	91	26	each	each	DET
dpc-500	91	27	sample	sample	NOUN
dpc-500	91	28	.	.	PUNCT
dpc-500	92	1	finally	finally	ADV
dpc-500	92	2	,	,	PUNCT
dpc-500	92	3	the	the	DET
dpc-500	92	4	concentration	concentration	NOUN
dpc-500	92	5	of	of	ADP
dpc-500	92	6	the	the	DET
dpc-500	92	7	samples	sample	NOUN
dpc-500	92	8	was	be	AUX
dpc-500	92	9	calculated	calculate	VERB
dpc-500	92	10	in	in	ADP
dpc-500	92	11	copies	copy	NOUN
dpc-500	92	12	per	per	ADP
dpc-500	92	13	microliter	microliter	NOUN
dpc-500	92	14	and	and	CCONJ
dpc-500	92	15	copies	copy	NOUN
dpc-500	92	16	per	per	ADP
dpc-500	92	17	milliliter	milliliter	NOUN
dpc-500	92	18	.	.	PUNCT
dpc-500	93	1	research	research	NOUN
dpc-500	93	2	|	|	ADV
dpc-500	93	3	dermatol	dermatol	ADJ
dpc-500	93	4	pract	pract	NOUN
dpc-500	93	5	concept	concept	NOUN
dpc-500	93	6	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	93	7	265	265	NUM
dpc-500	93	8	table	table	NOUN
dpc-500	93	9	1	1	NUM
dpc-500	93	10	.	.	PUNCT
dpc-500	93	11	demographic	demographic	ADJ
dpc-500	93	12	and	and	CCONJ
dpc-500	93	13	clinical	clinical	ADJ
dpc-500	93	14	characteristics	characteristic	NOUN
dpc-500	93	15	of	of	ADP
dpc-500	93	16	pemphigus	pemphigus	ADJ
dpc-500	93	17	vulgaris	vulgaris	NOUN
dpc-500	93	18	patients	patient	NOUN
dpc-500	93	19	i	i	NOUN
dpc-500	93	20	d	d	PROPN
dpc-500	93	21	sex	sex	NOUN
dpc-500	93	22	age	age	NOUN
dpc-500	93	23	(	(	PUNCT
dpc-500	93	24	years	year	NOUN
dpc-500	93	25	)	)	PUNCT
dpc-500	93	26	type	type	NOUN
dpc-500	93	27	duration	duration	NOUN
dpc-500	93	28	(	(	PUNCT
dpc-500	93	29	years	year	NOUN
dpc-500	93	30	)	)	PUNCT
dpc-500	93	31	activation	activation	NOUN
dpc-500	93	32	pdn	pdn	NOUN
dpc-500	93	33	dose	dose	NOUN
dpc-500	93	34	(	(	PUNCT
dpc-500	93	35	mg	mg	PROPN
dpc-500	93	36	/	/	SYM
dpc-500	93	37	d	d	NOUN
dpc-500	93	38	)	)	PUNCT
dpc-500	93	39	drug	drug	NOUN
dpc-500	93	40	history	history	NOUN
dpc-500	93	41	dsg1	dsg1	VERB
dpc-500	93	42	dsg3	dsg3	ADJ
dpc-500	93	43	pdai	pdai	PROPN
dpc-500	93	44	p1	p1	PROPN
dpc-500	93	45	f	f	PROPN
dpc-500	93	46	72	72	NUM
dpc-500	93	47	mcpv	mcpv	NOUN
dpc-500	93	48	2	2	NUM
dpc-500	93	49	relapse	relapse	NOUN
dpc-500	93	50	15	15	NUM
dpc-500	93	51	azathioprine	azathioprine	ADJ
dpc-500	93	52	positive	positive	ADJ
dpc-500	93	53	positive	positive	ADJ
dpc-500	93	54	94	94	NUM
dpc-500	93	55	p2	p2	NOUN
dpc-500	93	56	f	f	PROPN
dpc-500	93	57	41	41	NUM
dpc-500	93	58	mpv	mpv	PROPN
dpc-500	93	59	2.5	2.5	NUM
dpc-500	93	60	remission	remission	NOUN
dpc-500	93	61	5	5	NUM
dpc-500	93	62	azathioprine	azathioprine	ADJ
dpc-500	93	63	negative	negative	ADJ
dpc-500	93	64	positive	positive	ADJ
dpc-500	93	65	0	0	NUM
dpc-500	93	66	p3	p3	PROPN
dpc-500	93	67	f	f	PROPN
dpc-500	93	68	47	47	NUM
dpc-500	93	69	mcpv	mcpv	NOUN
dpc-500	93	70	4	4	NUM
dpc-500	93	71	remission	remission	NOUN
dpc-500	93	72	5	5	NUM
dpc-500	93	73	mycophenolic	mycophenolic	ADV
dpc-500	93	74	acid	acid	NOUN
dpc-500	93	75	,	,	PUNCT
dpc-500	93	76	azathioprine	azathioprine	ADJ
dpc-500	93	77	negative	negative	ADJ
dpc-500	93	78	positive	positive	ADJ
dpc-500	93	79	0	0	NUM
dpc-500	93	80	p4	p4	ADJ
dpc-500	93	81	f	f	PROPN
dpc-500	93	82	48	48	NUM
dpc-500	93	83	mcpv	mcpv	NOUN
dpc-500	93	84	1.5	1.5	NUM
dpc-500	93	85	remission	remission	NOUN
dpc-500	93	86	5	5	NUM
dpc-500	93	87	mycophenolic	mycophenolic	ADV
dpc-500	93	88	acid	acid	ADJ
dpc-500	93	89	negative	negative	ADJ
dpc-500	93	90	positive	positive	ADJ
dpc-500	93	91	0	0	NUM
dpc-500	93	92	p5	p5	ADJ
dpc-500	93	93	f	f	PROPN
dpc-500	93	94	31	31	NUM
dpc-500	93	95	mcpv	mcpv	NOUN
dpc-500	93	96	2	2	NUM
dpc-500	93	97	remission	remission	NOUN
dpc-500	93	98	5	5	NUM
dpc-500	93	99	azathioprine	azathioprine	NOUN
dpc-500	93	100	,	,	PUNCT
dpc-500	93	101	rituximab	rituximab	VERB
dpc-500	93	102	positive	positive	ADJ
dpc-500	93	103	positive	positive	ADJ
dpc-500	93	104	0	0	NUM
dpc-500	93	105	p6	p6	NOUN
dpc-500	93	106	f	f	PROPN
dpc-500	93	107	28	28	NUM
dpc-500	93	108	mcpv	mcpv	NOUN
dpc-500	93	109	5	5	NUM
dpc-500	93	110	relapse	relapse	NOUN
dpc-500	93	111	10	10	NUM
dpc-500	93	112	mycophenolic	mycophenolic	ADJ
dpc-500	93	113	acid	acid	NOUN
dpc-500	93	114	,	,	PUNCT
dpc-500	93	115	azathioprine	azathioprine	ADJ
dpc-500	93	116	positive	positive	ADJ
dpc-500	93	117	positive	positive	ADJ
dpc-500	93	118	12	12	NUM
dpc-500	93	119	p7	p7	NOUN
dpc-500	93	120	m	m	PROPN
dpc-500	93	121	61	61	NUM
dpc-500	93	122	mcpv	mcpv	NOUN
dpc-500	93	123	4	4	NUM
dpc-500	93	124	remission	remission	NOUN
dpc-500	93	125	5	5	NUM
dpc-500	93	126	azathioprine	azathioprine	NOUN
dpc-500	93	127	,	,	PUNCT
dpc-500	93	128	mycophenolic	mycophenolic	ADJ
dpc-500	93	129	acid	acid	NOUN
dpc-500	93	130	,	,	PUNCT
dpc-500	93	131	rituximab	rituximab	NOUN
dpc-500	93	132	,	,	PUNCT
dpc-500	93	133	mtx	mtx	VERB
dpc-500	93	134	negative	negative	ADJ
dpc-500	93	135	positive	positive	ADJ
dpc-500	93	136	0	0	NUM
dpc-500	93	137	p8	p8	PROPN
dpc-500	93	138	m	m	NUM
dpc-500	93	139	67	67	NUM
dpc-500	93	140	mcpv	mcpv	NOUN
dpc-500	93	141	10	10	NUM
dpc-500	93	142	relapse	relapse	NOUN
dpc-500	93	143	30	30	NUM
dpc-500	93	144	cyclophosphamide	cyclophosphamide	NOUN
dpc-500	93	145	,	,	PUNCT
dpc-500	93	146	mycophenolic	mycophenolic	ADJ
dpc-500	93	147	acid	acid	NOUN
dpc-500	93	148	,	,	PUNCT
dpc-500	93	149	rituximab	rituximab	VERB
dpc-500	93	150	negative	negative	ADJ
dpc-500	93	151	positive	positive	ADJ
dpc-500	93	152	34	34	NUM
dpc-500	93	153	p9	p9	PROPN
dpc-500	93	154	f	f	PROPN
dpc-500	93	155	63	63	NUM
dpc-500	93	156	mcpv	mcpv	NOUN
dpc-500	93	157	3.5	3.5	NUM
dpc-500	93	158	remission	remission	NOUN
dpc-500	93	159	0	0	NUM
dpc-500	93	160	mycophenolic	mycophenolic	ADJ
dpc-500	93	161	acid	acid	NOUN
dpc-500	93	162	monotherapy	monotherapy	NOUN
dpc-500	93	163	negative	negative	ADJ
dpc-500	93	164	negative	negative	ADJ
dpc-500	93	165	0	0	PUNCT
dpc-500	93	166	p10	p10	NOUN
dpc-500	93	167	m	m	NOUN
dpc-500	93	168	41	41	NUM
dpc-500	93	169	mcpv	mcpv	NOUN
dpc-500	93	170	3	3	NUM
dpc-500	93	171	remission	remission	NOUN
dpc-500	93	172	0	0	NUM
dpc-500	93	173	mycophenolic	mycophenolic	ADJ
dpc-500	93	174	acid	acid	PROPN
dpc-500	93	175	positive	positive	ADJ
dpc-500	93	176	negative	negative	ADJ
dpc-500	93	177	0	0	NUM
dpc-500	93	178	p11	p11	NOUN
dpc-500	93	179	m	m	VERB
dpc-500	93	180	60	60	NUM
dpc-500	93	181	mcpv	mcpv	NOUN
dpc-500	93	182	2.5	2.5	NUM
dpc-500	93	183	remission	remission	NOUN
dpc-500	93	184	5	5	NUM
dpc-500	94	1	azathioprine	azathioprine	ADJ
dpc-500	94	2	negative	negative	ADJ
dpc-500	94	3	negative	negative	ADJ
dpc-500	94	4	0	0	NUM
dpc-500	94	5	p12	p12	PROPN
dpc-500	94	6	m	m	PROPN
dpc-500	94	7	45	45	NUM
dpc-500	94	8	mcpv	mcpv	ADJ
dpc-500	94	9	7	7	NUM
dpc-500	94	10	remission	remission	NOUN
dpc-500	94	11	5	5	NUM
dpc-500	94	12	mycophenolic	mycophenolic	ADV
dpc-500	94	13	acid	acid	NOUN
dpc-500	94	14	,	,	PUNCT
dpc-500	94	15	azathioprine	azathioprine	ADJ
dpc-500	94	16	negative	negative	ADJ
dpc-500	94	17	negative	negative	ADJ
dpc-500	94	18	0	0	NUM
dpc-500	94	19	p13	p13	PROPN
dpc-500	94	20	m	m	NOUN
dpc-500	94	21	32	32	NUM
dpc-500	94	22	mcpv	mcpv	NOUN
dpc-500	94	23	10	10	NUM
dpc-500	94	24	remission	remission	NOUN
dpc-500	94	25	7.5	7.5	NUM
dpc-500	94	26	azathioprine	azathioprine	ADJ
dpc-500	94	27	negative	negative	ADJ
dpc-500	94	28	positive	positive	ADJ
dpc-500	94	29	0	0	NUM
dpc-500	94	30	p14	p14	NOUN
dpc-500	94	31	m	m	VERB
dpc-500	94	32	41	41	NUM
dpc-500	94	33	mcpv	mcpv	NOUN
dpc-500	94	34	1.5	1.5	NUM
dpc-500	94	35	remission	remission	NOUN
dpc-500	94	36	5	5	NUM
dpc-500	94	37	azathioprine	azathioprine	NOUN
dpc-500	94	38	,	,	PUNCT
dpc-500	94	39	rituximab	rituximab	VERB
dpc-500	94	40	negative	negative	ADJ
dpc-500	94	41	negative	negative	ADJ
dpc-500	94	42	0	0	NUM
dpc-500	94	43	p15	p15	PROPN
dpc-500	94	44	m	m	NUM
dpc-500	94	45	38	38	NUM
dpc-500	94	46	mcpv	mcpv	NOUN
dpc-500	94	47	4	4	NUM
dpc-500	94	48	remission	remission	NOUN
dpc-500	94	49	10	10	NUM
dpc-500	94	50	azathioprine	azathioprine	NOUN
dpc-500	94	51	,	,	PUNCT
dpc-500	94	52	mycophenolic	mycophenolic	ADJ
dpc-500	94	53	acid	acid	NOUN
dpc-500	94	54	,	,	PUNCT
dpc-500	94	55	rituximab	rituximab	VERB
dpc-500	94	56	positive	positive	ADJ
dpc-500	94	57	negative	negative	ADJ
dpc-500	94	58	0	0	NUM
dpc-500	94	59	p16	p16	PROPN
dpc-500	94	60	m	m	VERB
dpc-500	94	61	55	55	NUM
dpc-500	94	62	mpv	mpv	PROPN
dpc-500	94	63	2	2	NUM
dpc-500	94	64	remission	remission	NOUN
dpc-500	94	65	7.5	7.5	NUM
dpc-500	94	66	azathioprine	azathioprine	ADJ
dpc-500	94	67	negative	negative	ADJ
dpc-500	94	68	positive	positive	ADJ
dpc-500	94	69	0	0	NUM
dpc-500	94	70	p17	p17	NOUN
dpc-500	94	71	m	m	NOUN
dpc-500	94	72	65	65	NUM
dpc-500	94	73	mcpv	mcpv	ADJ
dpc-500	94	74	2	2	NUM
dpc-500	94	75	relapse	relapse	NOUN
dpc-500	94	76	5	5	NUM
dpc-500	94	77	azathioprine	azathioprine	ADJ
dpc-500	94	78	negative	negative	ADJ
dpc-500	94	79	positive	positive	ADJ
dpc-500	94	80	14	14	NUM
dpc-500	94	81	p18	p18	NOUN
dpc-500	94	82	f	f	PROPN
dpc-500	94	83	45	45	NUM
dpc-500	94	84	mcpv	mcpv	NOUN
dpc-500	94	85	2	2	NUM
dpc-500	94	86	relapse	relapse	NOUN
dpc-500	94	87	10	10	NUM
dpc-500	94	88	azathioprine	azathioprine	ADJ
dpc-500	94	89	positive	positive	ADJ
dpc-500	94	90	positive	positive	ADJ
dpc-500	94	91	12	12	NUM
dpc-500	94	92	p19	p19	NOUN
dpc-500	94	93	f	f	NOUN
dpc-500	94	94	58	58	NUM
dpc-500	94	95	mcpv	mcpv	NOUN
dpc-500	94	96	2	2	NUM
dpc-500	94	97	remission	remission	NOUN
dpc-500	94	98	7.5	7.5	NUM
dpc-500	94	99	azathioprine	azathioprine	ADJ
dpc-500	94	100	negative	negative	ADJ
dpc-500	94	101	positive	positive	ADJ
dpc-500	94	102	0	0	PUNCT
dpc-500	94	103	p20	p20	NOUN
dpc-500	94	104	m	m	VERB
dpc-500	94	105	39	39	NUM
dpc-500	94	106	mpv	mpv	PROPN
dpc-500	94	107	2	2	NUM
dpc-500	94	108	remission	remission	NOUN
dpc-500	94	109	1.25	1.25	NUM
dpc-500	94	110	azathioprine	azathioprine	ADJ
dpc-500	94	111	negative	negative	ADJ
dpc-500	94	112	negative	negative	ADJ
dpc-500	94	113	0	0	NUM
dpc-500	94	114	p21	p21	PROPN
dpc-500	94	115	f	f	PROPN
dpc-500	94	116	45	45	NUM
dpc-500	94	117	mpv	mpv	PROPN
dpc-500	94	118	2	2	NUM
dpc-500	94	119	relapse	relapse	NOUN
dpc-500	94	120	7.5	7.5	NUM
dpc-500	94	121	mycophenolic	mycophenolic	ADV
dpc-500	94	122	acid	acid	NOUN
dpc-500	94	123	negative	negative	ADJ
dpc-500	94	124	positive	positive	ADJ
dpc-500	94	125	5	5	NUM
dpc-500	94	126	p22	p22	NOUN
dpc-500	94	127	m	m	PROPN
dpc-500	94	128	21	21	NUM
dpc-500	94	129	mcpv	mcpv	NOUN
dpc-500	94	130	1	1	NUM
dpc-500	94	131	relapse	relapse	NOUN
dpc-500	94	132	15	15	NUM
dpc-500	94	133	azathioprine	azathioprine	ADJ
dpc-500	94	134	positive	positive	ADJ
dpc-500	94	135	positive	positive	ADJ
dpc-500	94	136	34	34	NUM
dpc-500	94	137	p23	p23	NOUN
dpc-500	94	138	f	f	PROPN
dpc-500	94	139	65	65	NUM
dpc-500	94	140	mcpv	mcpv	ADJ
dpc-500	94	141	12	12	NUM
dpc-500	94	142	remission	remission	NOUN
dpc-500	94	143	5	5	NUM
dpc-500	94	144	none	none	NOUN
dpc-500	94	145	negative	negative	ADJ
dpc-500	94	146	positive	positive	ADJ
dpc-500	94	147	0	0	NUM
dpc-500	94	148	p24	p24	NOUN
dpc-500	94	149	f	f	PROPN
dpc-500	94	150	45	45	NUM
dpc-500	94	151	mcpv	mcpv	NOUN
dpc-500	94	152	10	10	NUM
dpc-500	94	153	remission	remission	NOUN
dpc-500	94	154	5	5	NUM
dpc-500	94	155	azathioprine	azathioprine	ADJ
dpc-500	94	156	negative	negative	ADJ
dpc-500	94	157	positive	positive	ADJ
dpc-500	94	158	0	0	NUM
dpc-500	94	159	p25	p25	NOUN
dpc-500	94	160	f	f	NOUN
dpc-500	94	161	33	33	NUM
dpc-500	94	162	mcpv	mcpv	NOUN
dpc-500	94	163	5	5	NUM
dpc-500	94	164	relapse	relapse	NOUN
dpc-500	94	165	0	0	PUNCT
dpc-500	94	166	azathioprine	azathioprine	ADJ
dpc-500	94	167	15	15	NUM
dpc-500	94	168	p26	p26	NOUN
dpc-500	94	169	m	m	VERB
dpc-500	94	170	44	44	NUM
dpc-500	94	171	mpv	mpv	PROPN
dpc-500	94	172	19	19	NUM
dpc-500	94	173	remission	remission	NOUN
dpc-500	94	174	7.5	7.5	NUM
dpc-500	94	175	mycophenolic	mycophenolic	ADV
dpc-500	94	176	acid	acid	NOUN
dpc-500	94	177	,	,	PUNCT
dpc-500	94	178	azathioprine	azathioprine	ADJ
dpc-500	94	179	negative	negative	ADJ
dpc-500	94	180	positive	positive	ADJ
dpc-500	94	181	0	0	NUM
dpc-500	94	182	p27	p27	NOUN
dpc-500	94	183	f	f	PROPN
dpc-500	94	184	54	54	NUM
dpc-500	94	185	mcpv	mcpv	NOUN
dpc-500	94	186	2.5	2.5	NUM
dpc-500	94	187	remission	remission	NOUN
dpc-500	94	188	5	5	NUM
dpc-500	94	189	mycophenolic	mycophenolic	ADV
dpc-500	94	190	acid	acid	NOUN
dpc-500	94	191	,	,	PUNCT
dpc-500	94	192	rituximab	rituximab	VERB
dpc-500	94	193	positive	positive	ADJ
dpc-500	94	194	positive	positive	ADJ
dpc-500	94	195	0	0	NUM
dpc-500	94	196	p28	p28	NOUN
dpc-500	94	197	f	f	NOUN
dpc-500	94	198	62	62	NUM
dpc-500	94	199	mcpv	mcpv	NOUN
dpc-500	94	200	3	3	NUM
dpc-500	94	201	remission	remission	NOUN
dpc-500	94	202	2.5	2.5	NUM
dpc-500	94	203	azathioprine	azathioprine	ADJ
dpc-500	94	204	negative	negative	ADJ
dpc-500	94	205	negative	negative	ADJ
dpc-500	94	206	0	0	NUM
dpc-500	94	207	p29	p29	NOUN
dpc-500	94	208	f	f	PROPN
dpc-500	94	209	55	55	NUM
dpc-500	94	210	mcpv	mcpv	NOUN
dpc-500	94	211	1.5	1.5	NUM
dpc-500	94	212	remission	remission	NOUN
dpc-500	94	213	2.5	2.5	NUM
dpc-500	94	214	mycophenolic	mycophenolic	ADV
dpc-500	94	215	acid	acid	NOUN
dpc-500	94	216	,	,	PUNCT
dpc-500	95	1	mtx	mtx	NOUN
dpc-500	95	2	negative	negative	ADJ
dpc-500	95	3	negative	negative	ADJ
dpc-500	95	4	0	0	NUM
dpc-500	95	5	p30	p30	NOUN
dpc-500	95	6	m	m	VERB
dpc-500	95	7	38	38	NUM
dpc-500	95	8	mcpv	mcpv	ADJ
dpc-500	95	9	1.5	1.5	NUM
dpc-500	95	10	remission	remission	NOUN
dpc-500	95	11	7.5	7.5	NUM
dpc-500	95	12	rituximab	rituximab	NOUN
dpc-500	95	13	positive	positive	ADJ
dpc-500	95	14	positive	positive	ADJ
dpc-500	95	15	0	0	NUM
dpc-500	95	16	p31	p31	NOUN
dpc-500	95	17	f	f	PROPN
dpc-500	95	18	67	67	NUM
dpc-500	95	19	mcpv	mcpv	ADJ
dpc-500	95	20	11	11	NUM
dpc-500	95	21	remission	remission	NOUN
dpc-500	95	22	5	5	NUM
dpc-500	95	23	azathioprine	azathioprine	NOUN
dpc-500	95	24	,	,	PUNCT
dpc-500	95	25	mycophenolic	mycophenolic	ADJ
dpc-500	95	26	acid	acid	NOUN
dpc-500	95	27	,	,	PUNCT
dpc-500	95	28	rituximab	rituximab	NOUN
dpc-500	95	29	,	,	PUNCT
dpc-500	95	30	mtx	mtx	VERB
dpc-500	95	31	negative	negative	ADJ
dpc-500	95	32	positive	positive	ADJ
dpc-500	95	33	0	0	NUM
dpc-500	95	34	p32	p32	NOUN
dpc-500	95	35	f	f	PROPN
dpc-500	95	36	46	46	NUM
dpc-500	95	37	mcpv	mcpv	NOUN
dpc-500	95	38	0.5	0.5	NUM
dpc-500	95	39	remission	remission	NOUN
dpc-500	95	40	7.5	7.5	NUM
dpc-500	95	41	rituximab	rituximab	NOUN
dpc-500	95	42	negative	negative	ADJ
dpc-500	95	43	negative	negative	ADJ
dpc-500	95	44	0	0	PUNCT
dpc-500	95	45	(	(	PUNCT
dpc-500	95	46	continued	continue	VERB
dpc-500	95	47	next	next	ADJ
dpc-500	95	48	page	page	NOUN
dpc-500	95	49	)	)	PUNCT
dpc-500	95	50	266	266	NUM
dpc-500	95	51	research	research	NOUN
dpc-500	95	52	|	|	ADV
dpc-500	95	53	dermatol	dermatol	NOUN
dpc-500	95	54	pract	pract	NOUN
dpc-500	95	55	concept	concept	NOUN
dpc-500	96	1	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	96	2	i	i	PRON
dpc-500	96	3	d	d	PROPN
dpc-500	96	4	sex	sex	NOUN
dpc-500	96	5	age	age	NOUN
dpc-500	96	6	(	(	PUNCT
dpc-500	96	7	years	year	NOUN
dpc-500	96	8	)	)	PUNCT
dpc-500	96	9	type	type	NOUN
dpc-500	96	10	duration	duration	NOUN
dpc-500	96	11	(	(	PUNCT
dpc-500	96	12	years	year	NOUN
dpc-500	96	13	)	)	PUNCT
dpc-500	96	14	activation	activation	NOUN
dpc-500	96	15	pdn	pdn	NOUN
dpc-500	96	16	dose	dose	NOUN
dpc-500	96	17	(	(	PUNCT
dpc-500	96	18	mg	mg	PROPN
dpc-500	96	19	/	/	SYM
dpc-500	96	20	d	d	NOUN
dpc-500	96	21	)	)	PUNCT
dpc-500	96	22	drug	drug	NOUN
dpc-500	96	23	history	history	NOUN
dpc-500	96	24	dsg1	dsg1	VERB
dpc-500	96	25	dsg3	dsg3	PROPN
dpc-500	96	26	pdai	pdai	PROPN
dpc-500	96	27	p33	p33	NOUN
dpc-500	96	28	f	f	PROPN
dpc-500	96	29	40	40	NUM
dpc-500	96	30	mcpv	mcpv	NOUN
dpc-500	96	31	12	12	NUM
dpc-500	96	32	remission	remission	NOUN
dpc-500	96	33	10	10	NUM
dpc-500	96	34	azathioprine	azathioprine	ADJ
dpc-500	96	35	negative	negative	ADJ
dpc-500	96	36	positive	positive	ADJ
dpc-500	96	37	0	0	NUM
dpc-500	96	38	p34	p34	NOUN
dpc-500	96	39	m	m	VERB
dpc-500	96	40	40	40	NUM
dpc-500	96	41	mcpv	mcpv	NOUN
dpc-500	96	42	3	3	NUM
dpc-500	96	43	relapse	relapse	NOUN
dpc-500	96	44	25	25	NUM
dpc-500	96	45	azathioprine	azathioprine	NOUN
dpc-500	96	46	,	,	PUNCT
dpc-500	96	47	rituximab	rituximab	VERB
dpc-500	96	48	negative	negative	ADJ
dpc-500	96	49	positive	positive	ADJ
dpc-500	96	50	5	5	NUM
dpc-500	96	51	p35	p35	NOUN
dpc-500	96	52	m	m	PROPN
dpc-500	96	53	55	55	NUM
dpc-500	96	54	mcpv	mcpv	NOUN
dpc-500	96	55	6	6	NUM
dpc-500	96	56	remission	remission	NOUN
dpc-500	96	57	7.5	7.5	NUM
dpc-500	96	58	azathioprine	azathioprine	ADJ
dpc-500	96	59	negative	negative	ADJ
dpc-500	96	60	negative	negative	ADJ
dpc-500	96	61	0	0	NUM
dpc-500	96	62	p36	p36	NOUN
dpc-500	96	63	m	m	VERB
dpc-500	96	64	35	35	NUM
dpc-500	96	65	mcpv	mcpv	NOUN
dpc-500	96	66	14	14	NUM
dpc-500	96	67	remission	remission	NOUN
dpc-500	96	68	7.5	7.5	NUM
dpc-500	96	69	mycophenolic	mycophenolic	ADV
dpc-500	96	70	acid	acid	NOUN
dpc-500	96	71	,	,	PUNCT
dpc-500	96	72	azathioprine	azathioprine	NOUN
dpc-500	96	73	,	,	PUNCT
dpc-500	96	74	mtx	mtx	PROPN
dpc-500	96	75	,	,	PUNCT
dpc-500	96	76	rituximab	rituximab	NOUN
dpc-500	96	77	,	,	PUNCT
dpc-500	96	78	ivig	ivig	NOUN
dpc-500	96	79	negative	negative	ADJ
dpc-500	96	80	positive	positive	ADJ
dpc-500	96	81	0	0	NUM
dpc-500	96	82	p37	p37	NOUN
dpc-500	96	83	m	m	PROPN
dpc-500	96	84	65	65	NUM
dpc-500	96	85	mcpv	mcpv	ADJ
dpc-500	96	86	5	5	NUM
dpc-500	96	87	relapse	relapse	NOUN
dpc-500	96	88	0	0	NUM
dpc-500	96	89	mycophenolic	mycophenolic	ADJ
dpc-500	96	90	acid	acid	NOUN
dpc-500	96	91	,	,	PUNCT
dpc-500	96	92	azathioprine	azathioprine	ADJ
dpc-500	96	93	positive	positive	ADJ
dpc-500	96	94	negative	negative	ADJ
dpc-500	96	95	23	23	NUM
dpc-500	96	96	p38	p38	NOUN
dpc-500	96	97	f	f	NOUN
dpc-500	96	98	74	74	NUM
dpc-500	96	99	mcpv	mcpv	NOUN
dpc-500	96	100	2	2	NUM
dpc-500	96	101	relapse	relapse	NOUN
dpc-500	96	102	7.5	7.5	NUM
dpc-500	96	103	azathioprine	azathioprine	ADJ
dpc-500	96	104	positive	positive	ADJ
dpc-500	96	105	positive	positive	ADJ
dpc-500	96	106	24	24	NUM
dpc-500	96	107	p39	p39	NOUN
dpc-500	96	108	f	f	PROPN
dpc-500	96	109	32	32	NUM
dpc-500	96	110	mcpv	mcpv	NOUN
dpc-500	96	111	2	2	NUM
dpc-500	96	112	relapse	relapse	NOUN
dpc-500	96	113	10	10	NUM
dpc-500	96	114	rituximab	rituximab	NOUN
dpc-500	96	115	negative	negative	ADJ
dpc-500	96	116	positive	positive	ADJ
dpc-500	96	117	14	14	NUM
dpc-500	96	118	p40	p40	NOUN
dpc-500	96	119	f	f	NOUN
dpc-500	96	120	39	39	NUM
dpc-500	96	121	mcpv	mcpv	NOUN
dpc-500	96	122	8	8	NUM
dpc-500	96	123	relapse	relapse	NOUN
dpc-500	96	124	2.5	2.5	NUM
dpc-500	96	125	mycophenolic	mycophenolic	ADV
dpc-500	96	126	acid	acid	NOUN
dpc-500	96	127	,	,	PUNCT
dpc-500	96	128	rituximab	rituximab	VERB
dpc-500	96	129	positive	positive	ADJ
dpc-500	96	130	positive	positive	ADJ
dpc-500	96	131	3	3	NUM
dpc-500	96	132	p41	p41	PROPN
dpc-500	96	133	f	f	PROPN
dpc-500	96	134	36	36	NUM
dpc-500	96	135	mcpv	mcpv	NOUN
dpc-500	96	136	5	5	NUM
dpc-500	96	137	relapse	relapse	NOUN
dpc-500	96	138	5	5	NUM
dpc-500	96	139	mycophenolic	mycophenolic	ADJ
dpc-500	96	140	acid	acid	NOUN
dpc-500	96	141	,	,	PUNCT
dpc-500	96	142	azathioprine	azathioprine	ADJ
dpc-500	96	143	positive	positive	ADJ
dpc-500	96	144	positive	positive	ADJ
dpc-500	96	145	34	34	NUM
dpc-500	96	146	p42	p42	NOUN
dpc-500	96	147	f	f	PROPN
dpc-500	96	148	54	54	NUM
dpc-500	96	149	mcpv	mcpv	NOUN
dpc-500	96	150	2	2	NUM
dpc-500	96	151	relapse	relapse	NOUN
dpc-500	96	152	5	5	NUM
dpc-500	96	153	mycophenolic	mycophenolic	ADJ
dpc-500	96	154	acid	acid	NOUN
dpc-500	96	155	,	,	PUNCT
dpc-500	96	156	azathioprine	azathioprine	NOUN
dpc-500	96	157	,	,	PUNCT
dpc-500	96	158	mtx	mtx	VERB
dpc-500	96	159	positive	positive	ADJ
dpc-500	96	160	positive	positive	ADJ
dpc-500	96	161	12	12	NUM
dpc-500	96	162	p43	p43	NOUN
dpc-500	96	163	f	f	PROPN
dpc-500	96	164	54	54	NUM
dpc-500	96	165	mcpv	mcpv	NOUN
dpc-500	96	166	6	6	NUM
dpc-500	96	167	relapse	relapse	NOUN
dpc-500	96	168	25	25	NUM
dpc-500	96	169	rituximab	rituximab	NOUN
dpc-500	96	170	,	,	PUNCT
dpc-500	96	171	mycophenolic	mycophenolic	ADJ
dpc-500	96	172	acid	acid	ADJ
dpc-500	97	1	negative	negative	ADJ
dpc-500	97	2	positive	positive	ADJ
dpc-500	97	3	11	11	NUM
dpc-500	97	4	p44	p44	NOUN
dpc-500	97	5	m	m	NOUN
dpc-500	97	6	20	20	NUM
dpc-500	97	7	mcpv	mcpv	NOUN
dpc-500	97	8	1	1	NUM
dpc-500	97	9	relapse	relapse	NOUN
dpc-500	97	10	15	15	NUM
dpc-500	97	11	rituximab	rituximab	NOUN
dpc-500	97	12	negative	negative	ADJ
dpc-500	97	13	negative	negative	ADJ
dpc-500	97	14	5	5	NUM
dpc-500	97	15	p45	p45	PROPN
dpc-500	97	16	f	f	PROPN
dpc-500	97	17	42	42	NUM
dpc-500	97	18	mpv	mpv	PROPN
dpc-500	97	19	1	1	PROPN
dpc-500	97	20	remission	remission	NOUN
dpc-500	97	21	2.5	2.5	NUM
dpc-500	97	22	rituximab	rituximab	NOUN
dpc-500	97	23	negative	negative	ADJ
dpc-500	97	24	positive	positive	ADJ
dpc-500	97	25	0	0	NUM
dpc-500	97	26	p46	p46	NOUN
dpc-500	97	27	m	m	PROPN
dpc-500	97	28	38	38	NUM
dpc-500	97	29	mpv	mpv	PROPN
dpc-500	97	30	3	3	NUM
dpc-500	97	31	relapse	relapse	NOUN
dpc-500	97	32	15	15	NUM
dpc-500	97	33	none	none	NOUN
dpc-500	97	34	negative	negative	ADJ
dpc-500	97	35	positive	positive	ADJ
dpc-500	97	36	27	27	NUM
dpc-500	97	37	p47	p47	NOUN
dpc-500	97	38	f	f	NOUN
dpc-500	97	39	46	46	NUM
dpc-500	97	40	mcpv	mcpv	NOUN
dpc-500	97	41	15	15	NUM
dpc-500	97	42	relapse	relapse	NOUN
dpc-500	97	43	20	20	NUM
dpc-500	97	44	mycophenolic	mycophenolic	ADJ
dpc-500	97	45	acid	acid	NOUN
dpc-500	97	46	,	,	PUNCT
dpc-500	97	47	azathioprine	azathioprine	NOUN
dpc-500	97	48	,	,	PUNCT
dpc-500	97	49	mtx	mtx	PROPN
dpc-500	97	50	,	,	PUNCT
dpc-500	97	51	rituximab	rituximab	NOUN
dpc-500	97	52	,	,	PUNCT
dpc-500	97	53	ivig	ivig	NOUN
dpc-500	97	54	,	,	PUNCT
dpc-500	97	55	cyclophosphamide	cyclophosphamide	NOUN
dpc-500	97	56	positive	positive	ADJ
dpc-500	97	57	positive	positive	ADJ
dpc-500	97	58	0	0	NUM
dpc-500	97	59	p48	p48	NOUN
dpc-500	97	60	m	m	VERB
dpc-500	97	61	27	27	NUM
dpc-500	97	62	mcpv	mcpv	NOUN
dpc-500	97	63	1.5	1.5	NUM
dpc-500	97	64	relapse	relapse	NOUN
dpc-500	97	65	30	30	NUM
dpc-500	97	66	mycophenolic	mycophenolic	ADJ
dpc-500	97	67	acid	acid	NOUN
dpc-500	97	68	,	,	PUNCT
dpc-500	97	69	azathioprine	azathioprine	ADJ
dpc-500	97	70	positive	positive	ADJ
dpc-500	97	71	positive	positive	ADJ
dpc-500	97	72	0	0	NUM
dpc-500	97	73	p49	p49	NOUN
dpc-500	97	74	m	m	VERB
dpc-500	97	75	42	42	NUM
dpc-500	97	76	mcpv	mcpv	NOUN
dpc-500	97	77	0.5	0.5	NUM
dpc-500	97	78	relapse	relapse	NOUN
dpc-500	97	79	35	35	NUM
dpc-500	97	80	none	none	NOUN
dpc-500	97	81	negative	negative	ADJ
dpc-500	97	82	negative	negative	ADJ
dpc-500	97	83	17	17	NUM
dpc-500	97	84	p50	p50	NOUN
dpc-500	97	85	f	f	NOUN
dpc-500	97	86	34	34	NUM
dpc-500	97	87	mpv	mpv	PROPN
dpc-500	97	88	1	1	NUM
dpc-500	97	89	relapse	relapse	NOUN
dpc-500	97	90	10	10	NUM
dpc-500	97	91	mycophenolic	mycophenolic	ADJ
dpc-500	97	92	acid	acid	NOUN
dpc-500	97	93	,	,	PUNCT
dpc-500	97	94	azathioprine	azathioprine	NOUN
dpc-500	97	95	,	,	PUNCT
dpc-500	97	96	mtx	mtx	PROPN
dpc-500	97	97	,	,	PUNCT
dpc-500	97	98	rituximab	rituximab	NOUN
dpc-500	97	99	,	,	PUNCT
dpc-500	97	100	ivig	ivig	NOUN
dpc-500	97	101	,	,	PUNCT
dpc-500	97	102	cyclophosphamide	cyclophosphamide	PROPN
dpc-500	97	103	10	10	NUM
dpc-500	97	104	p51	p51	PROPN
dpc-500	97	105	f	f	PROPN
dpc-500	97	106	34	34	NUM
dpc-500	97	107	mcpv	mcpv	NOUN
dpc-500	97	108	1	1	NUM
dpc-500	97	109	relapse	relapse	NOUN
dpc-500	97	110	6.25	6.25	NUM
dpc-500	97	111	rituximab	rituximab	NOUN
dpc-500	97	112	positive	positive	ADJ
dpc-500	97	113	negative	negative	ADJ
dpc-500	97	114	38	38	NUM
dpc-500	97	115	p52	p52	NOUN
dpc-500	97	116	f	f	NOUN
dpc-500	97	117	37	37	NUM
dpc-500	97	118	mcpv	mcpv	NOUN
dpc-500	97	119	2	2	NUM
dpc-500	97	120	relapse	relapse	NOUN
dpc-500	97	121	25	25	NUM
dpc-500	97	122	azathioprine	azathioprine	NOUN
dpc-500	97	123	,	,	PUNCT
dpc-500	97	124	rituximab	rituximab	VERB
dpc-500	97	125	positive	positive	ADJ
dpc-500	97	126	positive	positive	ADJ
dpc-500	97	127	19	19	NUM
dpc-500	97	128	p53	p53	NOUN
dpc-500	97	129	m	m	NOUN
dpc-500	97	130	57	57	NUM
dpc-500	97	131	mcpv	mcpv	NOUN
dpc-500	97	132	3	3	NUM
dpc-500	97	133	relapse	relapse	NOUN
dpc-500	97	134	15	15	NUM
dpc-500	97	135	azathioprine	azathioprine	ADJ
dpc-500	97	136	positive	positive	ADJ
dpc-500	97	137	positive	positive	ADJ
dpc-500	97	138	84	84	NUM
dpc-500	97	139	p54	p54	NOUN
dpc-500	97	140	m	m	PROPN
dpc-500	97	141	54	54	NUM
dpc-500	97	142	mcpv	mcpv	NOUN
dpc-500	97	143	5.5	5.5	NUM
dpc-500	97	144	relapse	relapse	NOUN
dpc-500	97	145	2.5	2.5	NUM
dpc-500	97	146	azathioprine	azathioprine	NOUN
dpc-500	97	147	,	,	PUNCT
dpc-500	97	148	mycophenolic	mycophenolic	ADJ
dpc-500	97	149	acid	acid	NOUN
dpc-500	97	150	,	,	PUNCT
dpc-500	97	151	rituximab	rituximab	NOUN
dpc-500	97	152	,	,	PUNCT
dpc-500	97	153	mtx	mtx	NOUN
dpc-500	97	154	positive	positive	ADJ
dpc-500	97	155	negative	negative	ADJ
dpc-500	97	156	12	12	NUM
dpc-500	97	157	p55	p55	NOUN
dpc-500	97	158	f	f	PROPN
dpc-500	97	159	54	54	NUM
dpc-500	97	160	mcpv	mcpv	NOUN
dpc-500	97	161	2	2	NUM
dpc-500	97	162	relapse	relapse	NOUN
dpc-500	97	163	12.5	12.5	NUM
dpc-500	97	164	rituximab	rituximab	NOUN
dpc-500	97	165	negative	negative	ADJ
dpc-500	97	166	positive	positive	ADJ
dpc-500	97	167	8	8	NUM
dpc-500	97	168	p56	p56	NOUN
dpc-500	97	169	f	f	PROPN
dpc-500	97	170	48	48	NUM
dpc-500	97	171	mcpv	mcpv	NOUN
dpc-500	97	172	1	1	NUM
dpc-500	97	173	relapse	relapse	NOUN
dpc-500	97	174	10	10	NUM
dpc-500	97	175	azathioprine	azathioprine	ADJ
dpc-500	97	176	positive	positive	ADJ
dpc-500	97	177	positive	positive	ADJ
dpc-500	97	178	23	23	NUM
dpc-500	97	179	p57	p57	NOUN
dpc-500	97	180	f	f	NOUN
dpc-500	97	181	60	60	NUM
dpc-500	97	182	mcpv	mcpv	NOUN
dpc-500	97	183	10	10	NUM
dpc-500	97	184	remission	remission	NOUN
dpc-500	97	185	10	10	NUM
dpc-500	97	186	azathioprine	azathioprine	ADJ
dpc-500	97	187	negative	negative	ADJ
dpc-500	97	188	positive	positive	ADJ
dpc-500	97	189	0	0	NUM
dpc-500	97	190	p58	p58	NOUN
dpc-500	97	191	m	m	VERB
dpc-500	97	192	29	29	NUM
dpc-500	97	193	mcpv	mcpv	NOUN
dpc-500	97	194	3	3	NUM
dpc-500	97	195	relapse	relapse	NOUN
dpc-500	97	196	5	5	NUM
dpc-500	97	197	mycophenolic	mycophenolic	ADJ
dpc-500	97	198	acid	acid	NOUN
dpc-500	97	199	,	,	PUNCT
dpc-500	97	200	rituximab	rituximab	VERB
dpc-500	97	201	positive	positive	ADJ
dpc-500	97	202	positive	positive	ADJ
dpc-500	97	203	14	14	NUM
dpc-500	97	204	p59	p59	NOUN
dpc-500	97	205	m	m	VERB
dpc-500	97	206	45	45	NUM
dpc-500	97	207	mcpv	mcpv	NOUN
dpc-500	97	208	1	1	NUM
dpc-500	97	209	relapse	relapse	NOUN
dpc-500	97	210	15	15	NUM
dpc-500	97	211	azathioprine	azathioprine	ADJ
dpc-500	97	212	positive	positive	ADJ
dpc-500	97	213	positive	positive	ADJ
dpc-500	97	214	21	21	NUM
dpc-500	97	215	p60	p60	NOUN
dpc-500	97	216	f	f	PROPN
dpc-500	97	217	39	39	NUM
dpc-500	97	218	mcpv	mcpv	NOUN
dpc-500	97	219	1.5	1.5	NUM
dpc-500	97	220	relapse	relapse	NOUN
dpc-500	97	221	35	35	NUM
dpc-500	97	222	mycophenolic	mycophenolic	ADJ
dpc-500	97	223	acid	acid	NOUN
dpc-500	97	224	,	,	PUNCT
dpc-500	97	225	azathioprine	azathioprine	ADJ
dpc-500	97	226	negative	negative	ADJ
dpc-500	97	227	positive	positive	ADJ
dpc-500	97	228	15	15	NUM
dpc-500	97	229	abbreviations	abbreviation	NOUN
dpc-500	97	230	:	:	PUNCT
dpc-500	97	231	mtx	mtx	NOUN
dpc-500	97	232	,	,	PUNCT
dpc-500	97	233	methotrexate	methotrexate	NOUN
dpc-500	97	234	;	;	PUNCT
dpc-500	97	235	dsg	dsg	PROPN
dpc-500	97	236	,	,	PUNCT
dpc-500	97	237	desmoglein	desmoglein	NOUN
dpc-500	97	238	;	;	PUNCT
dpc-500	97	239	mcpv	mcpv	ADJ
dpc-500	97	240	,	,	PUNCT
dpc-500	97	241	mucocutaneous	mucocutaneous	ADJ
dpc-500	97	242	pv	pv	NOUN
dpc-500	97	243	;	;	PUNCT
dpc-500	97	244	mpv	mpv	PROPN
dpc-500	97	245	,	,	PUNCT
dpc-500	97	246	mucous	mucous	ADJ
dpc-500	97	247	pv	pv	NOUN
dpc-500	97	248	;	;	PUNCT
dpc-500	97	249	pdn	pdn	PROPN
dpc-500	97	250	dose	dose	PROPN
dpc-500	97	251	,	,	PUNCT
dpc-500	97	252	oral	oral	ADJ
dpc-500	97	253	prednisolone	prednisolone	PROPN
dpc-500	97	254	dose	dose	NOUN
dpc-500	97	255	at	at	ADP
dpc-500	97	256	the	the	DET
dpc-500	97	257	time	time	NOUN
dpc-500	97	258	of	of	ADP
dpc-500	97	259	the	the	DET
dpc-500	97	260	study	study	NOUN
dpc-500	97	261	;	;	PUNCT
dpc-500	98	1	pdai	pdai	X
dpc-500	98	2	,	,	PUNCT
dpc-500	98	3	pemphigus	pemphigus	PROPN
dpc-500	98	4	disease	disease	PROPN
dpc-500	98	5	area	area	NOUN
dpc-500	98	6	index	index	NOUN
dpc-500	98	7	table	table	NOUN
dpc-500	98	8	1	1	NUM
dpc-500	98	9	.	.	PUNCT
dpc-500	98	10	demographic	demographic	ADJ
dpc-500	98	11	and	and	CCONJ
dpc-500	98	12	clinical	clinical	ADJ
dpc-500	98	13	characteristics	characteristic	NOUN
dpc-500	98	14	of	of	ADP
dpc-500	98	15	pemphigus	pemphigus	ADJ
dpc-500	98	16	vulgaris	vulgaris	NOUN
dpc-500	98	17	patients	patient	NOUN
dpc-500	98	18	(	(	PUNCT
dpc-500	98	19	continued	continued	ADJ
dpc-500	98	20	)	)	PUNCT
dpc-500	98	21	research	research	NOUN
dpc-500	98	22	|	|	ADV
dpc-500	98	23	dermatol	dermatol	NOUN
dpc-500	98	24	pract	pract	NOUN
dpc-500	98	25	concept	concept	NOUN
dpc-500	98	26	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	98	27	267	267	NUM
dpc-500	98	28	46.60	46.60	NUM
dpc-500	98	29	 	 	SPACE
dpc-500	98	30	vs	vs	ADP
dpc-500	98	31	 	 	SPACE
dpc-500	98	32	112.00	112.00	NUM
dpc-500	98	33	±	±	NUM
dpc-500	98	34	50.86	50.86	NUM
dpc-500	98	35	,	,	PUNCT
dpc-500	98	36	p	p	X
dpc-500	98	37	=	=	NOUN
dpc-500	98	38	0.020	0.020	NUM
dpc-500	98	39	)	)	PUNCT
dpc-500	98	40	.	.	PUNCT
dpc-500	99	1	also	also	ADV
dpc-500	99	2	,	,	PUNCT
dpc-500	99	3	a	a	DET
dpc-500	99	4	direct	direct	ADJ
dpc-500	99	5	correlation	correlation	NOUN
dpc-500	99	6	was	be	AUX
dpc-500	99	7	revealed	reveal	VERB
dpc-500	99	8	between	between	ADP
dpc-500	99	9	patients	patient	NOUN
dpc-500	99	10	’	’	PART
dpc-500	99	11	age	age	NOUN
dpc-500	99	12	and	and	CCONJ
dpc-500	99	13	the	the	DET
dpc-500	99	14	level	level	NOUN
dpc-500	99	15	of	of	ADP
dpc-500	99	16	cmv	cmv	NOUN
dpc-500	99	17	-	-	PUNCT
dpc-500	99	18	igg	igg	PROPN
dpc-500	99	19	(	(	PUNCT
dpc-500	99	20	r	r	NOUN
dpc-500	99	21	coefficient	coefficient	NOUN
dpc-500	99	22	=	=	NOUN
dpc-500	99	23	0.404	0.404	NUM
dpc-500	99	24	,	,	PUNCT
dpc-500	99	25	p	p	NOUN
dpc-500	99	26	=	=	NOUN
dpc-500	99	27	0.001	0.001	NUM
dpc-500	99	28	)	)	PUNCT
dpc-500	99	29	.	.	PUNCT
dpc-500	100	1	discussion	discussion	NOUN
dpc-500	100	2	several	several	ADJ
dpc-500	100	3	studies	study	NOUN
dpc-500	100	4	have	have	AUX
dpc-500	100	5	investigated	investigate	VERB
dpc-500	100	6	the	the	DET
dpc-500	100	7	relationship	relationship	NOUN
dpc-500	100	8	between	between	ADP
dpc-500	100	9	viral	viral	ADJ
dpc-500	100	10	infections	infection	NOUN
dpc-500	100	11	and	and	CCONJ
dpc-500	100	12	the	the	DET
dpc-500	100	13	initiation	initiation	NOUN
dpc-500	100	14	or	or	CCONJ
dpc-500	100	15	exacerbation	exacerbation	NOUN
dpc-500	100	16	of	of	ADP
dpc-500	100	17	autoimmune	autoimmune	NOUN
dpc-500	100	18	as	as	SCONJ
dpc-500	100	19	indicated	indicate	VERB
dpc-500	100	20	in	in	ADP
dpc-500	100	21	table	table	NOUN
dpc-500	100	22	 	 	SPACE
dpc-500	100	23	4	4	NUM
dpc-500	100	24	 	 	SPACE
dpc-500	100	25	and	and	CCONJ
dpc-500	100	26	figure	figure	VERB
dpc-500	100	27	 	 	SPACE
dpc-500	100	28	1	1	NUM
dpc-500	100	29	 	 	SPACE
dpc-500	100	30	and	and	CCONJ
dpc-500	100	31	using	use	VERB
dpc-500	100	32	the	the	DET
dpc-500	100	33	multivariable	multivariable	ADJ
dpc-500	100	34	linear	linear	PROPN
dpc-500	100	35	regression	regression	NOUN
dpc-500	100	36	model	model	NOUN
dpc-500	100	37	,	,	PUNCT
dpc-500	100	38	the	the	DET
dpc-500	100	39	level	level	NOUN
dpc-500	100	40	of	of	ADP
dpc-500	100	41	hsv	hsv	PROPN
dpc-500	100	42	-	-	PUNCT
dpc-500	100	43	igg	igg	PROPN
dpc-500	100	44	was	be	AUX
dpc-500	100	45	not	not	PART
dpc-500	100	46	associated	associate	VERB
dpc-500	100	47	with	with	ADP
dpc-500	100	48	the	the	DET
dpc-500	100	49	baseline	baseline	PROPN
dpc-500	100	50	characteristics	characteristic	NOUN
dpc-500	100	51	including	include	VERB
dpc-500	100	52	demographics	demographic	NOUN
dpc-500	100	53	,	,	PUNCT
dpc-500	100	54	underlying	underlying	ADJ
dpc-500	100	55	comorbidities	comorbiditie	NOUN
dpc-500	100	56	,	,	PUNCT
dpc-500	100	57	disease	disease	NOUN
dpc-500	100	58	duration	duration	NOUN
dpc-500	100	59	,	,	PUNCT
dpc-500	100	60	and	and	CCONJ
dpc-500	100	61	form	form	NOUN
dpc-500	100	62	of	of	ADP
dpc-500	100	63	pv	pv	INTJ
dpc-500	100	64	.	.	PUNCT
dpc-500	101	1	however	however	ADV
dpc-500	101	2	,	,	PUNCT
dpc-500	101	3	as	as	SCONJ
dpc-500	101	4	shown	show	VERB
dpc-500	101	5	in	in	ADP
dpc-500	101	6	table	table	NOUN
dpc-500	101	7	 	 	SPACE
dpc-500	101	8	5	5	NUM
dpc-500	101	9	 	 	SPACE
dpc-500	101	10	and	and	CCONJ
dpc-500	101	11	figure	figure	VERB
dpc-500	101	12	 	 	SPACE
dpc-500	101	13	2	2	NUM
dpc-500	101	14	,	,	PUNCT
dpc-500	101	15	the	the	DET
dpc-500	101	16	level	level	NOUN
dpc-500	101	17	of	of	ADP
dpc-500	101	18	cmv	cmv	NOUN
dpc-500	101	19	-	-	PUNCT
dpc-500	101	20	igg	igg	PROPN
dpc-500	101	21	in	in	ADP
dpc-500	101	22	pv	pv	PROPN
dpc-500	101	23	patients	patient	NOUN
dpc-500	101	24	was	be	AUX
dpc-500	101	25	affected	affect	VERB
dpc-500	101	26	by	by	ADP
dpc-500	101	27	the	the	DET
dpc-500	101	28	gender	gender	NOUN
dpc-500	101	29	and	and	CCONJ
dpc-500	101	30	age	age	NOUN
dpc-500	101	31	factors	factor	NOUN
dpc-500	101	32	.	.	PUNCT
dpc-500	102	1	the	the	DET
dpc-500	102	2	mean	mean	ADJ
dpc-500	102	3	cmv	cmv	PROPN
dpc-500	102	4	-	-	PUNCT
dpc-500	102	5	igg	igg	PROPN
dpc-500	102	6	was	be	AUX
dpc-500	102	7	significantly	significantly	ADV
dpc-500	102	8	higher	high	ADJ
dpc-500	102	9	in	in	ADP
dpc-500	102	10	female	female	ADJ
dpc-500	102	11	than	than	ADP
dpc-500	102	12	in	in	ADP
dpc-500	102	13	male	male	ADJ
dpc-500	102	14	patients	patient	NOUN
dpc-500	102	15	suffering	suffer	VERB
dpc-500	102	16	from	from	ADP
dpc-500	102	17	pv	pv	PROPN
dpc-500	102	18	(	(	PUNCT
dpc-500	102	19	142.21	142.21	NUM
dpc-500	102	20	±	±	NUM
dpc-500	102	21	table	table	NOUN
dpc-500	102	22	2	2	NUM
dpc-500	102	23	.	.	PUNCT
dpc-500	102	24	comparing	compare	VERB
dpc-500	102	25	baseline	baseline	NOUN
dpc-500	102	26	characteristics	characteristic	NOUN
dpc-500	102	27	between	between	ADP
dpc-500	102	28	the	the	DET
dpc-500	102	29	patients	patient	NOUN
dpc-500	102	30	with	with	ADP
dpc-500	102	31	relapse	relapse	NOUN
dpc-500	102	32	and	and	CCONJ
dpc-500	102	33	those	those	PRON
dpc-500	102	34	in	in	ADP
dpc-500	102	35	remission	remission	NOUN
dpc-500	102	36	relapse	relapse	NOUN
dpc-500	102	37	type	type	NOUN
dpc-500	102	38	(	(	PUNCT
dpc-500	102	39	n	n	NOUN
dpc-500	102	40	=	=	SYM
dpc-500	102	41	30	30	NUM
dpc-500	102	42	)	)	PUNCT
dpc-500	102	43	remission	remission	NOUN
dpc-500	102	44	type	type	NOUN
dpc-500	102	45	(	(	PUNCT
dpc-500	102	46	n	n	NOUN
dpc-500	102	47	=	=	SYM
dpc-500	102	48	30	30	NUM
dpc-500	102	49	)	)	PUNCT
dpc-500	102	50	p	p	NOUN
dpc-500	102	51	value	value	NOUN
dpc-500	102	52	male	male	NOUN
dpc-500	102	53	12	12	NUM
dpc-500	102	54	(	(	PUNCT
dpc-500	102	55	40.0	40.0	NUM
dpc-500	102	56	)	)	PUNCT
dpc-500	102	57	14	14	NUM
dpc-500	102	58	(	(	PUNCT
dpc-500	102	59	46.7	46.7	NUM
dpc-500	102	60	)	)	PUNCT
dpc-500	102	61	0.602	0.602	NUM
dpc-500	102	62	mean	mean	NOUN
dpc-500	102	63	age	age	NOUN
dpc-500	102	64	,	,	PUNCT
dpc-500	102	65	years	year	NOUN
dpc-500	102	66	(	(	PUNCT
dpc-500	102	67	±sd	±sd	NOUN
dpc-500	102	68	)	)	PUNCT
dpc-500	102	69	44.90	44.90	NUM
dpc-500	102	70	±	±	NUM
dpc-500	102	71	14.30	14.30	NUM
dpc-500	102	72	47.83	47.83	NUM
dpc-500	102	73	±	±	NUM
dpc-500	102	74	11.04	11.04	NUM
dpc-500	102	75	0.377	0.377	NUM
dpc-500	102	76	disease	disease	NOUN
dpc-500	102	77	duration	duration	NOUN
dpc-500	102	78	,	,	PUNCT
dpc-500	102	79	years	year	NOUN
dpc-500	102	80	(	(	PUNCT
dpc-500	102	81	±sd	±sd	NOUN
dpc-500	102	82	)	)	PUNCT
dpc-500	102	83	3.42	3.42	NUM
dpc-500	102	84	±	±	NUM
dpc-500	102	85	3.14	3.14	NUM
dpc-500	102	86	5.23	5.23	NUM
dpc-500	102	87	±	±	NUM
dpc-500	102	88	4.75	4.75	NUM
dpc-500	102	89	0.086	0.086	NUM
dpc-500	102	90	medical	medical	ADJ
dpc-500	102	91	history	history	NOUN
dpc-500	102	92	history	history	NOUN
dpc-500	102	93	of	of	ADP
dpc-500	102	94	hypertension	hypertension	NOUN
dpc-500	102	95	9	9	NUM
dpc-500	102	96	(	(	PUNCT
dpc-500	102	97	30.0	30.0	NUM
dpc-500	102	98	)	)	SYM
dpc-500	102	99	2	2	NUM
dpc-500	102	100	(	(	PUNCT
dpc-500	102	101	6.7	6.7	NUM
dpc-500	102	102	)	)	PUNCT
dpc-500	102	103	0.020	0.020	NUM
dpc-500	102	104	history	history	NOUN
dpc-500	102	105	of	of	ADP
dpc-500	102	106	hyperlipidemia	hyperlipidemia	NOUN
dpc-500	102	107	5	5	NUM
dpc-500	102	108	(	(	PUNCT
dpc-500	102	109	16.7	16.7	NUM
dpc-500	102	110	)	)	PUNCT
dpc-500	102	111	0	0	NUM
dpc-500	103	1	(	(	PUNCT
dpc-500	103	2	0.0	0.0	NUM
dpc-500	103	3	)	)	PUNCT
dpc-500	103	4	0.050	0.050	NUM
dpc-500	103	5	history	history	NOUN
dpc-500	103	6	of	of	ADP
dpc-500	103	7	diabetes	diabetes	NOUN
dpc-500	103	8	mellitus	mellitus	NOUN
dpc-500	103	9	5	5	NUM
dpc-500	103	10	(	(	PUNCT
dpc-500	103	11	16.7	16.7	NUM
dpc-500	103	12	)	)	SYM
dpc-500	103	13	2	2	NUM
dpc-500	103	14	(	(	PUNCT
dpc-500	103	15	6.7	6.7	NUM
dpc-500	103	16	)	)	PUNCT
dpc-500	103	17	0.424	0.424	NUM
dpc-500	103	18	history	history	NOUN
dpc-500	103	19	of	of	ADP
dpc-500	103	20	smoking	smoking	NOUN
dpc-500	103	21	1	1	NUM
dpc-500	103	22	(	(	PUNCT
dpc-500	103	23	3.3	3.3	NUM
dpc-500	103	24	)	)	SYM
dpc-500	103	25	1	1	NUM
dpc-500	103	26	(	(	PUNCT
dpc-500	103	27	3.3	3.3	NUM
dpc-500	103	28	)	)	PUNCT
dpc-500	103	29	1.000	1.000	NUM
dpc-500	103	30	history	history	NOUN
dpc-500	103	31	of	of	ADP
dpc-500	103	32	coronary	coronary	ADJ
dpc-500	103	33	disease	disease	NOUN
dpc-500	103	34	2	2	NUM
dpc-500	103	35	(	(	PUNCT
dpc-500	103	36	6.7	6.7	NUM
dpc-500	103	37	)	)	SYM
dpc-500	103	38	1	1	NUM
dpc-500	103	39	(	(	PUNCT
dpc-500	103	40	3.3	3.3	NUM
dpc-500	103	41	)	)	PUNCT
dpc-500	103	42	0.998	0.998	NUM
dpc-500	103	43	history	history	NOUN
dpc-500	103	44	of	of	ADP
dpc-500	103	45	avn	avn	NOUN
dpc-500	103	46	2	2	NUM
dpc-500	103	47	(	(	PUNCT
dpc-500	103	48	6.7	6.7	NUM
dpc-500	103	49	)	)	PUNCT
dpc-500	103	50	0	0	NUM
dpc-500	103	51	(	(	PUNCT
dpc-500	103	52	0.0	0.0	NUM
dpc-500	103	53	)	)	PUNCT
dpc-500	103	54	0.492	0.492	NUM
dpc-500	103	55	history	history	NOUN
dpc-500	103	56	of	of	ADP
dpc-500	103	57	hypothyroidism	hypothyroidism	NOUN
dpc-500	103	58	2	2	NUM
dpc-500	103	59	(	(	PUNCT
dpc-500	103	60	6.7	6.7	NUM
dpc-500	103	61	)	)	PUNCT
dpc-500	103	62	0	0	NUM
dpc-500	103	63	(	(	PUNCT
dpc-500	103	64	0.0	0.0	NUM
dpc-500	103	65	)	)	PUNCT
dpc-500	103	66	0.492	0.492	NUM
dpc-500	103	67	form	form	NOUN
dpc-500	103	68	of	of	ADP
dpc-500	103	69	disease	disease	NOUN
dpc-500	103	70	0.706	0.706	NUM
dpc-500	103	71	mucous	mucous	ADJ
dpc-500	103	72	3	3	NUM
dpc-500	103	73	(	(	PUNCT
dpc-500	103	74	10.0	10.0	NUM
dpc-500	103	75	)	)	SYM
dpc-500	103	76	5	5	NUM
dpc-500	103	77	(	(	PUNCT
dpc-500	103	78	16.7	16.7	NUM
dpc-500	103	79	)	)	PUNCT
dpc-500	103	80	mucocutaneous	mucocutaneous	ADJ
dpc-500	103	81	27	27	NUM
dpc-500	103	82	(	(	PUNCT
dpc-500	103	83	90.0	90.0	NUM
dpc-500	103	84	)	)	PUNCT
dpc-500	103	85	25	25	NUM
dpc-500	103	86	(	(	PUNCT
dpc-500	103	87	83.3	83.3	NUM
dpc-500	103	88	)	)	PUNCT
dpc-500	103	89	medication	medication	NOUN
dpc-500	103	90	azathioprine	azathioprine	NOUN
dpc-500	103	91	19	19	NUM
dpc-500	103	92	(	(	PUNCT
dpc-500	103	93	63.3	63.3	NUM
dpc-500	103	94	)	)	PUNCT
dpc-500	103	95	20	20	NUM
dpc-500	103	96	(	(	PUNCT
dpc-500	103	97	66.7	66.7	NUM
dpc-500	103	98	)	)	PUNCT
dpc-500	103	99	0.787	0.787	NUM
dpc-500	103	100	mycophenolic	mycophenolic	ADJ
dpc-500	103	101	acid	acid	NOUN
dpc-500	103	102	13	13	NUM
dpc-500	103	103	(	(	PUNCT
dpc-500	103	104	43.3	43.3	NUM
dpc-500	103	105	)	)	PUNCT
dpc-500	103	106	13	13	NUM
dpc-500	103	107	(	(	PUNCT
dpc-500	103	108	43.3	43.3	NUM
dpc-500	103	109	)	)	PUNCT
dpc-500	103	110	1.000	1.000	NUM
dpc-500	103	111	rituximab	rituximab	NOUN
dpc-500	103	112	12	12	NUM
dpc-500	103	113	(	(	PUNCT
dpc-500	103	114	40.0	40.0	NUM
dpc-500	103	115	)	)	PUNCT
dpc-500	103	116	10	10	NUM
dpc-500	103	117	(	(	PUNCT
dpc-500	103	118	33.3	33.3	NUM
dpc-500	103	119	)	)	PUNCT
dpc-500	103	120	0.592	0.592	NUM
dpc-500	103	121	methotrexate	methotrexate	NOUN
dpc-500	103	122	4	4	NUM
dpc-500	103	123	(	(	PUNCT
dpc-500	103	124	13.3	13.3	NUM
dpc-500	103	125	)	)	PUNCT
dpc-500	103	126	4	4	NUM
dpc-500	103	127	(	(	PUNCT
dpc-500	103	128	13.3	13.3	NUM
dpc-500	103	129	)	)	PUNCT
dpc-500	103	130	1.000	1.000	NUM
dpc-500	103	131	ivig	ivig	NOUN
dpc-500	103	132	2	2	NUM
dpc-500	103	133	(	(	PUNCT
dpc-500	103	134	6.7	6.7	NUM
dpc-500	103	135	)	)	SYM
dpc-500	103	136	1	1	NUM
dpc-500	103	137	(	(	PUNCT
dpc-500	103	138	3.3	3.3	NUM
dpc-500	103	139	)	)	PUNCT
dpc-500	103	140	0.999	0.999	NUM
dpc-500	103	141	cyclophosphamide	cyclophosphamide	NOUN
dpc-500	103	142	3	3	NUM
dpc-500	103	143	(	(	PUNCT
dpc-500	103	144	10.0	10.0	NUM
dpc-500	103	145	)	)	PUNCT
dpc-500	103	146	0	0	NUM
dpc-500	103	147	(	(	PUNCT
dpc-500	103	148	0.0	0.0	NUM
dpc-500	103	149	)	)	PUNCT
dpc-500	103	150	0.237	0.237	NUM
dpc-500	103	151	unless	unless	SCONJ
dpc-500	103	152	noted	note	VERB
dpc-500	103	153	otherwise	otherwise	ADV
dpc-500	103	154	,	,	PUNCT
dpc-500	103	155	values	value	NOUN
dpc-500	103	156	represent	represent	VERB
dpc-500	103	157	number	number	NOUN
dpc-500	103	158	(	(	PUNCT
dpc-500	103	159	percent	percent	NOUN
dpc-500	103	160	)	)	PUNCT
dpc-500	103	161	.	.	PUNCT
dpc-500	104	1	table	table	NOUN
dpc-500	104	2	3	3	NUM
dpc-500	104	3	.	.	PUNCT
dpc-500	105	1	comparison	comparison	NOUN
dpc-500	105	2	of	of	ADP
dpc-500	105	3	hsv	hsv	PROPN
dpc-500	105	4	and	and	CCONJ
dpc-500	105	5	cmv	cmv	NOUN
dpc-500	105	6	detection	detection	NOUN
dpc-500	105	7	based	base	VERB
dpc-500	105	8	on	on	ADP
dpc-500	105	9	reverse	reverse	ADJ
dpc-500	105	10	transcriptase	transcriptase	NOUN
dpc-500	105	11	polymerase	polymerase	NOUN
dpc-500	105	12	chain	chain	NOUN
dpc-500	105	13	reaction	reaction	NOUN
dpc-500	105	14	techniques	technique	NOUN
dpc-500	105	15	according	accord	VERB
dpc-500	105	16	to	to	ADP
dpc-500	105	17	the	the	DET
dpc-500	105	18	source	source	NOUN
dpc-500	105	19	of	of	ADP
dpc-500	105	20	samples	sample	NOUN
dpc-500	105	21	between	between	ADP
dpc-500	105	22	the	the	DET
dpc-500	105	23	patients	patient	NOUN
dpc-500	105	24	with	with	ADP
dpc-500	105	25	relapse	relapse	NOUN
dpc-500	105	26	and	and	CCONJ
dpc-500	105	27	those	those	PRON
dpc-500	105	28	in	in	ADP
dpc-500	105	29	remission	remission	NOUN
dpc-500	105	30	relapse	relapse	NOUN
dpc-500	105	31	type	type	NOUN
dpc-500	105	32	(	(	PUNCT
dpc-500	105	33	n	n	NOUN
dpc-500	105	34	=	=	SYM
dpc-500	105	35	30	30	NUM
dpc-500	105	36	)	)	PUNCT
dpc-500	105	37	remission	remission	NOUN
dpc-500	105	38	type	type	NOUN
dpc-500	105	39	(	(	PUNCT
dpc-500	105	40	n	n	NOUN
dpc-500	105	41	=	=	SYM
dpc-500	105	42	30	30	NUM
dpc-500	105	43	)	)	PUNCT
dpc-500	105	44	p	p	NOUN
dpc-500	105	45	value	value	NOUN
dpc-500	105	46	hsv	hsv	NOUN
dpc-500	105	47	skin	skin	NOUN
dpc-500	105	48	1	1	NUM
dpc-500	105	49	(	(	PUNCT
dpc-500	105	50	3.3	3.3	NUM
dpc-500	105	51	)	)	PUNCT
dpc-500	105	52	0	0	NUM
dpc-500	106	1	(	(	PUNCT
dpc-500	106	2	0.0	0.0	NUM
dpc-500	106	3	)	)	PUNCT
dpc-500	106	4	0.998	0.998	NUM
dpc-500	106	5	pbmc	pbmc	NOUN
dpc-500	106	6	1	1	NUM
dpc-500	106	7	(	(	PUNCT
dpc-500	106	8	3.3	3.3	NUM
dpc-500	106	9	)	)	SYM
dpc-500	106	10	2	2	NUM
dpc-500	106	11	(	(	PUNCT
dpc-500	106	12	6.7	6.7	NUM
dpc-500	106	13	)	)	PUNCT
dpc-500	106	14	0.898	0.898	NUM
dpc-500	106	15	throat	throat	NOUN
dpc-500	106	16	0	0	NUM
dpc-500	106	17	(	(	PUNCT
dpc-500	106	18	0.0	0.0	NUM
dpc-500	106	19	)	)	PUNCT
dpc-500	106	20	0	0	NUM
dpc-500	106	21	(	(	PUNCT
dpc-500	106	22	0.0	0.0	NUM
dpc-500	106	23	)	)	PUNCT
dpc-500	106	24	1.000	1.000	NUM
dpc-500	106	25	cmv	cmv	NOUN
dpc-500	106	26	skin	skin	NOUN
dpc-500	106	27	3	3	NUM
dpc-500	106	28	(	(	PUNCT
dpc-500	106	29	10.0	10.0	NUM
dpc-500	106	30	)	)	PUNCT
dpc-500	106	31	0	0	NUM
dpc-500	106	32	(	(	PUNCT
dpc-500	106	33	0.0	0.0	NUM
dpc-500	106	34	)	)	PUNCT
dpc-500	106	35	0.237	0.237	NUM
dpc-500	106	36	pbmc	pbmc	NOUN
dpc-500	106	37	5	5	NUM
dpc-500	106	38	(	(	PUNCT
dpc-500	106	39	16.7	16.7	NUM
dpc-500	106	40	)	)	PUNCT
dpc-500	106	41	0	0	NUM
dpc-500	106	42	(	(	PUNCT
dpc-500	106	43	0.0	0.0	NUM
dpc-500	106	44	)	)	PUNCT
dpc-500	106	45	0.052	0.052	NUM
dpc-500	106	46	throat	throat	NOUN
dpc-500	106	47	3	3	NUM
dpc-500	106	48	(	(	PUNCT
dpc-500	106	49	10.0	10.0	NUM
dpc-500	106	50	)	)	PUNCT
dpc-500	106	51	0	0	NUM
dpc-500	106	52	(	(	PUNCT
dpc-500	106	53	0.0	0.0	NUM
dpc-500	106	54	)	)	PUNCT
dpc-500	106	55	0.237	0.237	NUM
dpc-500	106	56	values	value	NOUN
dpc-500	106	57	represent	represent	VERB
dpc-500	106	58	number	number	NOUN
dpc-500	106	59	(	(	PUNCT
dpc-500	106	60	percent	percent	NOUN
dpc-500	106	61	)	)	PUNCT
dpc-500	106	62	.	.	PUNCT
dpc-500	107	1	abbreviation	abbreviation	NOUN
dpc-500	107	2	:	:	PUNCT
dpc-500	107	3	pbmc	pbmc	NOUN
dpc-500	107	4	,	,	PUNCT
dpc-500	107	5	peripheral	peripheral	ADJ
dpc-500	107	6	blood	blood	NOUN
dpc-500	107	7	mononuclear	mononuclear	ADJ
dpc-500	107	8	cell	cell	NOUN
dpc-500	107	9	.	.	PUNCT
dpc-500	108	1	268	268	NUM
dpc-500	108	2	research	research	NOUN
dpc-500	108	3	|	|	ADV
dpc-500	108	4	dermatol	dermatol	NOUN
dpc-500	108	5	pract	pract	NOUN
dpc-500	108	6	concept	concept	NOUN
dpc-500	108	7	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	108	8	table	table	NOUN
dpc-500	108	9	4	4	NUM
dpc-500	108	10	.	.	PUNCT
dpc-500	108	11	multivariable	multivariable	ADJ
dpc-500	108	12	linear	linear	PROPN
dpc-500	108	13	regression	regression	NOUN
dpc-500	108	14	model	model	NOUN
dpc-500	108	15	to	to	PART
dpc-500	108	16	assess	assess	VERB
dpc-500	108	17	the	the	DET
dpc-500	108	18	main	main	ADJ
dpc-500	108	19	correlates	correlate	NOUN
dpc-500	108	20	of	of	ADP
dpc-500	108	21	hsv	hsv	PROPN
dpc-500	108	22	-	-	PUNCT
dpc-500	108	23	igg	igg	NOUN
dpc-500	108	24	antibody	antibody	NOUN
dpc-500	108	25	in	in	ADP
dpc-500	108	26	patients	patient	NOUN
dpc-500	108	27	with	with	ADP
dpc-500	108	28	pemphigus	pemphigus	ADJ
dpc-500	108	29	vulgaris	vulgaris	NOUN
dpc-500	108	30	unstandardized	unstandardized	ADJ
dpc-500	108	31	coefficients	coefficient	NOUN
dpc-500	108	32	standardized	standardize	VERB
dpc-500	108	33	coefficients	coefficient	NOUN
dpc-500	108	34	t	t	PROPN
dpc-500	108	35	p	p	NOUN
dpc-500	108	36	value	value	NOUN
dpc-500	108	37	(	(	PUNCT
dpc-500	108	38	constant	constant	ADJ
dpc-500	108	39	)	)	PUNCT
dpc-500	108	40	b	b	NOUN
dpc-500	108	41	std	std	PROPN
dpc-500	108	42	.	.	NOUN
dpc-500	108	43	error	error	NOUN
dpc-500	108	44	beta	beta	NOUN
dpc-500	108	45	sex	sex	NOUN
dpc-500	108	46	−35.727	−35.727	NOUN
dpc-500	108	47	164.984	164.984	PROPN
dpc-500	108	48	−0.217	−0.217	NOUN
dpc-500	108	49	0.829	0.829	NUM
dpc-500	108	50	age	age	NOUN
dpc-500	108	51	−3.982	−3.982	PROPN
dpc-500	108	52	18.674	18.674	NUM
dpc-500	108	53	−0.031	−0.031	PROPN
dpc-500	108	54	−0.213	−0.213	NOUN
dpc-500	108	55	0.832	0.832	NUM
dpc-500	108	56	type	type	NOUN
dpc-500	108	57	0.492	0.492	NUM
dpc-500	108	58	0.809	0.809	NUM
dpc-500	108	59	0.098	0.098	NUM
dpc-500	108	60	0.608	0.608	NUM
dpc-500	108	61	0.546	0.546	NUM
dpc-500	108	62	duration	duration	NOUN
dpc-500	108	63	−10.558	−10.558	NOUN
dpc-500	108	64	26.124	26.124	NUM
dpc-500	108	65	−0.056	−0.056	NOUN
dpc-500	108	66	−0.404	−0.404	NOUN
dpc-500	108	67	0.688	0.688	NUM
dpc-500	108	68	form	form	NOUN
dpc-500	108	69	0.825	0.825	NUM
dpc-500	108	70	2.345	2.345	NUM
dpc-500	108	71	0.053	0.053	NUM
dpc-500	108	72	0.352	0.352	NUM
dpc-500	108	73	0.726	0.726	NUM
dpc-500	108	74	hypertension	hypertension	NOUN
dpc-500	108	75	−15.421	−15.421	NOUN
dpc-500	108	76	19.720	19.720	NUM
dpc-500	108	77	−0.121	−0.121	VERB
dpc-500	108	78	−0.782	−0.782	PROPN
dpc-500	108	79	0.438	0.438	NUM
dpc-500	108	80	hyperlipidemia	hyperlipidemia	NOUN
dpc-500	108	81	0.185	0.185	NUM
dpc-500	108	82	34.852	34.852	NUM
dpc-500	108	83	0.001	0.001	NUM
dpc-500	108	84	0.005	0.005	NUM
dpc-500	108	85	0.996	0.996	NUM
dpc-500	108	86	diabetes	diabetes	NOUN
dpc-500	108	87	58.505	58.505	NUM
dpc-500	108	88	46.066	46.066	NUM
dpc-500	108	89	0.254	0.254	NUM
dpc-500	108	90	1.270	1.270	NUM
dpc-500	108	91	0.210	0.210	NUM
dpc-500	108	92	coronary	coronary	ADJ
dpc-500	108	93	disease	disease	NOUN
dpc-500	108	94	−14.900	−14.900	NOUN
dpc-500	108	95	33.394	33.394	NUM
dpc-500	108	96	−0.075	−0.075	NOUN
dpc-500	108	97	−0.446	−0.446	NOUN
dpc-500	108	98	0.657	0.657	NUM
dpc-500	108	99	smoking	smoke	VERB
dpc-500	108	100	−2.827	−2.827	PROPN
dpc-500	109	1	45.347	45.347	NUM
dpc-500	109	2	−0.010	−0.010	ADJ
dpc-500	109	3	−0.062	−0.062	NUM
dpc-500	109	4	0.951	0.951	NUM
dpc-500	109	5	(	(	PUNCT
dpc-500	109	6	constant	constant	ADJ
dpc-500	109	7	)	)	PUNCT
dpc-500	109	8	67.297	67.297	NUM
dpc-500	109	9	54.454	54.454	NUM
dpc-500	109	10	0.190	0.190	NUM
dpc-500	109	11	1.236	1.236	NUM
dpc-500	109	12	0.222	0.222	NUM
dpc-500	109	13	figure	figure	NOUN
dpc-500	109	14	 	 	SPACE
dpc-500	109	15	1	1	NUM
dpc-500	109	16	.	.	PUNCT
dpc-500	109	17	level	level	NOUN
dpc-500	109	18	of	of	ADP
dpc-500	109	19	hsv	hsv	PROPN
dpc-500	109	20	-	-	PUNCT
dpc-500	109	21	igg	igg	NOUN
dpc-500	109	22	antibody	antibody	NOUN
dpc-500	109	23	(	(	PUNCT
dpc-500	109	24	cut	cut	VERB
dpc-500	109	25	-	-	PUNCT
dpc-500	109	26	off	off	ADP
dpc-500	109	27	value	value	NOUN
dpc-500	109	28	:	:	PUNCT
dpc-500	109	29	22	22	NUM
dpc-500	109	30	 	 	SPACE
dpc-500	109	31	ru	ru	NOUN
dpc-500	109	32	/	/	SYM
dpc-500	109	33	ml	ml	NOUN
dpc-500	109	34	)	)	PUNCT
dpc-500	109	35	according	accord	VERB
dpc-500	109	36	to	to	ADP
dpc-500	109	37	baseline	baseline	NOUN
dpc-500	109	38	variables	variable	NOUN
dpc-500	109	39	.	.	PUNCT
dpc-500	110	1	research	research	NOUN
dpc-500	110	2	|	|	ADV
dpc-500	110	3	dermatol	dermatol	NOUN
dpc-500	110	4	pract	pract	NOUN
dpc-500	110	5	concept	concept	NOUN
dpc-500	110	6	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	110	7	269	269	NUM
dpc-500	110	8	table	table	NOUN
dpc-500	110	9	5	5	NUM
dpc-500	110	10	.	.	PUNCT
dpc-500	110	11	multivariable	multivariable	ADJ
dpc-500	110	12	linear	linear	PROPN
dpc-500	110	13	regression	regression	NOUN
dpc-500	110	14	model	model	NOUN
dpc-500	110	15	to	to	PART
dpc-500	110	16	assess	assess	VERB
dpc-500	110	17	the	the	DET
dpc-500	110	18	main	main	ADJ
dpc-500	110	19	correlates	correlate	NOUN
dpc-500	110	20	of	of	ADP
dpc-500	110	21	cmv	cmv	NOUN
dpc-500	110	22	-	-	PUNCT
dpc-500	110	23	igg	igg	NOUN
dpc-500	110	24	antibody	antibody	NOUN
dpc-500	110	25	in	in	ADP
dpc-500	110	26	patients	patient	NOUN
dpc-500	110	27	with	with	ADP
dpc-500	110	28	pemphigus	pemphigus	ADJ
dpc-500	110	29	vulgaris	vulgaris	NOUN
dpc-500	110	30	unstandardized	unstandardized	ADJ
dpc-500	110	31	coefficients	coefficient	NOUN
dpc-500	110	32	standardized	standardize	VERB
dpc-500	110	33	coefficients	coefficient	NOUN
dpc-500	110	34	t	t	PROPN
dpc-500	110	35	p	p	NOUN
dpc-500	110	36	value	value	NOUN
dpc-500	110	37	(	(	PUNCT
dpc-500	110	38	constant	constant	ADJ
dpc-500	110	39	)	)	PUNCT
dpc-500	110	40	b	b	NOUN
dpc-500	110	41	std	std	PROPN
dpc-500	110	42	.	.	NOUN
dpc-500	110	43	error	error	NOUN
dpc-500	110	44	beta	beta	NOUN
dpc-500	110	45	sex	sex	NOUN
dpc-500	110	46	−62.825	−62.825	NOUN
dpc-500	110	47	114.201	114.201	NUM
dpc-500	110	48	−0.550	−0.550	NOUN
dpc-500	110	49	0.585	0.585	NUM
dpc-500	110	50	age	age	NOUN
dpc-500	110	51	28.334	28.334	NUM
dpc-500	110	52	12.926	12.926	NUM
dpc-500	110	53	0.281	0.281	NUM
dpc-500	110	54	2.192	2.192	NUM
dpc-500	110	55	0.033	0.033	NUM
dpc-500	110	56	type	type	NOUN
dpc-500	110	57	1.196	1.196	NUM
dpc-500	110	58	0.560	0.560	NUM
dpc-500	110	59	0.303	0.303	NUM
dpc-500	110	60	2.135	2.135	NUM
dpc-500	110	61	0.038	0.038	NUM
dpc-500	110	62	duration	duration	NOUN
dpc-500	110	63	24.026	24.026	NUM
dpc-500	110	64	18.083	18.083	NUM
dpc-500	110	65	0.163	0.163	NUM
dpc-500	110	66	1.329	1.329	NUM
dpc-500	110	67	0.190	0.190	NUM
dpc-500	110	68	form	form	NOUN
dpc-500	110	69	−0.515	−0.515	NOUN
dpc-500	110	70	1.623	1.623	NUM
dpc-500	110	71	−0.042	−0.042	NOUN
dpc-500	110	72	−0.317	−0.317	PROPN
dpc-500	110	73	0.752	0.752	NUM
dpc-500	110	74	hypertension	hypertension	NOUN
dpc-500	110	75	−2.244	−2.244	NOUN
dpc-500	110	76	13.650	13.650	NUM
dpc-500	110	77	−0.022	−0.022	PROPN
dpc-500	110	78	−0.164	−0.164	NOUN
dpc-500	110	79	0.870	0.870	NUM
dpc-500	110	80	hyperlipidemia	hyperlipidemia	NOUN
dpc-500	110	81	−14.238	−14.238	NOUN
dpc-500	110	82	24.124	24.124	NUM
dpc-500	110	83	−0.110	−0.110	PROPN
dpc-500	110	84	−0.590	−0.590	NOUN
dpc-500	110	85	0.558	0.558	NUM
dpc-500	110	86	diabetes	diabetes	NOUN
dpc-500	110	87	12.675	12.675	NUM
dpc-500	110	88	31.886	31.886	NUM
dpc-500	110	89	0.070	0.070	NUM
dpc-500	110	90	0.397	0.397	NUM
dpc-500	110	91	0.693	0.693	NUM
dpc-500	110	92	coronary	coronary	ADJ
dpc-500	110	93	dis	dis	NOUN
dpc-500	110	94	.	.	PUNCT
dpc-500	111	1	35.510	35.510	NUM
dpc-500	111	2	23.115	23.115	NUM
dpc-500	111	3	0.228	0.228	NUM
dpc-500	111	4	1.536	1.536	NUM
dpc-500	111	5	0.131	0.131	NUM
dpc-500	111	6	smoking	smoking	NOUN
dpc-500	111	7	−46.372	−46.372	NOUN
dpc-500	111	8	31.389	31.389	NUM
dpc-500	111	9	−0.202	−0.202	ADP
dpc-500	111	10	−1.477	−1.477	NOUN
dpc-500	111	11	0.146	0.146	NUM
dpc-500	111	12	(	(	PUNCT
dpc-500	111	13	constant	constant	ADJ
dpc-500	111	14	)	)	PUNCT
dpc-500	111	15	39.650	39.650	NUM
dpc-500	111	16	37.693	37.693	NUM
dpc-500	111	17	0.142	0.142	NUM
dpc-500	111	18	1.052	1.052	NUM
dpc-500	111	19	0.298	0.298	NUM
dpc-500	111	20	figure	figure	NOUN
dpc-500	111	21	 	 	SPACE
dpc-500	111	22	2	2	NUM
dpc-500	111	23	.	.	PUNCT
dpc-500	111	24	level	level	NOUN
dpc-500	111	25	of	of	ADP
dpc-500	111	26	cmv	cmv	NOUN
dpc-500	111	27	-	-	PUNCT
dpc-500	111	28	igg	igg	NOUN
dpc-500	111	29	antibody	antibody	NOUN
dpc-500	111	30	(	(	PUNCT
dpc-500	111	31	cut	cut	VERB
dpc-500	111	32	-	-	PUNCT
dpc-500	111	33	off	off	ADP
dpc-500	111	34	value	value	NOUN
dpc-500	111	35	:	:	PUNCT
dpc-500	111	36	22	22	NUM
dpc-500	111	37	 	 	SPACE
dpc-500	111	38	ru	ru	NOUN
dpc-500	111	39	/	/	SYM
dpc-500	111	40	ml	ml	NOUN
dpc-500	111	41	)	)	PUNCT
dpc-500	111	42	according	accord	VERB
dpc-500	111	43	to	to	ADP
dpc-500	111	44	baseline	baseline	NOUN
dpc-500	111	45	variables	variable	NOUN
dpc-500	111	46	.	.	PUNCT
dpc-500	112	1	270	270	NUM
dpc-500	112	2	research	research	NOUN
dpc-500	112	3	|	|	ADV
dpc-500	112	4	dermatol	dermatol	NOUN
dpc-500	112	5	pract	pract	NOUN
dpc-500	112	6	concept	concept	NOUN
dpc-500	112	7	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	112	8	mati	mati	PROPN
dpc-500	112	9	-	-	PUNCT
dpc-500	112	10	roodsari	roodsari	PROPN
dpc-500	112	11	et	et	PROPN
dpc-500	112	12	 	 	SPACE
dpc-500	112	13	al	al	PROPN
dpc-500	112	14	,	,	PUNCT
dpc-500	112	15	similar	similar	ADJ
dpc-500	112	16	to	to	ADP
dpc-500	112	17	our	our	PRON
dpc-500	112	18	study	study	NOUN
dpc-500	112	19	,	,	PUNCT
dpc-500	112	20	only	only	ADV
dpc-500	112	21	 	 	SPACE
dpc-500	112	22	1	1	NUM
dpc-500	112	23	 	 	SPACE
dpc-500	112	24	patient	patient	NOUN
dpc-500	112	25	had	have	VERB
dpc-500	112	26	a	a	DET
dpc-500	112	27	positive	positive	ADJ
dpc-500	112	28	hsv	hsv	NOUN
dpc-500	112	29	pcr	pcr	NOUN
dpc-500	112	30	result	result	NOUN
dpc-500	112	31	for	for	ADP
dpc-500	112	32	skin	skin	NOUN
dpc-500	112	33	samples	sample	NOUN
dpc-500	112	34	[	[	X
dpc-500	112	35	32,33	32,33	NUM
dpc-500	112	36	]	]	PUNCT
dpc-500	112	37	.	.	PUNCT
dpc-500	113	1	these	these	DET
dpc-500	113	2	values	value	NOUN
dpc-500	113	3	are	be	AUX
dpc-500	113	4	less	less	ADJ
dpc-500	113	5	than	than	ADP
dpc-500	113	6	the	the	DET
dpc-500	113	7	findings	finding	NOUN
dpc-500	113	8	of	of	ADP
dpc-500	113	9	the	the	DET
dpc-500	113	10	study	study	NOUN
dpc-500	113	11	by	by	ADP
dpc-500	113	12	tufano	tufano	ADJ
dpc-500	113	13	et	et	PROPN
dpc-500	113	14	 	 	SPACE
dpc-500	113	15	al	al	PROPN
dpc-500	113	16	,	,	PUNCT
dpc-500	113	17	reporting	report	VERB
dpc-500	113	18	positive	positive	ADJ
dpc-500	113	19	hsv	hsv	NOUN
dpc-500	113	20	pcr	pcr	NOUN
dpc-500	113	21	in	in	ADP
dpc-500	113	22	 	 	SPACE
dpc-500	113	23	5	5	NUM
dpc-500	113	24	 	 	SPACE
dpc-500	113	25	of	of	ADP
dpc-500	113	26	 	 	SPACE
dpc-500	113	27	7	7	NUM
dpc-500	113	28	 	 	SPACE
dpc-500	113	29	skin	skin	NOUN
dpc-500	113	30	specimens	specimen	NOUN
dpc-500	113	31	[	[	X
dpc-500	113	32	29	29	NUM
dpc-500	113	33	]	]	PUNCT
dpc-500	113	34	.	.	PUNCT
dpc-500	114	1	other	other	ADJ
dpc-500	114	2	pcr	pcr	PROPN
dpc-500	114	3	results	result	NOUN
dpc-500	114	4	show	show	VERB
dpc-500	114	5	evidence	evidence	NOUN
dpc-500	114	6	of	of	ADP
dpc-500	114	7	hsv1	hsv1	PROPN
dpc-500	114	8	 	 	SPACE
dpc-500	114	9	infection	infection	NOUN
dpc-500	114	10	in	in	ADP
dpc-500	114	11	 	 	SPACE
dpc-500	114	12	10	10	NUM
dpc-500	114	13	%	%	NOUN
dpc-500	114	14	of	of	ADP
dpc-500	114	15	all	all	DET
dpc-500	114	16	blood	blood	NOUN
dpc-500	114	17	samples	sample	NOUN
dpc-500	114	18	and	and	CCONJ
dpc-500	114	19	cmv	cmv	NOUN
dpc-500	114	20	infection	infection	NOUN
dpc-500	114	21	in	in	ADP
dpc-500	114	22	 	 	SPACE
dpc-500	114	23	16.6	16.6	NUM
dpc-500	114	24	%	%	NOUN
dpc-500	114	25	of	of	ADP
dpc-500	114	26	all	all	DET
dpc-500	114	27	blood	blood	NOUN
dpc-500	114	28	samples	sample	NOUN
dpc-500	114	29	,	,	PUNCT
dpc-500	114	30	10	10	NUM
dpc-500	114	31	%	%	NOUN
dpc-500	114	32	of	of	ADP
dpc-500	114	33	all	all	DET
dpc-500	114	34	skin	skin	NOUN
dpc-500	114	35	samples	sample	NOUN
dpc-500	114	36	,	,	PUNCT
dpc-500	114	37	and	and	CCONJ
dpc-500	114	38	 	 	SPACE
dpc-500	114	39	10	10	NUM
dpc-500	114	40	%	%	NOUN
dpc-500	114	41	of	of	ADP
dpc-500	114	42	all	all	DET
dpc-500	114	43	throat	throat	NOUN
dpc-500	114	44	samples	sample	NOUN
dpc-500	114	45	.	.	PUNCT
dpc-500	115	1	on	on	ADP
dpc-500	115	2	the	the	DET
dpc-500	115	3	other	other	ADJ
dpc-500	115	4	hand	hand	NOUN
dpc-500	115	5	,	,	PUNCT
dpc-500	115	6	several	several	ADJ
dpc-500	115	7	studies	study	NOUN
dpc-500	115	8	failed	fail	VERB
dpc-500	115	9	to	to	PART
dpc-500	115	10	detect	detect	VERB
dpc-500	115	11	herpes	herpe	NOUN
dpc-500	115	12	dna	dna	PROPN
dpc-500	115	13	viruses	virus	NOUN
dpc-500	115	14	in	in	ADP
dpc-500	115	15	pemphigus	pemphigus	ADJ
dpc-500	115	16	patient	patient	ADJ
dpc-500	115	17	specimens	specimen	NOUN
dpc-500	115	18	[	[	X
dpc-500	115	19	26,27	26,27	NUM
dpc-500	115	20	]	]	PUNCT
dpc-500	115	21	.	.	PUNCT
dpc-500	116	1	senger	senger	PROPN
dpc-500	116	2	et	et	PROPN
dpc-500	116	3	 	 	SPACE
dpc-500	116	4	al	al	PROPN
dpc-500	116	5	showed	show	VERB
dpc-500	116	6	the	the	DET
dpc-500	116	7	role	role	NOUN
dpc-500	116	8	of	of	ADP
dpc-500	116	9	hsv1	hsv1	PROPN
dpc-500	116	10	 	 	SPACE
dpc-500	116	11	in	in	ADP
dpc-500	116	12	exacerbation	exacerbation	NOUN
dpc-500	116	13	of	of	ADP
dpc-500	116	14	pemphigus	pemphigus	NOUN
dpc-500	116	15	by	by	ADP
dpc-500	116	16	using	use	VERB
dpc-500	116	17	the	the	DET
dpc-500	116	18	elisa	elisa	NOUN
dpc-500	116	19	technique	technique	NOUN
dpc-500	116	20	[	[	X
dpc-500	116	21	31	31	NUM
dpc-500	116	22	]	]	PUNCT
dpc-500	116	23	.	.	PUNCT
dpc-500	117	1	however	however	ADV
dpc-500	117	2	,	,	PUNCT
dpc-500	117	3	we	we	PRON
dpc-500	117	4	found	find	VERB
dpc-500	117	5	no	no	DET
dpc-500	117	6	correlation	correlation	NOUN
dpc-500	117	7	between	between	ADP
dpc-500	117	8	hsv	hsv	PROPN
dpc-500	117	9	and	and	CCONJ
dpc-500	117	10	cmv	cmv	NOUN
dpc-500	117	11	pcr	pcr	NOUN
dpc-500	117	12	results	result	NOUN
dpc-500	117	13	or	or	CCONJ
dpc-500	117	14	igg	igg	NOUN
dpc-500	117	15	antibody	antibody	NOUN
dpc-500	117	16	levels	level	NOUN
dpc-500	117	17	and	and	CCONJ
dpc-500	117	18	disease	disease	NOUN
dpc-500	117	19	activity	activity	NOUN
dpc-500	117	20	(	(	PUNCT
dpc-500	117	21	relapse	relapse	NOUN
dpc-500	117	22	or	or	CCONJ
dpc-500	117	23	remission	remission	NOUN
dpc-500	117	24	)	)	PUNCT
dpc-500	117	25	.	.	PUNCT
dpc-500	118	1	these	these	DET
dpc-500	118	2	findings	finding	NOUN
dpc-500	118	3	can	can	AUX
dpc-500	118	4	not	not	PART
dpc-500	118	5	rule	rule	VERB
dpc-500	118	6	out	out	ADP
dpc-500	118	7	the	the	DET
dpc-500	118	8	role	role	NOUN
dpc-500	118	9	of	of	ADP
dpc-500	118	10	these	these	DET
dpc-500	118	11	viruses	virus	NOUN
dpc-500	118	12	in	in	ADP
dpc-500	118	13	exacerbation	exacerbation	NOUN
dpc-500	118	14	of	of	ADP
dpc-500	118	15	the	the	DET
dpc-500	118	16	disease	disease	NOUN
dpc-500	118	17	;	;	PUNCT
dpc-500	118	18	improvement	improvement	NOUN
dpc-500	118	19	in	in	ADP
dpc-500	118	20	some	some	DET
dpc-500	118	21	patients	patient	NOUN
dpc-500	118	22	,	,	PUNCT
dpc-500	118	23	especially	especially	ADV
dpc-500	118	24	those	those	PRON
dpc-500	118	25	with	with	ADP
dpc-500	118	26	the	the	DET
dpc-500	118	27	mucosal	mucosal	NOUN
dpc-500	118	28	form	form	NOUN
dpc-500	118	29	,	,	PUNCT
dpc-500	118	30	after	after	ADP
dpc-500	118	31	receiving	receive	VERB
dpc-500	118	32	antiviral	antiviral	ADJ
dpc-500	118	33	therapy	therapy	NOUN
dpc-500	118	34	as	as	ADV
dpc-500	118	35	well	well	ADV
dpc-500	118	36	as	as	ADP
dpc-500	118	37	exacerbation	exacerbation	NOUN
dpc-500	118	38	of	of	ADP
dpc-500	118	39	pemphigus	pemphigus	NOUN
dpc-500	118	40	after	after	SCONJ
dpc-500	118	41	hsv	hsv	PROPN
dpc-500	118	42	infection	infection	NOUN
dpc-500	118	43	are	be	AUX
dpc-500	118	44	clinical	clinical	ADJ
dpc-500	118	45	evidence	evidence	NOUN
dpc-500	118	46	of	of	ADP
dpc-500	118	47	the	the	DET
dpc-500	118	48	possible	possible	ADJ
dpc-500	118	49	role	role	NOUN
dpc-500	118	50	of	of	ADP
dpc-500	118	51	viruses	virus	NOUN
dpc-500	118	52	in	in	ADP
dpc-500	118	53	disease	disease	NOUN
dpc-500	118	54	exacerbation	exacerbation	NOUN
dpc-500	118	55	[	[	X
dpc-500	118	56	22	22	NUM
dpc-500	118	57	]	]	PUNCT
dpc-500	118	58	.	.	PUNCT
dpc-500	119	1	therefore	therefore	ADV
dpc-500	119	2	,	,	PUNCT
dpc-500	119	3	the	the	DET
dpc-500	119	4	role	role	NOUN
dpc-500	119	5	of	of	ADP
dpc-500	119	6	viruses	virus	NOUN
dpc-500	119	7	in	in	ADP
dpc-500	119	8	exacerbation	exacerbation	NOUN
dpc-500	119	9	of	of	ADP
dpc-500	119	10	pemphigus	pemphigus	NOUN
dpc-500	119	11	remains	remain	VERB
dpc-500	119	12	a	a	DET
dpc-500	119	13	hypothesis	hypothesis	NOUN
dpc-500	119	14	and	and	CCONJ
dpc-500	119	15	requires	require	VERB
dpc-500	119	16	further	further	ADJ
dpc-500	119	17	study	study	NOUN
dpc-500	119	18	.	.	PUNCT
dpc-500	120	1	our	our	PRON
dpc-500	120	2	study	study	NOUN
dpc-500	120	3	is	be	AUX
dpc-500	120	4	unique	unique	ADJ
dpc-500	120	5	for	for	ADP
dpc-500	120	6	several	several	ADJ
dpc-500	120	7	reasons	reason	NOUN
dpc-500	120	8	.	.	PUNCT
dpc-500	121	1	first	first	ADV
dpc-500	121	2	,	,	PUNCT
dpc-500	121	3	we	we	PRON
dpc-500	121	4	used	use	VERB
dpc-500	121	5	both	both	CCONJ
dpc-500	121	6	elisa	elisa	NOUN
dpc-500	121	7	and	and	CCONJ
dpc-500	121	8	pcr	pcr	NOUN
dpc-500	121	9	techniques	technique	NOUN
dpc-500	121	10	to	to	PART
dpc-500	121	11	find	find	VERB
dpc-500	121	12	evidence	evidence	NOUN
dpc-500	121	13	of	of	ADP
dpc-500	121	14	viruses	virus	NOUN
dpc-500	121	15	,	,	PUNCT
dpc-500	121	16	whereas	whereas	SCONJ
dpc-500	121	17	most	most	ADJ
dpc-500	121	18	previous	previous	ADJ
dpc-500	121	19	studies	study	NOUN
dpc-500	121	20	used	use	VERB
dpc-500	121	21	only	only	ADV
dpc-500	121	22	one	one	NUM
dpc-500	121	23	technique	technique	NOUN
dpc-500	121	24	.	.	PUNCT
dpc-500	122	1	second	second	ADJ
dpc-500	122	2	,	,	PUNCT
dpc-500	122	3	the	the	DET
dpc-500	122	4	samples	sample	NOUN
dpc-500	122	5	were	be	AUX
dpc-500	122	6	sourced	source	VERB
dpc-500	122	7	from	from	ADP
dpc-500	122	8	several	several	ADJ
dpc-500	122	9	sites	site	NOUN
dpc-500	122	10	including	include	VERB
dpc-500	122	11	skin	skin	NOUN
dpc-500	122	12	,	,	PUNCT
dpc-500	122	13	throat	throat	NOUN
dpc-500	122	14	,	,	PUNCT
dpc-500	122	15	and	and	CCONJ
dpc-500	122	16	blood	blood	NOUN
dpc-500	122	17	.	.	PUNCT
dpc-500	123	1	third	third	ADJ
dpc-500	123	2	,	,	PUNCT
dpc-500	123	3	we	we	PRON
dpc-500	123	4	evaluated	evaluate	VERB
dpc-500	123	5	virus	virus	NOUN
dpc-500	123	6	status	status	NOUN
dpc-500	123	7	in	in	ADP
dpc-500	123	8	relapse	relapse	NOUN
dpc-500	123	9	and	and	CCONJ
dpc-500	123	10	remission	remission	NOUN
dpc-500	123	11	pv	pv	NOUN
dpc-500	123	12	patients	patient	NOUN
dpc-500	123	13	to	to	PART
dpc-500	123	14	determine	determine	VERB
dpc-500	123	15	the	the	DET
dpc-500	123	16	role	role	NOUN
dpc-500	123	17	of	of	ADP
dpc-500	123	18	viruses	virus	NOUN
dpc-500	123	19	in	in	ADP
dpc-500	123	20	the	the	DET
dpc-500	123	21	exacerbation	exacerbation	NOUN
dpc-500	123	22	of	of	ADP
dpc-500	123	23	the	the	DET
dpc-500	123	24	disease	disease	NOUN
dpc-500	123	25	,	,	PUNCT
dpc-500	123	26	whereas	whereas	SCONJ
dpc-500	123	27	most	most	ADJ
dpc-500	123	28	previous	previous	ADJ
dpc-500	123	29	studies	study	NOUN
dpc-500	123	30	examined	examine	VERB
dpc-500	123	31	the	the	DET
dpc-500	123	32	status	status	NOUN
dpc-500	123	33	of	of	ADP
dpc-500	123	34	viruses	virus	NOUN
dpc-500	123	35	in	in	ADP
dpc-500	123	36	newly	newly	ADV
dpc-500	123	37	diagnosed	diagnose	VERB
dpc-500	123	38	patients	patient	NOUN
dpc-500	123	39	and	and	CCONJ
dpc-500	123	40	healthy	healthy	ADJ
dpc-500	123	41	controls	control	NOUN
dpc-500	123	42	to	to	PART
dpc-500	123	43	determine	determine	VERB
dpc-500	123	44	the	the	DET
dpc-500	123	45	etiological	etiological	ADJ
dpc-500	123	46	role	role	NOUN
dpc-500	123	47	of	of	ADP
dpc-500	123	48	viruses	virus	NOUN
dpc-500	123	49	.	.	PUNCT
dpc-500	124	1	however	however	ADV
dpc-500	124	2	,	,	PUNCT
dpc-500	124	3	this	this	DET
dpc-500	124	4	study	study	NOUN
dpc-500	124	5	had	have	VERB
dpc-500	124	6	some	some	DET
dpc-500	124	7	limitations	limitation	NOUN
dpc-500	124	8	.	.	PUNCT
dpc-500	125	1	we	we	PRON
dpc-500	125	2	could	could	AUX
dpc-500	125	3	not	not	PART
dpc-500	125	4	evaluate	evaluate	VERB
dpc-500	125	5	other	other	ADJ
dpc-500	125	6	types	type	NOUN
dpc-500	125	7	of	of	ADP
dpc-500	125	8	pemphigus	pemphigus	NOUN
dpc-500	125	9	disease	disease	NOUN
dpc-500	125	10	due	due	ADP
dpc-500	125	11	to	to	ADP
dpc-500	125	12	their	their	PRON
dpc-500	125	13	lower	low	ADJ
dpc-500	125	14	prevalence	prevalence	NOUN
dpc-500	125	15	.	.	PUNCT
dpc-500	126	1	because	because	SCONJ
dpc-500	126	2	of	of	ADP
dpc-500	126	3	high	high	ADJ
dpc-500	126	4	costs	cost	NOUN
dpc-500	126	5	of	of	ADP
dpc-500	126	6	the	the	DET
dpc-500	126	7	techniques	technique	NOUN
dpc-500	126	8	,	,	PUNCT
dpc-500	126	9	we	we	PRON
dpc-500	126	10	were	be	AUX
dpc-500	126	11	able	able	ADJ
dpc-500	126	12	to	to	PART
dpc-500	126	13	investigate	investigate	VERB
dpc-500	126	14	only	only	ADV
dpc-500	126	15	the	the	DET
dpc-500	126	16	role	role	NOUN
dpc-500	126	17	of	of	ADP
dpc-500	126	18	hsv1/2	hsv1/2	PRON
dpc-500	126	19	 	 	SPACE
dpc-500	126	20	and	and	CCONJ
dpc-500	126	21	cmv	cmv	NOUN
dpc-500	126	22	in	in	ADP
dpc-500	126	23	the	the	DET
dpc-500	126	24	exacerbation	exacerbation	NOUN
dpc-500	126	25	of	of	ADP
dpc-500	126	26	disease	disease	NOUN
dpc-500	126	27	.	.	PUNCT
dpc-500	127	1	conclusions	conclusion	NOUN
dpc-500	127	2	in	in	ADP
dpc-500	127	3	conclusion	conclusion	NOUN
dpc-500	127	4	,	,	PUNCT
dpc-500	127	5	our	our	PRON
dpc-500	127	6	study	study	NOUN
dpc-500	127	7	could	could	AUX
dpc-500	127	8	not	not	PART
dpc-500	127	9	demonstrate	demonstrate	VERB
dpc-500	127	10	the	the	DET
dpc-500	127	11	role	role	NOUN
dpc-500	127	12	of	of	ADP
dpc-500	127	13	hsv1/2	hsv1/2	PRON
dpc-500	127	14	 	 	SPACE
dpc-500	127	15	and	and	CCONJ
dpc-500	127	16	cmv	cmv	NOUN
dpc-500	127	17	as	as	ADP
dpc-500	127	18	triggering	trigger	VERB
dpc-500	127	19	factors	factor	NOUN
dpc-500	127	20	for	for	ADP
dpc-500	127	21	pv	pv	NOUN
dpc-500	127	22	exacerbation	exacerbation	NOUN
dpc-500	127	23	.	.	PUNCT
dpc-500	128	1	further	further	ADJ
dpc-500	128	2	studies	study	NOUN
dpc-500	128	3	are	be	AUX
dpc-500	128	4	needed	need	VERB
dpc-500	128	5	to	to	PART
dpc-500	128	6	evaluate	evaluate	VERB
dpc-500	128	7	the	the	DET
dpc-500	128	8	potential	potential	ADJ
dpc-500	128	9	role	role	NOUN
dpc-500	128	10	of	of	ADP
dpc-500	128	11	these	these	DET
dpc-500	128	12	viruses	virus	NOUN
dpc-500	128	13	in	in	ADP
dpc-500	128	14	pv	pv	NOUN
dpc-500	128	15	exacerbation	exacerbation	NOUN
dpc-500	128	16	.	.	PUNCT
dpc-500	129	1	references	reference	NOUN
dpc-500	129	2	1	1	NUM
dpc-500	129	3	.	.	PUNCT
dpc-500	129	4	kasperkiewicz	kasperkiewicz	PROPN
dpc-500	129	5	m	m	PROPN
dpc-500	129	6	,	,	PUNCT
dpc-500	129	7	ellebrecht	ellebrecht	PROPN
dpc-500	129	8	ct	ct	PROPN
dpc-500	129	9	,	,	PUNCT
dpc-500	129	10	takahashi	takahashi	PROPN
dpc-500	129	11	h	h	PROPN
dpc-500	129	12	,	,	PUNCT
dpc-500	129	13	et	et	PROPN
dpc-500	129	14	 	 	SPACE
dpc-500	129	15	al	al	PROPN
dpc-500	129	16	.	.	PROPN
dpc-500	129	17	pemphigus	pemphigus	PROPN
dpc-500	129	18	.	.	PUNCT
dpc-500	130	1	nat	nat	PROPN
dpc-500	130	2	rev	rev	VERB
dpc-500	130	3	dis	dis	PROPN
dpc-500	130	4	primers	primer	NOUN
dpc-500	130	5	.	.	PUNCT
dpc-500	131	1	2017;3:17026	2017;3:17026	NOUN
dpc-500	131	2	.	.	PUNCT
dpc-500	132	1	2	2	NUM
dpc-500	132	2	.	.	X
dpc-500	132	3	spindler	spindler	PROPN
dpc-500	132	4	v	v	PROPN
dpc-500	132	5	,	,	PUNCT
dpc-500	132	6	waschke	waschke	VERB
dpc-500	132	7	j.	j.	PROPN
dpc-500	132	8	pemphigus	pemphigus	PROPN
dpc-500	132	9	:	:	PUNCT
dpc-500	132	10	a	a	DET
dpc-500	132	11	disease	disease	NOUN
dpc-500	132	12	of	of	ADP
dpc-500	132	13	desmosome	desmosome	ADJ
dpc-500	132	14	dysfunction	dysfunction	NOUN
dpc-500	132	15	caused	cause	VERB
dpc-500	132	16	by	by	ADP
dpc-500	132	17	multiple	multiple	ADJ
dpc-500	132	18	mechanisms	mechanism	NOUN
dpc-500	132	19	.	.	PUNCT
dpc-500	133	1	front	front	ADJ
dpc-500	133	2	immunol	immunol	NOUN
dpc-500	133	3	.	.	PUNCT
dpc-500	134	1	2018;9:136	2018;9:136	NUM
dpc-500	134	2	.	.	PUNCT
dpc-500	135	1	3	3	X
dpc-500	135	2	.	.	X
dpc-500	135	3	kridin	kridin	VERB
dpc-500	135	4	k.	k.	PROPN
dpc-500	136	1	pemphigus	pemphigus	PROPN
dpc-500	136	2	 	 	SPACE
dpc-500	136	3	group	group	NOUN
dpc-500	136	4	:	:	PUNCT
dpc-500	136	5	overview	overview	NOUN
dpc-500	136	6	,	,	PUNCT
dpc-500	136	7	epidemiology	epidemiology	NOUN
dpc-500	136	8	,	,	PUNCT
dpc-500	136	9	mortality	mortality	NOUN
dpc-500	136	10	,	,	PUNCT
dpc-500	136	11	and	and	CCONJ
dpc-500	136	12	comorbidities	comorbiditie	NOUN
dpc-500	136	13	.	.	PUNCT
dpc-500	137	1	immunol	immunol	NOUN
dpc-500	137	2	res	re	NOUN
dpc-500	137	3	.	.	PUNCT
dpc-500	138	1	2018;66(2):255	2018;66(2):255	NUM
dpc-500	138	2	-	-	SYM
dpc-500	138	3	270	270	NUM
dpc-500	138	4	.	.	PUNCT
dpc-500	139	1	4	4	NUM
dpc-500	139	2	.	.	X
dpc-500	139	3	tur	tur	PROPN
dpc-500	139	4	e	e	X
dpc-500	139	5	,	,	PUNCT
dpc-500	139	6	brenner	brenner	PROPN
dpc-500	139	7	s.	s.	PROPN
dpc-500	139	8	contributing	contributing	PROPN
dpc-500	139	9	 	 	SPACE
dpc-500	139	10	exogenous	exogenous	ADJ
dpc-500	139	11	 	 	SPACE
dpc-500	139	12	factors	factor	NOUN
dpc-500	139	13	in	in	ADP
dpc-500	139	14	 	 	SPACE
dpc-500	139	15	pemphigus	pemphigus	PROPN
dpc-500	139	16	.	.	PUNCT
dpc-500	140	1	int	int	PROPN
dpc-500	140	2	j	j	PROPN
dpc-500	140	3	dermatol	dermatol	NOUN
dpc-500	140	4	.	.	PUNCT
dpc-500	141	1	1997;36(12):888	1997;36(12):888	NUM
dpc-500	141	2	-	-	PUNCT
dpc-500	141	3	893	893	NUM
dpc-500	141	4	.	.	PUNCT
dpc-500	142	1	diseases	disease	NOUN
dpc-500	142	2	such	such	ADJ
dpc-500	142	3	as	as	ADP
dpc-500	142	4	systemic	systemic	ADJ
dpc-500	142	5	lupus	lupus	PROPN
dpc-500	142	6	erythematosus	erythematosus	PROPN
dpc-500	142	7	,	,	PUNCT
dpc-500	142	8	rheumatoid	rheumatoid	NOUN
dpc-500	142	9	arthritis	arthritis	NOUN
dpc-500	142	10	,	,	PUNCT
dpc-500	142	11	multiple	multiple	ADJ
dpc-500	142	12	sclerosis	sclerosis	NOUN
dpc-500	142	13	,	,	PUNCT
dpc-500	142	14	and	and	CCONJ
dpc-500	142	15	diabetes	diabetes	NOUN
dpc-500	142	16	mellitus	mellitus	NOUN
dpc-500	142	17	[	[	X
dpc-500	142	18	24	24	NUM
dpc-500	142	19	]	]	PUNCT
dpc-500	142	20	.	.	PUNCT
dpc-500	143	1	in	in	ADP
dpc-500	143	2	this	this	DET
dpc-500	143	3	regard	regard	NOUN
dpc-500	143	4	,	,	PUNCT
dpc-500	143	5	efforts	effort	NOUN
dpc-500	143	6	have	have	AUX
dpc-500	143	7	been	be	AUX
dpc-500	143	8	made	make	VERB
dpc-500	143	9	to	to	PART
dpc-500	143	10	detect	detect	VERB
dpc-500	143	11	viral	viral	ADJ
dpc-500	143	12	pathogens	pathogen	NOUN
dpc-500	143	13	in	in	ADP
dpc-500	143	14	blood	blood	NOUN
dpc-500	143	15	samples	sample	NOUN
dpc-500	143	16	and	and	CCONJ
dpc-500	143	17	skin	skin	NOUN
dpc-500	143	18	specimens	specimen	NOUN
dpc-500	143	19	of	of	ADP
dpc-500	143	20	patients	patient	NOUN
dpc-500	143	21	with	with	ADP
dpc-500	143	22	pemphigus	pemphigus	NOUN
dpc-500	143	23	by	by	ADP
dpc-500	143	24	techniques	technique	NOUN
dpc-500	143	25	such	such	ADJ
dpc-500	143	26	as	as	ADP
dpc-500	143	27	immunochemistry	immunochemistry	NOUN
dpc-500	143	28	and	and	CCONJ
dpc-500	143	29	pcr	pcr	NOUN
dpc-500	143	30	for	for	ADP
dpc-500	143	31	dna	dna	NOUN
dpc-500	143	32	particles	particle	NOUN
dpc-500	143	33	.	.	PUNCT
dpc-500	144	1	the	the	DET
dpc-500	144	2	association	association	NOUN
dpc-500	144	3	between	between	ADP
dpc-500	144	4	onset	onset	NOUN
dpc-500	144	5	or	or	CCONJ
dpc-500	144	6	reactivation	reactivation	NOUN
dpc-500	144	7	of	of	ADP
dpc-500	144	8	pemphigus	pemphigus	NOUN
dpc-500	144	9	disease	disease	NOUN
dpc-500	144	10	and	and	CCONJ
dpc-500	144	11	viral	viral	ADJ
dpc-500	144	12	infections	infection	NOUN
dpc-500	144	13	may	may	AUX
dpc-500	144	14	be	be	AUX
dpc-500	144	15	causal	causal	ADJ
dpc-500	144	16	,	,	PUNCT
dpc-500	144	17	or	or	CCONJ
dpc-500	144	18	as	as	ADP
dpc-500	144	19	a	a	DET
dpc-500	144	20	result	result	NOUN
dpc-500	144	21	of	of	ADP
dpc-500	144	22	drug	drug	NOUN
dpc-500	144	23	-	-	PUNCT
dpc-500	144	24	induced	induce	VERB
dpc-500	144	25	immunosuppression	immunosuppression	NOUN
dpc-500	144	26	which	which	PRON
dpc-500	144	27	can	can	AUX
dpc-500	144	28	increase	increase	VERB
dpc-500	144	29	the	the	DET
dpc-500	144	30	likelihood	likelihood	NOUN
dpc-500	144	31	of	of	ADP
dpc-500	144	32	viral	viral	ADJ
dpc-500	144	33	infections	infection	NOUN
dpc-500	144	34	,	,	PUNCT
dpc-500	144	35	or	or	CCONJ
dpc-500	144	36	established	establish	VERB
dpc-500	144	37	on	on	ADP
dpc-500	144	38	the	the	DET
dpc-500	144	39	pathogenic	pathogenic	ADJ
dpc-500	144	40	connection	connection	NOUN
dpc-500	144	41	between	between	ADP
dpc-500	144	42	viral	viral	ADJ
dpc-500	144	43	infection	infection	NOUN
dpc-500	144	44	and	and	CCONJ
dpc-500	144	45	immune	immune	ADJ
dpc-500	144	46	dysregulation	dysregulation	NOUN
dpc-500	144	47	leading	lead	VERB
dpc-500	144	48	to	to	ADP
dpc-500	144	49	autoimmunity	autoimmunity	NOUN
dpc-500	144	50	.	.	PUNCT
dpc-500	145	1	the	the	DET
dpc-500	145	2	mechanism	mechanism	NOUN
dpc-500	145	3	of	of	ADP
dpc-500	145	4	viral	viral	ADJ
dpc-500	145	5	induction	induction	NOUN
dpc-500	145	6	of	of	ADP
dpc-500	145	7	autoimmunity	autoimmunity	NOUN
dpc-500	145	8	can	can	AUX
dpc-500	145	9	be	be	AUX
dpc-500	145	10	explained	explain	VERB
dpc-500	145	11	in	in	ADP
dpc-500	145	12	several	several	ADJ
dpc-500	145	13	ways	way	NOUN
dpc-500	145	14	,	,	PUNCT
dpc-500	145	15	including	include	VERB
dpc-500	145	16	molecular	molecular	ADJ
dpc-500	145	17	mimicry	mimicry	NOUN
dpc-500	145	18	(	(	PUNCT
dpc-500	145	19	due	due	ADP
dpc-500	145	20	to	to	ADP
dpc-500	145	21	cross	cross	NOUN
dpc-500	145	22	-	-	NOUN
dpc-500	145	23	reactions	reaction	NOUN
dpc-500	145	24	between	between	ADP
dpc-500	145	25	pathogen	pathogen	NOUN
dpc-500	145	26	-	-	PUNCT
dpc-500	145	27	derived	derive	VERB
dpc-500	145	28	epitopes	epitope	NOUN
dpc-500	145	29	and	and	CCONJ
dpc-500	145	30	self	self	NOUN
dpc-500	145	31	-	-	PUNCT
dpc-500	145	32	derived	derive	VERB
dpc-500	145	33	epitopes	epitope	NOUN
dpc-500	145	34	)	)	PUNCT
dpc-500	145	35	;	;	PUNCT
dpc-500	145	36	bystander	bystander	NOUN
dpc-500	145	37	activation	activation	NOUN
dpc-500	145	38	(	(	PUNCT
dpc-500	145	39	due	due	ADP
dpc-500	145	40	to	to	ADP
dpc-500	145	41	activation	activation	NOUN
dpc-500	145	42	of	of	ADP
dpc-500	145	43	preexisting	preexist	VERB
dpc-500	145	44	autoreactive	autoreactive	ADJ
dpc-500	145	45	t	t	NOUN
dpc-500	145	46	cells	cell	NOUN
dpc-500	145	47	as	as	ADP
dpc-500	145	48	a	a	DET
dpc-500	145	49	result	result	NOUN
dpc-500	145	50	of	of	ADP
dpc-500	145	51	the	the	DET
dpc-500	145	52	inflammatory	inflammatory	ADJ
dpc-500	145	53	environment	environment	NOUN
dpc-500	145	54	)	)	PUNCT
dpc-500	145	55	;	;	PUNCT
dpc-500	145	56	epitope	epitope	NOUN
dpc-500	145	57	spreading	spread	VERB
dpc-500	145	58	(	(	PUNCT
dpc-500	145	59	when	when	SCONJ
dpc-500	145	60	antigen	antigen	NOUN
dpc-500	145	61	-	-	PUNCT
dpc-500	145	62	presenting	present	VERB
dpc-500	145	63	cells	cell	NOUN
dpc-500	145	64	recognize	recognize	VERB
dpc-500	145	65	self	self	NOUN
dpc-500	145	66	-	-	PUNCT
dpc-500	145	67	antigens	antigen	NOUN
dpc-500	145	68	which	which	PRON
dpc-500	145	69	were	be	AUX
dpc-500	145	70	not	not	PART
dpc-500	145	71	initially	initially	ADV
dpc-500	145	72	directed	direct	VERB
dpc-500	145	73	by	by	ADP
dpc-500	145	74	the	the	DET
dpc-500	145	75	immune	immune	ADJ
dpc-500	145	76	system	system	NOUN
dpc-500	145	77	)	)	PUNCT
dpc-500	145	78	;	;	PUNCT
dpc-500	145	79	polyclonal	polyclonal	ADJ
dpc-500	145	80	activation	activation	NOUN
dpc-500	145	81	(	(	PUNCT
dpc-500	145	82	due	due	ADP
dpc-500	145	83	to	to	ADP
dpc-500	145	84	infection	infection	NOUN
dpc-500	145	85	of	of	ADP
dpc-500	145	86	b	b	NOUN
dpc-500	145	87	cells	cell	NOUN
dpc-500	145	88	by	by	ADP
dpc-500	145	89	lymphocytotropic	lymphocytotropic	ADJ
dpc-500	145	90	viruses	virus	NOUN
dpc-500	145	91	which	which	PRON
dpc-500	145	92	lead	lead	VERB
dpc-500	145	93	to	to	ADP
dpc-500	145	94	b	b	NOUN
dpc-500	145	95	cell	cell	NOUN
dpc-500	145	96	proliferation	proliferation	NOUN
dpc-500	145	97	and	and	CCONJ
dpc-500	145	98	increased	increase	VERB
dpc-500	145	99	antibody	antibody	NOUN
dpc-500	145	100	production	production	NOUN
dpc-500	145	101	)	)	PUNCT
dpc-500	145	102	;	;	PUNCT
dpc-500	145	103	and	and	CCONJ
dpc-500	145	104	viral	viral	ADJ
dpc-500	145	105	superantigens	superantigen	NOUN
dpc-500	145	106	(	(	PUNCT
dpc-500	145	107	encoded	encode	VERB
dpc-500	145	108	by	by	ADP
dpc-500	145	109	some	some	DET
dpc-500	145	110	viruses	virus	NOUN
dpc-500	145	111	,	,	PUNCT
dpc-500	145	112	are	be	AUX
dpc-500	145	113	able	able	ADJ
dpc-500	145	114	to	to	PART
dpc-500	145	115	activate	activate	VERB
dpc-500	145	116	polyclonal	polyclonal	ADJ
dpc-500	145	117	t	t	NOUN
dpc-500	145	118	cells	cell	NOUN
dpc-500	145	119	)	)	PUNCT
dpc-500	146	1	[	[	X
dpc-500	146	2	25	25	NUM
dpc-500	146	3	]	]	PUNCT
dpc-500	146	4	.	.	PUNCT
dpc-500	147	1	molecular	molecular	ADJ
dpc-500	147	2	mimicry	mimicry	NOUN
dpc-500	147	3	is	be	AUX
dpc-500	147	4	possibly	possibly	ADV
dpc-500	147	5	the	the	DET
dpc-500	147	6	most	most	ADV
dpc-500	147	7	acceptable	acceptable	ADJ
dpc-500	147	8	explanation	explanation	NOUN
dpc-500	147	9	for	for	ADP
dpc-500	147	10	the	the	DET
dpc-500	147	11	association	association	NOUN
dpc-500	147	12	of	of	ADP
dpc-500	147	13	viral	viral	ADJ
dpc-500	147	14	infections	infection	NOUN
dpc-500	147	15	and	and	CCONJ
dpc-500	147	16	pemphigus	pemphigus	NOUN
dpc-500	147	17	.	.	PUNCT
dpc-500	148	1	further	further	ADJ
dpc-500	148	2	explanation	explanation	NOUN
dpc-500	148	3	is	be	AUX
dpc-500	148	4	that	that	SCONJ
dpc-500	148	5	viruses	virus	NOUN
dpc-500	148	6	upregulate	upregulate	VERB
dpc-500	148	7	production	production	NOUN
dpc-500	148	8	of	of	ADP
dpc-500	148	9	interferon	interferon	NOUN
dpc-500	148	10	and	and	CCONJ
dpc-500	148	11	interleukins	interleukin	NOUN
dpc-500	148	12	.	.	PUNCT
dpc-500	149	1	high	high	ADJ
dpc-500	149	2	levels	level	NOUN
dpc-500	149	3	of	of	ADP
dpc-500	149	4	interferon	interferon	ADJ
dpc-500	149	5	gamma	gamma	NOUN
dpc-500	149	6	lead	lead	VERB
dpc-500	149	7	to	to	ADP
dpc-500	149	8	increased	increase	VERB
dpc-500	149	9	expression	expression	NOUN
dpc-500	149	10	of	of	ADP
dpc-500	149	11	hla2	hla2	PROPN
dpc-500	149	12	 	 	SPACE
dpc-500	149	13	on	on	ADP
dpc-500	149	14	keratinocytes	keratinocyte	NOUN
dpc-500	149	15	,	,	PUNCT
dpc-500	149	16	making	make	VERB
dpc-500	149	17	the	the	DET
dpc-500	149	18	pemphigus	pemphigus	NOUN
dpc-500	149	19	antigen	antigen	ADJ
dpc-500	149	20	structural	structural	ADJ
dpc-500	149	21	site	site	NOUN
dpc-500	149	22	active	active	ADJ
dpc-500	149	23	.	.	PUNCT
dpc-500	150	1	also	also	ADV
dpc-500	150	2	,	,	PUNCT
dpc-500	150	3	overproduction	overproduction	NOUN
dpc-500	150	4	of	of	ADP
dpc-500	150	5	il4	il4	NOUN
dpc-500	150	6	 	 	SPACE
dpc-500	150	7	and	and	CCONJ
dpc-500	150	8	il10	il10	PROPN
dpc-500	150	9	 	 	SPACE
dpc-500	150	10	causes	cause	VERB
dpc-500	150	11	a	a	DET
dpc-500	150	12	shift	shift	NOUN
dpc-500	150	13	of	of	ADP
dpc-500	150	14	th1	th1	PROPN
dpc-500	150	15	 	 	SPACE
dpc-500	150	16	to	to	ADP
dpc-500	150	17	th2	th2	PROPN
dpc-500	150	18	 	 	SPACE
dpc-500	150	19	response	response	NOUN
dpc-500	150	20	which	which	PRON
dpc-500	150	21	potentiates	potentiate	VERB
dpc-500	150	22	antibody	antibody	NOUN
dpc-500	150	23	response	response	NOUN
dpc-500	150	24	[	[	X
dpc-500	150	25	26,27	26,27	NUM
dpc-500	150	26	]	]	PUNCT
dpc-500	150	27	.	.	PUNCT
dpc-500	151	1	the	the	DET
dpc-500	151	2	role	role	NOUN
dpc-500	151	3	of	of	ADP
dpc-500	151	4	viruses	virus	NOUN
dpc-500	151	5	in	in	ADP
dpc-500	151	6	the	the	DET
dpc-500	151	7	pathogenesis	pathogenesis	NOUN
dpc-500	151	8	of	of	ADP
dpc-500	151	9	pemphigus	pemphigus	PROPN
dpc-500	151	10	has	have	AUX
dpc-500	151	11	been	be	AUX
dpc-500	151	12	assessed	assess	VERB
dpc-500	151	13	in	in	ADP
dpc-500	151	14	some	some	DET
dpc-500	151	15	previous	previous	ADJ
dpc-500	151	16	studies	study	NOUN
dpc-500	151	17	.	.	PUNCT
dpc-500	152	1	‘	'	PUNCT
dpc-500	152	2	the	the	DET
dpc-500	152	3	importance	importance	NOUN
dpc-500	152	4	of	of	ADP
dpc-500	152	5	viral	viral	ADJ
dpc-500	152	6	infections	infection	NOUN
dpc-500	152	7	as	as	ADP
dpc-500	152	8	an	an	DET
dpc-500	152	9	exacerbating	exacerbate	VERB
dpc-500	152	10	factor	factor	NOUN
dpc-500	152	11	of	of	ADP
dpc-500	152	12	pv	pv	PROPN
dpc-500	152	13	is	be	AUX
dpc-500	152	14	neglected	neglect	VERB
dpc-500	152	15	by	by	ADP
dpc-500	152	16	some	some	DET
dpc-500	152	17	clinicians	clinician	NOUN
dpc-500	152	18	.	.	PUNCT
dpc-500	153	1	concerning	concern	VERB
dpc-500	153	2	this	this	PRON
dpc-500	153	3	,	,	PUNCT
dpc-500	153	4	in	in	ADP
dpc-500	153	5	our	our	PRON
dpc-500	153	6	current	current	ADJ
dpc-500	153	7	case	case	NOUN
dpc-500	153	8	-	-	PUNCT
dpc-500	153	9	control	control	NOUN
dpc-500	153	10	study	study	NOUN
dpc-500	153	11	,	,	PUNCT
dpc-500	153	12	we	we	PRON
dpc-500	153	13	evaluated	evaluate	VERB
dpc-500	153	14	the	the	DET
dpc-500	153	15	probable	probable	ADJ
dpc-500	153	16	role	role	NOUN
dpc-500	153	17	of	of	ADP
dpc-500	153	18	hsv1/2	hsv1/2	PRON
dpc-500	153	19	 	 	SPACE
dpc-500	153	20	and	and	CCONJ
dpc-500	153	21	cmv	cmv	NOUN
dpc-500	153	22	in	in	ADP
dpc-500	153	23	the	the	DET
dpc-500	153	24	exacerbation	exacerbation	NOUN
dpc-500	153	25	of	of	ADP
dpc-500	153	26	pv	pv	INTJ
dpc-500	153	27	.	.	PUNCT
dpc-500	154	1	in	in	ADP
dpc-500	154	2	our	our	PRON
dpc-500	154	3	study	study	NOUN
dpc-500	154	4	,	,	PUNCT
dpc-500	154	5	a	a	DET
dpc-500	154	6	significantly	significantly	ADV
dpc-500	154	7	higher	high	ADJ
dpc-500	154	8	number	number	NOUN
dpc-500	154	9	of	of	ADP
dpc-500	154	10	pv	pv	NOUN
dpc-500	154	11	patients	patient	NOUN
dpc-500	154	12	(	(	PUNCT
dpc-500	154	13	regardless	regardless	ADV
dpc-500	154	14	of	of	ADP
dpc-500	154	15	disease	disease	NOUN
dpc-500	154	16	activity	activity	NOUN
dpc-500	154	17	)	)	PUNCT
dpc-500	154	18	were	be	AUX
dpc-500	154	19	positive	positive	ADJ
dpc-500	154	20	for	for	ADP
dpc-500	154	21	hsvand	hsvand	NOUN
dpc-500	154	22	cmv	cmv	PROPN
dpc-500	154	23	-	-	PUNCT
dpc-500	154	24	igg	igg	PROPN
dpc-500	154	25	antibodies	antibodie	VERB
dpc-500	154	26	,	,	PUNCT
dpc-500	154	27	similar	similar	ADJ
dpc-500	154	28	to	to	ADP
dpc-500	154	29	the	the	DET
dpc-500	154	30	studies	study	NOUN
dpc-500	154	31	by	by	ADP
dpc-500	154	32	tufano	tufano	ADJ
dpc-500	154	33	et	et	PROPN
dpc-500	154	34	 	 	SPACE
dpc-500	154	35	al	al	PROPN
dpc-500	154	36	and	and	CCONJ
dpc-500	154	37	sagi	sagi	PROPN
dpc-500	154	38	et	et	PROPN
dpc-500	154	39	 	 	SPACE
dpc-500	154	40	al	al	PROPN
dpc-500	155	1	[	[	X
dpc-500	155	2	28,29	28,29	NUM
dpc-500	155	3	]	]	PUNCT
dpc-500	155	4	.	.	PUNCT
dpc-500	156	1	this	this	PRON
dpc-500	156	2	may	may	AUX
dpc-500	156	3	show	show	VERB
dpc-500	156	4	a	a	DET
dpc-500	156	5	history	history	NOUN
dpc-500	156	6	of	of	ADP
dpc-500	156	7	hsv	hsv	PROPN
dpc-500	156	8	and	and	CCONJ
dpc-500	156	9	cmv	cmv	NOUN
dpc-500	156	10	exposure	exposure	NOUN
dpc-500	156	11	in	in	ADP
dpc-500	156	12	most	most	ADJ
dpc-500	156	13	patients	patient	NOUN
dpc-500	156	14	and	and	CCONJ
dpc-500	156	15	may	may	AUX
dpc-500	156	16	indicate	indicate	VERB
dpc-500	156	17	more	more	ADJ
dpc-500	156	18	frequent	frequent	ADJ
dpc-500	156	19	recrudescence	recrudescence	NOUN
dpc-500	156	20	of	of	ADP
dpc-500	156	21	latent	latent	NOUN
dpc-500	156	22	viruses	virus	NOUN
dpc-500	156	23	[	[	X
dpc-500	156	24	30	30	NUM
dpc-500	156	25	]	]	PUNCT
dpc-500	156	26	.	.	PUNCT
dpc-500	157	1	a	a	DET
dpc-500	157	2	significant	significant	ADJ
dpc-500	157	3	increase	increase	NOUN
dpc-500	157	4	in	in	ADP
dpc-500	157	5	igg	igg	PROPN
dpc-500	157	6	antibody	antibody	NOUN
dpc-500	157	7	levels	level	NOUN
dpc-500	157	8	,	,	PUNCT
dpc-500	157	9	discovered	discover	VERB
dpc-500	157	10	by	by	ADP
dpc-500	157	11	comparing	compare	VERB
dpc-500	157	12	relapse	relapse	NOUN
dpc-500	157	13	and	and	CCONJ
dpc-500	157	14	remission	remission	NOUN
dpc-500	157	15	samples	sample	NOUN
dpc-500	157	16	,	,	PUNCT
dpc-500	157	17	indicates	indicate	VERB
dpc-500	157	18	an	an	DET
dpc-500	157	19	active	active	ADJ
dpc-500	157	20	infection	infection	NOUN
dpc-500	157	21	.	.	PUNCT
dpc-500	158	1	according	accord	VERB
dpc-500	158	2	to	to	ADP
dpc-500	158	3	a	a	DET
dpc-500	158	4	general	general	ADJ
dpc-500	158	5	consensus	consensus	NOUN
dpc-500	158	6	,	,	PUNCT
dpc-500	158	7	relatively	relatively	ADV
dpc-500	158	8	higher	high	ADJ
dpc-500	158	9	igg	igg	NOUN
dpc-500	158	10	levels	level	NOUN
dpc-500	158	11	are	be	AUX
dpc-500	158	12	associated	associate	VERB
dpc-500	158	13	with	with	ADP
dpc-500	158	14	a	a	DET
dpc-500	158	15	higher	high	ADJ
dpc-500	158	16	probability	probability	NOUN
dpc-500	158	17	of	of	ADP
dpc-500	158	18	having	have	VERB
dpc-500	158	19	an	an	DET
dpc-500	158	20	active	active	ADJ
dpc-500	158	21	viral	viral	ADJ
dpc-500	158	22	infection	infection	NOUN
dpc-500	158	23	and	and	CCONJ
dpc-500	158	24	relatively	relatively	ADV
dpc-500	158	25	lower	low	ADJ
dpc-500	158	26	igg	igg	PROPN
dpc-500	158	27	levels	level	NOUN
dpc-500	158	28	represent	represent	VERB
dpc-500	158	29	a	a	DET
dpc-500	158	30	previous	previous	ADJ
dpc-500	158	31	viral	viral	ADJ
dpc-500	158	32	infection	infection	NOUN
dpc-500	158	33	rather	rather	ADV
dpc-500	158	34	than	than	ADP
dpc-500	158	35	an	an	DET
dpc-500	158	36	active	active	ADJ
dpc-500	158	37	viral	viral	ADJ
dpc-500	158	38	infection	infection	NOUN
dpc-500	158	39	.	.	PUNCT
dpc-500	159	1	in	in	ADP
dpc-500	159	2	this	this	DET
dpc-500	159	3	regard	regard	NOUN
dpc-500	159	4	,	,	PUNCT
dpc-500	159	5	senger	senger	PROPN
dpc-500	159	6	et	et	PROPN
dpc-500	159	7	 	 	SPACE
dpc-500	159	8	al	al	PROPN
dpc-500	159	9	showed	show	VERB
dpc-500	159	10	higher	high	ADJ
dpc-500	159	11	levels	level	NOUN
dpc-500	159	12	of	of	ADP
dpc-500	159	13	hsv1	hsv1	PROPN
dpc-500	159	14	 	 	SPACE
dpc-500	159	15	antibody	antibody	NOUN
dpc-500	159	16	in	in	ADP
dpc-500	159	17	patients	patient	NOUN
dpc-500	159	18	in	in	ADP
dpc-500	159	19	the	the	DET
dpc-500	159	20	active	active	ADJ
dpc-500	159	21	phase	phase	NOUN
dpc-500	159	22	of	of	ADP
dpc-500	159	23	disease	disease	NOUN
dpc-500	159	24	than	than	ADP
dpc-500	159	25	in	in	ADP
dpc-500	159	26	remission	remission	NOUN
dpc-500	159	27	patients	patient	NOUN
dpc-500	159	28	[	[	X
dpc-500	159	29	31	31	NUM
dpc-500	159	30	]	]	PUNCT
dpc-500	159	31	.	.	PUNCT
dpc-500	160	1	in	in	ADP
dpc-500	160	2	contrast	contrast	NOUN
dpc-500	160	3	to	to	ADP
dpc-500	160	4	our	our	PRON
dpc-500	160	5	study	study	NOUN
dpc-500	160	6	,	,	PUNCT
dpc-500	160	7	there	there	PRON
dpc-500	160	8	was	be	VERB
dpc-500	160	9	no	no	DET
dpc-500	160	10	significant	significant	ADJ
dpc-500	160	11	difference	difference	NOUN
dpc-500	160	12	in	in	ADP
dpc-500	160	13	antibody	antibody	NOUN
dpc-500	160	14	levels	level	NOUN
dpc-500	160	15	between	between	ADP
dpc-500	160	16	relapse	relapse	NOUN
dpc-500	160	17	and	and	CCONJ
dpc-500	160	18	remission	remission	NOUN
dpc-500	160	19	patients	patient	NOUN
dpc-500	160	20	.	.	PUNCT
dpc-500	161	1	in	in	ADP
dpc-500	161	2	the	the	DET
dpc-500	161	3	studies	study	NOUN
dpc-500	161	4	of	of	ADP
dpc-500	161	5	marzano	marzano	PROPN
dpc-500	161	6	et	et	PROPN
dpc-500	161	7	 	 	SPACE
dpc-500	161	8	al	al	PROPN
dpc-500	161	9	and	and	CCONJ
dpc-500	161	10	rahresearch	rahresearch	VERB
dpc-500	161	11	|	|	ADV
dpc-500	161	12	dermatol	dermatol	ADJ
dpc-500	161	13	pract	pract	NOUN
dpc-500	161	14	concept	concept	NOUN
dpc-500	161	15	2018;8(4):3	2018;8(4):3	PROPN
dpc-500	161	16	271	271	NUM
dpc-500	161	17	20	20	NUM
dpc-500	161	18	.	.	PUNCT
dpc-500	162	1	oliveira	oliveira	PROPN
dpc-500	162	2	-	-	PUNCT
dpc-500	162	3	batista	batista	PROPN
dpc-500	162	4	dp	dp	PROPN
dpc-500	162	5	,	,	PUNCT
dpc-500	162	6	janini	janini	VERB
dpc-500	162	7	me	i	PRON
dpc-500	162	8	,	,	PUNCT
dpc-500	162	9	fernandes	fernandes	PROPN
dpc-500	162	10	nc	nc	PROPN
dpc-500	162	11	,	,	PUNCT
dpc-500	162	12	santos	santos	PROPN
dpc-500	162	13	n.	n.	PROPN
dpc-500	162	14	laboratory	laboratory	NOUN
dpc-500	162	15	diagnosis	diagnosis	NOUN
dpc-500	162	16	of	of	ADP
dpc-500	162	17	herpesvirus	herpesvirus	NOUN
dpc-500	162	18	infections	infection	NOUN
dpc-500	162	19	in	in	ADP
dpc-500	162	20	patients	patient	NOUN
dpc-500	162	21	with	with	ADP
dpc-500	162	22	 	 	SPACE
dpc-500	162	23	pemphigus	pemphigus	NOUN
dpc-500	162	24	 	 	SPACE
dpc-500	162	25	vulgaris	vulgaris	NOUN
dpc-500	162	26	lesions	lesion	NOUN
dpc-500	162	27	.	.	PUNCT
dpc-500	163	1	intervirology	intervirology	NOUN
dpc-500	163	2	.	.	PUNCT
dpc-500	164	1	2013;56(4):231	2013;56(4):231	PROPN
dpc-500	164	2	-	-	SYM
dpc-500	164	3	236	236	NUM
dpc-500	164	4	.	.	PUNCT
dpc-500	164	5	21	21	NUM
dpc-500	164	6	.	.	PUNCT
dpc-500	165	1	cohen	cohen	PROPN
dpc-500	165	2	ss	ss	PROPN
dpc-500	165	3	,	,	PUNCT
dpc-500	165	4	blauvelt	blauvelt	VERB
dpc-500	165	5	a	a	PRON
dpc-500	165	6	,	,	PUNCT
dpc-500	165	7	weinstein	weinstein	PROPN
dpc-500	165	8	md	md	PROPN
dpc-500	165	9	,	,	PUNCT
dpc-500	165	10	herndier	herndi	ADJ
dpc-500	165	11	bg	bg	PROPN
dpc-500	165	12	,	,	PUNCT
dpc-500	165	13	anhalt	anhalt	PROPN
dpc-500	165	14	gj	gj	PROPN
dpc-500	165	15	.	.	PUNCT
dpc-500	166	1	no	no	DET
dpc-500	166	2	evidence	evidence	NOUN
dpc-500	166	3	of	of	ADP
dpc-500	166	4	human	human	ADJ
dpc-500	166	5	herpesvirus	herpesvirus	NOUN
dpc-500	166	6	 	 	SPACE
dpc-500	166	7	8	8	NUM
dpc-500	166	8	 	 	SPACE
dpc-500	166	9	infection	infection	NOUN
dpc-500	166	10	in	in	ADP
dpc-500	166	11	patients	patient	NOUN
dpc-500	166	12	with	with	ADP
dpc-500	166	13	paraneoplastic	paraneoplastic	ADJ
dpc-500	166	14	pemphigus	pemphigus	NOUN
dpc-500	166	15	,	,	PUNCT
dpc-500	166	16	pemphigus	pemphigus	NOUN
dpc-500	166	17	vulgaris	vulgaris	NOUN
dpc-500	166	18	,	,	PUNCT
dpc-500	166	19	or	or	CCONJ
dpc-500	166	20	pemphigus	pemphigus	PROPN
dpc-500	166	21	foliaceus	foliaceus	NOUN
dpc-500	166	22	.	.	PUNCT
dpc-500	167	1	j	j	PROPN
dpc-500	167	2	invest	invest	VERB
dpc-500	167	3	dermatol	dermatol	NOUN
dpc-500	167	4	.	.	PUNCT
dpc-500	168	1	1998;111(5):781	1998;111(5):781	NUM
dpc-500	168	2	-	-	SYM
dpc-500	168	3	783	783	NUM
dpc-500	168	4	.	.	PUNCT
dpc-500	169	1	22	22	NUM
dpc-500	169	2	.	.	PUNCT
dpc-500	169	3	esmaili	esmaili	PROPN
dpc-500	169	4	n	n	CCONJ
dpc-500	169	5	,	,	PUNCT
dpc-500	169	6	hallaji	hallaji	PROPN
dpc-500	169	7	z	z	NOUN
dpc-500	169	8	,	,	PUNCT
dpc-500	169	9	abedini	abedini	ADJ
dpc-500	169	10	r	r	NOUN
dpc-500	169	11	,	,	PUNCT
dpc-500	169	12	soori	soori	PROPN
dpc-500	169	13	t	t	PROPN
dpc-500	169	14	,	,	PUNCT
dpc-500	169	15	mortazavi	mortazavi	ADJ
dpc-500	169	16	h	h	NOUN
dpc-500	169	17	,	,	PUNCT
dpc-500	169	18	chamsdavatchi	chamsdavatchi	PROPN
dpc-500	169	19	c.	c.	PROPN
dpc-500	169	20	pemphigus	pemphigus	PROPN
dpc-500	169	21	vulgaris	vulgaris	PROPN
dpc-500	169	22	and	and	CCONJ
dpc-500	169	23	herpesviruses	herpesviruse	NOUN
dpc-500	169	24	:	:	PUNCT
dpc-500	169	25	is	be	AUX
dpc-500	169	26	there	there	PRON
dpc-500	169	27	any	any	DET
dpc-500	169	28	relationship	relationship	NOUN
dpc-500	169	29	?	?	PUNCT
dpc-500	170	1	int	int	NOUN
dpc-500	170	2	j	j	PROPN
dpc-500	170	3	dermatol	dermatol	NOUN
dpc-500	170	4	.	.	PUNCT
dpc-500	171	1	2010;49(11):1261	2010;49(11):1261	NUM
dpc-500	171	2	-	-	SYM
dpc-500	171	3	1265	1265	NUM
dpc-500	171	4	.	.	PUNCT
dpc-500	172	1	23	23	NUM
dpc-500	172	2	.	.	PUNCT
dpc-500	173	1	murrell	murrell	PROPN
dpc-500	173	2	df	df	PROPN
dpc-500	173	3	,	,	PUNCT
dpc-500	173	4	dick	dick	PROPN
dpc-500	173	5	s	s	PROPN
dpc-500	173	6	,	,	PUNCT
dpc-500	173	7	ahmed	ahmed	PROPN
dpc-500	173	8	ar	ar	PROPN
dpc-500	173	9	,	,	PUNCT
dpc-500	173	10	et	et	PROPN
dpc-500	173	11	 	 	SPACE
dpc-500	173	12	al	al	PROPN
dpc-500	173	13	.	.	PUNCT
dpc-500	174	1	consensus	consensus	NOUN
dpc-500	174	2	statement	statement	NOUN
dpc-500	174	3	on	on	ADP
dpc-500	174	4	definitions	definition	NOUN
dpc-500	174	5	of	of	ADP
dpc-500	174	6	disease	disease	NOUN
dpc-500	174	7	,	,	PUNCT
dpc-500	174	8	end	end	NOUN
dpc-500	174	9	points	point	NOUN
dpc-500	174	10	,	,	PUNCT
dpc-500	174	11	and	and	CCONJ
dpc-500	174	12	therapeutic	therapeutic	ADJ
dpc-500	174	13	response	response	NOUN
dpc-500	174	14	for	for	ADP
dpc-500	174	15	pemphigus	pemphigus	PROPN
dpc-500	174	16	.	.	PUNCT
dpc-500	175	1	j	j	PROPN
dpc-500	175	2	am	be	AUX
dpc-500	175	3	acad	acad	ADJ
dpc-500	175	4	dermatol	dermatol	NOUN
dpc-500	175	5	.	.	PUNCT
dpc-500	176	1	2008;58(6):1043	2008;58(6):1043	NUM
dpc-500	176	2	-	-	SYM
dpc-500	176	3	1046	1046	NUM
dpc-500	176	4	.	.	PUNCT
dpc-500	177	1	24	24	NUM
dpc-500	177	2	.	.	PUNCT
dpc-500	177	3	ercolini	ercolini	PROPN
dpc-500	177	4	am	am	PROPN
dpc-500	177	5	,	,	PUNCT
dpc-500	177	6	miller	miller	PROPN
dpc-500	177	7	sd	sd	PROPN
dpc-500	177	8	.	.	PUNCT
dpc-500	178	1	the	the	DET
dpc-500	178	2	role	role	NOUN
dpc-500	178	3	of	of	ADP
dpc-500	178	4	infections	infection	NOUN
dpc-500	178	5	in	in	ADP
dpc-500	178	6	autoimmune	autoimmune	ADJ
dpc-500	178	7	disease	disease	NOUN
dpc-500	178	8	.	.	PUNCT
dpc-500	179	1	clin	clin	PROPN
dpc-500	179	2	exp	exp	NOUN
dpc-500	179	3	immunol	immunol	NOUN
dpc-500	179	4	.	.	PUNCT
dpc-500	180	1	2009;155(1):1	2009;155(1):1	NUM
dpc-500	180	2	-	-	SYM
dpc-500	180	3	15	15	NUM
dpc-500	180	4	.	.	PUNCT
dpc-500	181	1	25	25	NUM
dpc-500	181	2	.	.	PUNCT
dpc-500	182	1	lossius	lossius	PROPN
dpc-500	182	2	a	a	PROPN
dpc-500	182	3	,	,	PUNCT
dpc-500	182	4	johansen	johansen	PROPN
dpc-500	182	5	jn	jn	PROPN
dpc-500	182	6	,	,	PUNCT
dpc-500	182	7	torkildsen	torkildsen	PROPN
dpc-500	182	8	ø	ø	PROPN
dpc-500	182	9	,	,	PUNCT
dpc-500	182	10	vartdal	vartdal	NOUN
dpc-500	182	11	f	f	NOUN
dpc-500	182	12	,	,	PUNCT
dpc-500	182	13	holmoy	holmoy	PROPN
dpc-500	182	14	t.	t.	PROPN
dpc-500	182	15	epstein	epstein	PROPN
dpc-500	182	16	-	-	PUNCT
dpc-500	182	17	barr	barr	PROPN
dpc-500	182	18	virus	virus	PROPN
dpc-500	182	19	in	in	ADP
dpc-500	182	20	systemic	systemic	ADJ
dpc-500	182	21	lupus	lupus	PROPN
dpc-500	182	22	erythematosus	erythematosus	PROPN
dpc-500	182	23	,	,	PUNCT
dpc-500	182	24	rheumatoid	rheumatoid	VERB
dpc-500	182	25	arthritis	arthritis	NOUN
dpc-500	182	26	and	and	CCONJ
dpc-500	182	27	multiple	multiple	ADJ
dpc-500	182	28	sclerosis	sclerosis	NOUN
dpc-500	182	29	:	:	PUNCT
dpc-500	182	30	association	association	NOUN
dpc-500	182	31	and	and	CCONJ
dpc-500	182	32	causation	causation	NOUN
dpc-500	182	33	.	.	PUNCT
dpc-500	183	1	viruses	virus	NOUN
dpc-500	183	2	.	.	PUNCT
dpc-500	184	1	2012;4(12):3701	2012;4(12):3701	X
dpc-500	184	2	-	-	SYM
dpc-500	184	3	3730	3730	NUM
dpc-500	184	4	.	.	PUNCT
dpc-500	185	1	26	26	NUM
dpc-500	185	2	.	.	PUNCT
dpc-500	185	3	ruocco	ruocco	PROPN
dpc-500	185	4	e	e	PROPN
dpc-500	185	5	,	,	PUNCT
dpc-500	185	6	ruocco	ruocco	PROPN
dpc-500	185	7	v	v	NOUN
dpc-500	185	8	,	,	PUNCT
dpc-500	185	9	lo	lo	PROPN
dpc-500	185	10	schiavo	schiavo	PROPN
dpc-500	185	11	a	a	PROPN
dpc-500	185	12	,	,	PUNCT
dpc-500	185	13	brunetti	brunetti	NOUN
dpc-500	185	14	g	g	NOUN
dpc-500	185	15	,	,	PUNCT
dpc-500	185	16	wolf	wolf	PROPN
dpc-500	185	17	r.	r.	PROPN
dpc-500	185	18	viruses	virus	NOUN
dpc-500	185	19	and	and	CCONJ
dpc-500	185	20	pemphigus	pemphigus	X
dpc-500	185	21	:	:	PUNCT
dpc-500	185	22	an	an	DET
dpc-500	185	23	intriguing	intriguing	ADJ
dpc-500	185	24	never	never	ADV
dpc-500	185	25	-	-	PUNCT
dpc-500	185	26	ending	end	VERB
dpc-500	185	27	story	story	NOUN
dpc-500	185	28	.	.	PUNCT
dpc-500	186	1	dermatology	dermatology	NOUN
dpc-500	186	2	.	.	PUNCT
dpc-500	187	1	2014;229(4):310	2014;229(4):310	NUM
dpc-500	187	2	-	-	SYM
dpc-500	187	3	315	315	NUM
dpc-500	187	4	.	.	PUNCT
dpc-500	188	1	27	27	NUM
dpc-500	188	2	.	.	PUNCT
dpc-500	189	1	vercelli	vercelli	PROPN
dpc-500	189	2	d	d	PROPN
dpc-500	189	3	,	,	PUNCT
dpc-500	189	4	jabara	jabara	PROPN
dpc-500	189	5	hh	hh	PROPN
dpc-500	189	6	,	,	PUNCT
dpc-500	189	7	lauener	lauener	NOUN
dpc-500	189	8	rp	rp	NOUN
dpc-500	189	9	,	,	PUNCT
dpc-500	189	10	geha	geha	ADJ
dpc-500	189	11	rs	r	NOUN
dpc-500	189	12	.	.	PUNCT
dpc-500	190	1	il-4	il-4	NOUN
dpc-500	190	2	 	 	SPACE
dpc-500	190	3	inhibits	inhibit	VERB
dpc-500	190	4	the	the	DET
dpc-500	190	5	synthesis	synthesis	NOUN
dpc-500	190	6	of	of	ADP
dpc-500	190	7	ifn	ifn	NOUN
dpc-500	190	8	-	-	PUNCT
dpc-500	190	9	gamma	gamma	NOUN
dpc-500	190	10	and	and	CCONJ
dpc-500	190	11	induces	induce	VERB
dpc-500	190	12	the	the	DET
dpc-500	190	13	synthesis	synthesis	NOUN
dpc-500	190	14	of	of	ADP
dpc-500	190	15	ige	ige	PROPN
dpc-500	190	16	in	in	ADP
dpc-500	190	17	human	human	ADJ
dpc-500	190	18	mixed	mixed	ADJ
dpc-500	190	19	lymphocyte	lymphocyte	ADJ
dpc-500	190	20	cultures	culture	NOUN
dpc-500	190	21	.	.	PUNCT
dpc-500	191	1	j	j	PROPN
dpc-500	191	2	immunol	immunol	NOUN
dpc-500	191	3	.	.	PUNCT
dpc-500	192	1	1990;144(2):570	1990;144(2):570	NUM
dpc-500	192	2	-	-	SYM
dpc-500	192	3	573	573	NUM
dpc-500	192	4	.	.	PUNCT
dpc-500	192	5	28	28	NUM
dpc-500	192	6	.	.	PUNCT
dpc-500	193	1	sagi	sagi	PROPN
dpc-500	193	2	l	l	PROPN
dpc-500	193	3	,	,	PUNCT
dpc-500	193	4	baum	baum	PROPN
dpc-500	193	5	s	s	PROPN
dpc-500	193	6	,	,	PUNCT
dpc-500	193	7	agmon	agmon	PROPN
dpc-500	193	8	-	-	PUNCT
dpc-500	193	9	levin	levin	PROPN
dpc-500	193	10	n	n	PROPN
dpc-500	193	11	,	,	PUNCT
dpc-500	193	12	et	et	PROPN
dpc-500	193	13	 	 	SPACE
dpc-500	193	14	al	al	PROPN
dpc-500	193	15	.	.	PROPN
dpc-500	193	16	autoimmune	autoimmune	ADJ
dpc-500	193	17	bullous	bullous	ADJ
dpc-500	193	18	diseases	disease	NOUN
dpc-500	193	19	:	:	PUNCT
dpc-500	193	20	the	the	DET
dpc-500	193	21	spectrum	spectrum	NOUN
dpc-500	193	22	of	of	ADP
dpc-500	193	23	infectious	infectious	ADJ
dpc-500	193	24	agent	agent	NOUN
dpc-500	193	25	antibodies	antibodie	VERB
dpc-500	193	26	and	and	CCONJ
dpc-500	193	27	review	review	NOUN
dpc-500	193	28	of	of	ADP
dpc-500	193	29	the	the	DET
dpc-500	193	30	literature	literature	NOUN
dpc-500	193	31	.	.	PUNCT
dpc-500	194	1	autoimmun	autoimmun	PROPN
dpc-500	194	2	rev	rev	PROPN
dpc-500	194	3	.	.	PUNCT
dpc-500	195	1	2011;10(9):527	2011;10(9):527	PROPN
dpc-500	195	2	-	-	PUNCT
dpc-500	195	3	535	535	NUM
dpc-500	195	4	.	.	PUNCT
dpc-500	196	1	29	29	NUM
dpc-500	196	2	.	.	PUNCT
dpc-500	197	1	tufano	tufano	PROPN
dpc-500	197	2	ma	ma	PROPN
dpc-500	197	3	,	,	PUNCT
dpc-500	197	4	baroni	baroni	PROPN
dpc-500	197	5	a	a	PROPN
dpc-500	197	6	,	,	PUNCT
dpc-500	197	7	buommino	buommino	PROPN
dpc-500	197	8	e	e	NOUN
dpc-500	197	9	,	,	PUNCT
dpc-500	197	10	ruocco	ruocco	PROPN
dpc-500	197	11	e	e	NOUN
dpc-500	197	12	,	,	PUNCT
dpc-500	197	13	lombardi	lombardi	PROPN
dpc-500	197	14	ml	ml	PROPN
dpc-500	197	15	,	,	PUNCT
dpc-500	197	16	ruocco	ruocco	PROPN
dpc-500	197	17	v.	v.	ADP
dpc-500	197	18	detection	detection	NOUN
dpc-500	197	19	of	of	ADP
dpc-500	197	20	herpesvirus	herpesvirus	NOUN
dpc-500	197	21	dna	dna	NOUN
dpc-500	197	22	in	in	ADP
dpc-500	197	23	peripheral	peripheral	ADJ
dpc-500	197	24	blood	blood	NOUN
dpc-500	197	25	mononuclear	mononuclear	ADJ
dpc-500	197	26	cells	cell	NOUN
dpc-500	197	27	and	and	CCONJ
dpc-500	197	28	skin	skin	NOUN
dpc-500	197	29	lesions	lesion	NOUN
dpc-500	197	30	of	of	ADP
dpc-500	197	31	patients	patient	NOUN
dpc-500	197	32	with	with	ADP
dpc-500	197	33	pemphigus	pemphigus	NOUN
dpc-500	197	34	by	by	ADP
dpc-500	197	35	polymerase	polymerase	NOUN
dpc-500	197	36	chain	chain	NOUN
dpc-500	197	37	reaction	reaction	NOUN
dpc-500	197	38	.	.	PUNCT
dpc-500	198	1	br	br	PROPN
dpc-500	198	2	j	j	PROPN
dpc-500	198	3	dermatol	dermatol	NOUN
dpc-500	198	4	.	.	PUNCT
dpc-500	199	1	1999;141(6):10331039	1999;141(6):10331039	NUM
dpc-500	199	2	.	.	PUNCT
dpc-500	200	1	30	30	NUM
dpc-500	200	2	.	.	X
dpc-500	201	1	hashido	hashido	PROPN
dpc-500	201	2	m	m	PROPN
dpc-500	201	3	,	,	PUNCT
dpc-500	201	4	kawana	kawana	PROPN
dpc-500	201	5	t.	t.	PROPN
dpc-500	201	6	herpes	herpes	PROPN
dpc-500	201	7	simplex	simplex	NOUN
dpc-500	201	8	virus	virus	NOUN
dpc-500	201	9	-	-	PUNCT
dpc-500	201	10	specific	specific	ADJ
dpc-500	201	11	igm	igm	PROPN
dpc-500	201	12	,	,	PUNCT
dpc-500	201	13	iga	iga	PROPN
dpc-500	201	14	and	and	CCONJ
dpc-500	201	15	igg	igg	PROPN
dpc-500	201	16	subclass	subclass	NOUN
dpc-500	201	17	antibody	antibody	NOUN
dpc-500	201	18	responses	response	NOUN
dpc-500	201	19	in	in	ADP
dpc-500	201	20	primary	primary	ADJ
dpc-500	201	21	and	and	CCONJ
dpc-500	201	22	nonprimary	nonprimary	ADJ
dpc-500	201	23	genital	genital	ADJ
dpc-500	201	24	herpes	herpe	NOUN
dpc-500	201	25	patients	patient	NOUN
dpc-500	201	26	.	.	PUNCT
dpc-500	202	1	microbiol	microbiol	PROPN
dpc-500	202	2	immunol	immunol	NOUN
dpc-500	202	3	.	.	PUNCT
dpc-500	203	1	1997;41(5):415	1997;41(5):415	NUM
dpc-500	203	2	-	-	PUNCT
dpc-500	203	3	420	420	NUM
dpc-500	203	4	.	.	PUNCT
dpc-500	204	1	31	31	NUM
dpc-500	204	2	.	.	PUNCT
dpc-500	205	1	senger	senger	NOUN
dpc-500	205	2	p	p	PROPN
dpc-500	205	3	,	,	PUNCT
dpc-500	205	4	abidi	abidi	PROPN
dpc-500	205	5	n	n	CCONJ
dpc-500	205	6	,	,	PUNCT
dpc-500	205	7	lin	lin	PROPN
dpc-500	205	8	dm	dm	PROPN
dpc-500	205	9	,	,	PUNCT
dpc-500	205	10	seiffert	seiffert	PROPN
dpc-500	205	11	-	-	PUNCT
dpc-500	205	12	sinha	sinha	NOUN
dpc-500	205	13	k	k	PROPN
dpc-500	205	14	,	,	PUNCT
dpc-500	205	15	sinha	sinha	PROPN
dpc-500	205	16	aa	aa	PROPN
dpc-500	205	17	.	.	PUNCT
dpc-500	206	1	positive	positive	ADJ
dpc-500	206	2	correlation	correlation	NOUN
dpc-500	206	3	of	of	ADP
dpc-500	206	4	anti	anti	ADJ
dpc-500	206	5	-	-	ADJ
dpc-500	206	6	herpes	herpes	ADJ
dpc-500	206	7	simplex	simplex	NOUN
dpc-500	206	8	type	type	NOUN
dpc-500	206	9	i	i	PRON
dpc-500	206	10	virus	virus	VERB
dpc-500	206	11	antibody	antibody	NOUN
dpc-500	206	12	levels	level	NOUN
dpc-500	206	13	with	with	ADP
dpc-500	206	14	pemphigus	pemphigus	NOUN
dpc-500	206	15	vulgaris	vulgaris	NOUN
dpc-500	206	16	disease	disease	NOUN
dpc-500	206	17	status	status	NOUN
dpc-500	206	18	and	and	CCONJ
dpc-500	206	19	activity	activity	NOUN
dpc-500	206	20	in	in	ADP
dpc-500	206	21	a	a	DET
dpc-500	206	22	large	large	ADJ
dpc-500	206	23	patient	patient	NOUN
dpc-500	206	24	cohort	cohort	NOUN
dpc-500	206	25	.	.	PUNCT
dpc-500	207	1	eur	eur	PROPN
dpc-500	207	2	j	j	PROPN
dpc-500	207	3	dermatol	dermatol	NOUN
dpc-500	207	4	.	.	PUNCT
dpc-500	208	1	2017;27(2):132	2017;27(2):132	NUM
dpc-500	208	2	-	-	SYM
dpc-500	208	3	138	138	NUM
dpc-500	208	4	.	.	PUNCT
dpc-500	209	1	32	32	NUM
dpc-500	209	2	.	.	PUNCT
dpc-500	210	1	marzano	marzano	PROPN
dpc-500	210	2	av	av	PROPN
dpc-500	210	3	,	,	PUNCT
dpc-500	210	4	tourlaki	tourlaki	ADV
dpc-500	210	5	a	a	PRON
dpc-500	210	6	,	,	PUNCT
dpc-500	210	7	merlo	merlo	PROPN
dpc-500	210	8	v	v	PROPN
dpc-500	210	9	,	,	PUNCT
dpc-500	210	10	spinelli	spinelli	PROPN
dpc-500	210	11	d	d	NOUN
dpc-500	210	12	,	,	PUNCT
dpc-500	210	13	venegoni	venegoni	X
dpc-500	210	14	l	l	NOUN
dpc-500	210	15	,	,	PUNCT
dpc-500	210	16	crosti	crosti	PROPN
dpc-500	210	17	c.	c.	PROPN
dpc-500	210	18	herpes	herpe	NOUN
dpc-500	210	19	simplex	simplex	NOUN
dpc-500	210	20	virus	virus	NOUN
dpc-500	210	21	infection	infection	NOUN
dpc-500	210	22	and	and	CCONJ
dpc-500	210	23	pemphigus	pemphigus	PROPN
dpc-500	210	24	.	.	PUNCT
dpc-500	211	1	int	int	PROPN
dpc-500	211	2	j	j	PROPN
dpc-500	211	3	immunopathol	immunopathol	PROPN
dpc-500	211	4	pharmacol	pharmacol	PROPN
dpc-500	211	5	.	.	PUNCT
dpc-500	212	1	2009;22(3):781	2009;22(3):781	NUM
dpc-500	212	2	-	-	SYM
dpc-500	212	3	786	786	NUM
dpc-500	212	4	.	.	PUNCT
dpc-500	213	1	33	33	NUM
dpc-500	213	2	.	.	PUNCT
dpc-500	214	1	rahmati	rahmati	NOUN
dpc-500	214	2	-	-	PUNCT
dpc-500	214	3	roodsari	roodsari	PROPN
dpc-500	214	4	m	m	PRON
dpc-500	214	5	,	,	PUNCT
dpc-500	214	6	rahmdar	rahmdar	PROPN
dpc-500	214	7	sr	sr	PROPN
dpc-500	214	8	,	,	PUNCT
dpc-500	214	9	alfaragi	alfaragi	PROPN
dpc-500	214	10	m	m	PROPN
dpc-500	214	11	,	,	PUNCT
dpc-500	214	12	saeedi	saeedi	PROPN
dpc-500	214	13	m	m	PROPN
dpc-500	214	14	,	,	PUNCT
dpc-500	214	15	rahmati	rahmati	PROPN
dpc-500	214	16	roodsari	roodsari	PROPN
dpc-500	214	17	s	s	SYM
dpc-500	214	18	,	,	PUNCT
dpc-500	214	19	sajadi	sajadi	PROPN
dpc-500	214	20	nia	nia	PROPN
dpc-500	214	21	rs	rs	PROPN
dpc-500	214	22	.	.	PUNCT
dpc-500	215	1	association	association	NOUN
dpc-500	215	2	of	of	ADP
dpc-500	215	3	hsv1/2	hsv1/2	PROPN
dpc-500	215	4	 	 	SPACE
dpc-500	215	5	infection	infection	NOUN
dpc-500	215	6	and	and	CCONJ
dpc-500	215	7	pemphigus	pemphigus	NOUN
dpc-500	215	8	disease	disease	NOUN
dpc-500	215	9	.	.	PUNCT
dpc-500	216	1	arch	arch	ADJ
dpc-500	216	2	pediatr	pediatr	PROPN
dpc-500	216	3	infect	infect	VERB
dpc-500	216	4	dis	dis	PROPN
dpc-500	216	5	.	.	PUNCT
dpc-500	217	1	2014;2(2):207210	2014;2(2):207210	X
dpc-500	217	2	.	.	NOUN
dpc-500	218	1	5	5	NUM
dpc-500	218	2	.	.	X
dpc-500	218	3	paolino	paolino	NOUN
dpc-500	218	4	g	g	PROPN
dpc-500	218	5	,	,	PUNCT
dpc-500	218	6	didona	didona	PROPN
dpc-500	218	7	d	d	NOUN
dpc-500	218	8	,	,	PUNCT
dpc-500	218	9	magliulo	magliulo	NOUN
dpc-500	218	10	g	g	NOUN
dpc-500	218	11	,	,	PUNCT
dpc-500	218	12	et	et	PROPN
dpc-500	218	13	 	 	SPACE
dpc-500	218	14	al	al	PROPN
dpc-500	218	15	.	.	PUNCT
dpc-500	219	1	paraneoplastic	paraneoplastic	PROPN
dpc-500	219	2	 	 	SPACE
dpc-500	219	3	pemphigus	pemphigus	NOUN
dpc-500	219	4	:	:	PUNCT
dpc-500	219	5	insight	insight	NOUN
dpc-500	219	6	into	into	ADP
dpc-500	219	7	the	the	DET
dpc-500	219	8	autoimmune	autoimmune	ADJ
dpc-500	219	9	pathogenesis	pathogenesis	NOUN
dpc-500	219	10	,	,	PUNCT
dpc-500	219	11	clinical	clinical	ADJ
dpc-500	219	12	features	feature	NOUN
dpc-500	219	13	and	and	CCONJ
dpc-500	219	14	therapy	therapy	NOUN
dpc-500	219	15	.	.	PUNCT
dpc-500	220	1	int	int	PROPN
dpc-500	220	2	j	j	PROPN
dpc-500	220	3	mol	mol	ADP
dpc-500	220	4	sci	sci	PROPN
dpc-500	220	5	.	.	PUNCT
dpc-500	221	1	2017;18(12):e2532	2017;18(12):e2532	PROPN
dpc-500	221	2	.	.	PUNCT
dpc-500	222	1	6	6	NUM
dpc-500	222	2	.	.	X
dpc-500	222	3	ruocco	ruocco	PROPN
dpc-500	222	4	e	e	NOUN
dpc-500	222	5	,	,	PUNCT
dpc-500	222	6	wolf	wolf	PROPN
dpc-500	222	7	r	r	PROPN
dpc-500	222	8	,	,	PUNCT
dpc-500	222	9	ruocco	ruocco	NOUN
dpc-500	222	10	v	v	NOUN
dpc-500	222	11	,	,	PUNCT
dpc-500	222	12	brunetti	brunetti	NOUN
dpc-500	222	13	g	g	NOUN
dpc-500	222	14	,	,	PUNCT
dpc-500	222	15	romano	romano	NOUN
dpc-500	222	16	f	f	X
dpc-500	222	17	,	,	PUNCT
dpc-500	222	18	lo	lo	PROPN
dpc-500	222	19	schiavo	schiavo	PROPN
dpc-500	222	20	a.	a.	PROPN
dpc-500	222	21	pemphigus	pemphigus	PROPN
dpc-500	222	22	:	:	PUNCT
dpc-500	222	23	associations	association	NOUN
dpc-500	222	24	and	and	CCONJ
dpc-500	222	25	management	management	NOUN
dpc-500	222	26	guidelines	guideline	NOUN
dpc-500	222	27	:	:	PUNCT
dpc-500	222	28	facts	fact	NOUN
dpc-500	222	29	and	and	CCONJ
dpc-500	222	30	controversies	controversy	NOUN
dpc-500	222	31	.	.	PUNCT
dpc-500	223	1	clin	clin	PROPN
dpc-500	223	2	dermatol	dermatol	NOUN
dpc-500	223	3	.	.	PUNCT
dpc-500	224	1	2013;31(4):382	2013;31(4):382	NUM
dpc-500	224	2	-	-	SYM
dpc-500	224	3	390	390	NUM
dpc-500	224	4	.	.	PUNCT
dpc-500	224	5	7	7	X
dpc-500	224	6	.	.	X
dpc-500	224	7	tavakolpour	tavakolpour	NUM
dpc-500	224	8	s.	s.	PROPN
dpc-500	224	9	pemphigus	pemphigus	PROPN
dpc-500	224	10	 	 	SPACE
dpc-500	224	11	trigger	trigger	NOUN
dpc-500	224	12	factors	factor	NOUN
dpc-500	224	13	:	:	PUNCT
dpc-500	224	14	special	special	ADJ
dpc-500	224	15	focus	focus	NOUN
dpc-500	224	16	on	on	ADP
dpc-500	224	17	 	 	SPACE
dpc-500	224	18	pemphigus	pemphigus	NOUN
dpc-500	224	19	vulgaris	vulgaris	NOUN
dpc-500	224	20	 	 	SPACE
dpc-500	224	21	and	and	CCONJ
dpc-500	224	22	 	 	SPACE
dpc-500	224	23	pemphigus	pemphigus	NOUN
dpc-500	224	24	 	 	SPACE
dpc-500	224	25	foliaceus	foliaceus	PROPN
dpc-500	224	26	.	.	PUNCT
dpc-500	225	1	arch	arch	ADJ
dpc-500	225	2	dermatol	dermatol	NOUN
dpc-500	225	3	res	re	NOUN
dpc-500	225	4	.	.	PUNCT
dpc-500	226	1	2018;310(2):95	2018;310(2):95	NUM
dpc-500	226	2	-	-	SYM
dpc-500	226	3	106	106	NUM
dpc-500	226	4	.	.	PUNCT
dpc-500	227	1	8	8	NUM
dpc-500	227	2	.	.	PUNCT
dpc-500	228	1	ruocco	ruocco	PROPN
dpc-500	228	2	e	e	PROPN
dpc-500	228	3	,	,	PUNCT
dpc-500	228	4	ruocco	ruocco	PROPN
dpc-500	228	5	v	v	NOUN
dpc-500	228	6	,	,	PUNCT
dpc-500	228	7	lo	lo	PROPN
dpc-500	228	8	schiavo	schiavo	PROPN
dpc-500	228	9	a	a	PROPN
dpc-500	228	10	,	,	PUNCT
dpc-500	228	11	brunetti	brunetti	NOUN
dpc-500	228	12	g	g	NOUN
dpc-500	228	13	,	,	PUNCT
dpc-500	228	14	wolf	wolf	PROPN
dpc-500	228	15	r.	r.	PROPN
dpc-500	228	16	viruses	virus	NOUN
dpc-500	228	17	 	 	SPACE
dpc-500	228	18	and	and	CCONJ
dpc-500	228	19	 	 	SPACE
dpc-500	228	20	pemphigus	pemphigus	NOUN
dpc-500	228	21	:	:	PUNCT
dpc-500	228	22	an	an	DET
dpc-500	228	23	intriguing	intriguing	ADJ
dpc-500	228	24	never	never	ADV
dpc-500	228	25	-	-	PUNCT
dpc-500	228	26	ending	end	VERB
dpc-500	228	27	story	story	NOUN
dpc-500	228	28	.	.	PUNCT
dpc-500	229	1	dermatology	dermatology	NOUN
dpc-500	229	2	.	.	PUNCT
dpc-500	230	1	2014;229(4):310	2014;229(4):310	NUM
dpc-500	230	2	-	-	SYM
dpc-500	230	3	315	315	NUM
dpc-500	230	4	.	.	PUNCT
dpc-500	230	5	  	  	SPACE
dpc-500	231	1	9	9	NUM
dpc-500	231	2	.	.	X
dpc-500	231	3	brandão	brandão	AUX
dpc-500	231	4	ml	ml	NOUN
dpc-500	231	5	,	,	PUNCT
dpc-500	231	6	 	 	SPACE
dpc-500	231	7	fernandes	fernandes	PROPN
dpc-500	231	8	nc	nc	PROPN
dpc-500	231	9	,	,	PUNCT
dpc-500	231	10	 	 	SPACE
dpc-500	231	11	batista	batista	PROPN
dpc-500	231	12	dp	dp	PROPN
dpc-500	231	13	,	,	PUNCT
dpc-500	231	14	 	 	SPACE
dpc-500	231	15	santos	santos	PROPN
dpc-500	231	16	n.	n.	PROPN
dpc-500	231	17	refractory	refractory	NOUN
dpc-500	231	18	 	 	SPACE
dpc-500	231	19	pemphigus	pemphigus	PROPN
dpc-500	231	20	vulgaris	vulgaris	NOUN
dpc-500	231	21	 	 	SPACE
dpc-500	231	22	associated	associate	VERB
dpc-500	231	23	with	with	ADP
dpc-500	231	24	herpes	herpe	NOUN
dpc-500	231	25	infection	infection	NOUN
dpc-500	231	26	:	:	PUNCT
dpc-500	231	27	case	case	NOUN
dpc-500	231	28	report	report	NOUN
dpc-500	231	29	and	and	CCONJ
dpc-500	231	30	 	 	SPACE
dpc-500	231	31	review	review	NOUN
dpc-500	231	32	.	.	PUNCT
dpc-500	232	1	rev	rev	PROPN
dpc-500	232	2	inst	inst	PROPN
dpc-500	232	3	med	med	PROPN
dpc-500	232	4	trop	trop	X
dpc-500	232	5	sao	sao	PROPN
dpc-500	232	6	paulo	paulo	PROPN
dpc-500	232	7	.	.	PUNCT
dpc-500	232	8	 	 	SPACE
dpc-500	233	1	2011;53(2):113	2011;53(2):113	NUM
dpc-500	233	2	-	-	PUNCT
dpc-500	233	3	117	117	NUM
dpc-500	233	4	.	.	PUNCT
dpc-500	233	5	10	10	NUM
dpc-500	233	6	.	.	PUNCT
dpc-500	234	1	oliveira	oliveira	PROPN
dpc-500	234	2	-	-	PUNCT
dpc-500	234	3	batista	batista	PROPN
dpc-500	234	4	dp	dp	PROPN
dpc-500	234	5	,	,	PUNCT
dpc-500	234	6	janini	janini	VERB
dpc-500	234	7	me	i	PRON
dpc-500	234	8	,	,	PUNCT
dpc-500	234	9	fernandes	fernandes	PROPN
dpc-500	234	10	nc	nc	PROPN
dpc-500	234	11	,	,	PUNCT
dpc-500	234	12	santos	santos	PROPN
dpc-500	234	13	n.	n.	PROPN
dpc-500	234	14	laboratory	laboratory	NOUN
dpc-500	234	15	diagnosis	diagnosis	NOUN
dpc-500	234	16	of	of	ADP
dpc-500	234	17	herpesvirus	herpesvirus	NOUN
dpc-500	234	18	infections	infection	NOUN
dpc-500	234	19	in	in	ADP
dpc-500	234	20	patients	patient	NOUN
dpc-500	234	21	with	with	ADP
dpc-500	234	22	pemphigus	pemphigus	ADJ
dpc-500	234	23	vulgaris	vulgaris	NOUN
dpc-500	234	24	lesions	lesion	NOUN
dpc-500	234	25	.	.	PUNCT
dpc-500	235	1	intervirology	intervirology	NOUN
dpc-500	235	2	.	.	PUNCT
dpc-500	236	1	2013;56(4):231	2013;56(4):231	PROPN
dpc-500	236	2	-	-	SYM
dpc-500	236	3	236	236	NUM
dpc-500	236	4	.	.	PUNCT
dpc-500	236	5	11	11	NUM
dpc-500	236	6	.	.	PUNCT
dpc-500	237	1	marzano	marzano	PROPN
dpc-500	237	2	av	av	PROPN
dpc-500	237	3	,	,	PUNCT
dpc-500	237	4	tourlaki	tourlaki	ADV
dpc-500	237	5	a	a	PRON
dpc-500	237	6	,	,	PUNCT
dpc-500	237	7	merlo	merlo	PROPN
dpc-500	237	8	v	v	PROPN
dpc-500	237	9	,	,	PUNCT
dpc-500	237	10	spinelli	spinelli	PROPN
dpc-500	237	11	d	d	NOUN
dpc-500	237	12	,	,	PUNCT
dpc-500	237	13	venegoni	venegoni	X
dpc-500	237	14	l	l	NOUN
dpc-500	237	15	,	,	PUNCT
dpc-500	237	16	crosti	crosti	PROPN
dpc-500	237	17	c.	c.	PROPN
dpc-500	237	18	herpes	herpe	NOUN
dpc-500	237	19	simplex	simplex	NOUN
dpc-500	237	20	virus	virus	NOUN
dpc-500	237	21	infection	infection	NOUN
dpc-500	237	22	and	and	CCONJ
dpc-500	237	23	pemphigus	pemphigus	PROPN
dpc-500	237	24	.	.	PUNCT
dpc-500	238	1	int	int	PROPN
dpc-500	238	2	j	j	PROPN
dpc-500	238	3	immunopathol	immunopathol	PROPN
dpc-500	238	4	pharmacol	pharmacol	PROPN
dpc-500	238	5	.	.	PUNCT
dpc-500	239	1	2009;22(3):781	2009;22(3):781	NUM
dpc-500	239	2	-	-	SYM
dpc-500	239	3	786	786	NUM
dpc-500	239	4	.	.	PUNCT
dpc-500	239	5	12	12	NUM
dpc-500	239	6	.	.	PUNCT
dpc-500	240	1	looker	look	ADJ
dpc-500	240	2	kj	kj	PROPN
dpc-500	240	3	,	,	PUNCT
dpc-500	240	4	magaret	magaret	ADJ
dpc-500	240	5	as	as	ADP
dpc-500	240	6	,	,	PUNCT
dpc-500	240	7	turner	turner	PROPN
dpc-500	240	8	km	km	PROPN
dpc-500	240	9	,	,	PUNCT
dpc-500	240	10	vickerman	vickerman	NOUN
dpc-500	240	11	p	p	NOUN
dpc-500	240	12	,	,	PUNCT
dpc-500	240	13	gottlieb	gottlieb	PROPN
dpc-500	240	14	sl	sl	PROPN
dpc-500	240	15	,	,	PUNCT
dpc-500	240	16	newman	newman	PROPN
dpc-500	240	17	lm	lm	PROPN
dpc-500	240	18	.	.	PUNCT
dpc-500	241	1	global	global	ADJ
dpc-500	241	2	estimates	estimate	NOUN
dpc-500	241	3	of	of	ADP
dpc-500	241	4	prevalent	prevalent	NOUN
dpc-500	241	5	and	and	CCONJ
dpc-500	241	6	incident	incident	NOUN
dpc-500	241	7	herpes	herpe	NOUN
dpc-500	241	8	simplex	simplex	NOUN
dpc-500	241	9	 	 	SPACE
dpc-500	241	10	virus	virus	NOUN
dpc-500	241	11	 	 	SPACE
dpc-500	241	12	type	type	NOUN
dpc-500	241	13	 	 	SPACE
dpc-500	241	14	2	2	NUM
dpc-500	241	15	 	 	SPACE
dpc-500	241	16	infections	infection	NOUN
dpc-500	241	17	in	in	ADP
dpc-500	241	18	 	 	SPACE
dpc-500	241	19	2012	2012	NUM
dpc-500	241	20	.	.	PUNCT
dpc-500	242	1	plos	plos	PROPN
dpc-500	242	2	one	one	NUM
dpc-500	242	3	.	.	PUNCT
dpc-500	243	1	2015;10(1):e114989	2015;10(1):e114989	NUM
dpc-500	243	2	.	.	NOUN
dpc-500	244	1	13	13	NUM
dpc-500	244	2	.	.	PUNCT
dpc-500	245	1	swanson	swanson	PROPN
dpc-500	245	2	ec	ec	PROPN
dpc-500	245	3	,	,	PUNCT
dpc-500	245	4	schleiss	schleis	VERB
dpc-500	245	5	mr	mr	PROPN
dpc-500	245	6	.	.	PROPN
dpc-500	245	7	congenital	congenital	ADJ
dpc-500	245	8	cytomegalovirus	cytomegalovirus	NOUN
dpc-500	245	9	infection	infection	NOUN
dpc-500	245	10	:	:	PUNCT
dpc-500	245	11	new	new	ADJ
dpc-500	245	12	prospects	prospect	NOUN
dpc-500	245	13	for	for	ADP
dpc-500	245	14	prevention	prevention	NOUN
dpc-500	245	15	and	and	CCONJ
dpc-500	245	16	therapy	therapy	NOUN
dpc-500	245	17	.	.	PUNCT
dpc-500	246	1	pediatr	pediatr	PROPN
dpc-500	246	2	clin	clin	PROPN
dpc-500	246	3	north	north	PROPN
dpc-500	246	4	am	am	PROPN
dpc-500	246	5	.	.	PUNCT
dpc-500	247	1	2013;60(2):335	2013;60(2):335	NUM
dpc-500	247	2	-	-	SYM
dpc-500	247	3	349	349	NUM
dpc-500	247	4	.	.	PUNCT
dpc-500	248	1	14	14	NUM
dpc-500	248	2	.	.	PUNCT
dpc-500	249	1	schenkel	schenkel	PROPN
dpc-500	249	2	jm	jm	PROPN
dpc-500	249	3	,	,	PUNCT
dpc-500	249	4	masopust	masopust	ADV
dpc-500	249	5	d.	d.	PROPN
dpc-500	249	6	tissue	tissue	NOUN
dpc-500	249	7	-	-	PUNCT
dpc-500	249	8	resident	resident	NOUN
dpc-500	249	9	memory	memory	NOUN
dpc-500	249	10	t	t	NOUN
dpc-500	249	11	cells	cell	NOUN
dpc-500	249	12	.	.	PUNCT
dpc-500	250	1	immunity	immunity	NOUN
dpc-500	250	2	.	.	PUNCT
dpc-500	251	1	2014;41(6):886	2014;41(6):886	PROPN
dpc-500	251	2	-	-	SYM
dpc-500	251	3	897	897	NUM
dpc-500	251	4	.	.	PUNCT
dpc-500	252	1	15	15	NUM
dpc-500	252	2	.	.	PUNCT
dpc-500	253	1	ariotti	ariotti	PROPN
dpc-500	253	2	s	s	PROPN
dpc-500	253	3	,	,	PUNCT
dpc-500	253	4	hogenbirk	hogenbirk	PROPN
dpc-500	253	5	ma	ma	PROPN
dpc-500	253	6	,	,	PUNCT
dpc-500	253	7	dijkgraaf	dijkgraaf	PROPN
dpc-500	253	8	fe	fe	PROPN
dpc-500	253	9	,	,	PUNCT
dpc-500	253	10	et	et	PROPN
dpc-500	253	11	 	 	SPACE
dpc-500	253	12	al	al	PROPN
dpc-500	253	13	.	.	PROPN
dpc-500	253	14	t	t	PROPN
dpc-500	253	15	cell	cell	NOUN
dpc-500	253	16	memory	memory	NOUN
dpc-500	253	17	.	.	PUNCT
dpc-500	254	1	skin	skin	NOUN
dpc-500	254	2	-	-	PUNCT
dpc-500	254	3	resident	resident	NOUN
dpc-500	254	4	memory	memory	NOUN
dpc-500	254	5	cd8(+	cd8(+	PROPN
dpc-500	254	6	)	)	PUNCT
dpc-500	254	7	t	t	NOUN
dpc-500	254	8	cells	cell	NOUN
dpc-500	254	9	trigger	trigger	VERB
dpc-500	254	10	a	a	DET
dpc-500	254	11	state	state	NOUN
dpc-500	254	12	of	of	ADP
dpc-500	254	13	tissue	tissue	NOUN
dpc-500	254	14	-	-	PUNCT
dpc-500	254	15	wide	wide	ADJ
dpc-500	254	16	pathogen	pathogen	NOUN
dpc-500	254	17	alert	alert	NOUN
dpc-500	254	18	.	.	PUNCT
dpc-500	255	1	science	science	NOUN
dpc-500	255	2	.	.	PUNCT
dpc-500	256	1	2014;346(6205):101	2014;346(6205):101	NUM
dpc-500	256	2	-	-	SYM
dpc-500	256	3	105	105	NUM
dpc-500	256	4	.	.	PUNCT
dpc-500	257	1	16	16	NUM
dpc-500	257	2	.	.	PUNCT
dpc-500	258	1	desai	desai	PROPN
dpc-500	258	2	dv	dv	PROPN
dpc-500	258	3	,	,	PUNCT
dpc-500	258	4	kulkarni	kulkarni	PROPN
dpc-500	258	5	ss	ss	PROPN
dpc-500	258	6	.	.	PUNCT
dpc-500	259	1	herpes	herpe	NOUN
dpc-500	259	2	simplex	simplex	NOUN
dpc-500	259	3	 	 	SPACE
dpc-500	259	4	virus	virus	NOUN
dpc-500	259	5	:	:	PUNCT
dpc-500	259	6	the	the	DET
dpc-500	259	7	interplay	interplay	NOUN
dpc-500	259	8	between	between	ADP
dpc-500	259	9	 	 	SPACE
dpc-500	259	10	hsv	hsv	PROPN
dpc-500	259	11	,	,	PUNCT
dpc-500	259	12	host	host	NOUN
dpc-500	259	13	,	,	PUNCT
dpc-500	259	14	and	and	CCONJ
dpc-500	259	15	hiv-1	hiv-1	X
dpc-500	259	16	.	.	PUNCT
dpc-500	259	17	viral	viral	ADJ
dpc-500	259	18	immunol	immunol	NOUN
dpc-500	259	19	.	.	PUNCT
dpc-500	260	1	2015;28(10):546	2015;28(10):546	NUM
dpc-500	260	2	-	-	SYM
dpc-500	260	3	555	555	NUM
dpc-500	260	4	.	.	PUNCT
dpc-500	261	1	17	17	NUM
dpc-500	261	2	.	.	X
dpc-500	262	1	brandão	brandão	AUX
dpc-500	262	2	ml	ml	PROPN
dpc-500	262	3	,	,	PUNCT
dpc-500	262	4	fernandes	fernandes	PROPN
dpc-500	262	5	nc	nc	PROPN
dpc-500	262	6	,	,	PUNCT
dpc-500	262	7	batista	batista	PROPN
dpc-500	262	8	dp	dp	PROPN
dpc-500	262	9	,	,	PUNCT
dpc-500	262	10	santos	santos	PROPN
dpc-500	262	11	n.	n.	PROPN
dpc-500	262	12	refractory	refractory	PROPN
dpc-500	262	13	 	 	SPACE
dpc-500	262	14	pemphigus	pemphigus	PROPN
dpc-500	262	15	 	 	SPACE
dpc-500	262	16	vulgaris	vulgaris	NOUN
dpc-500	262	17	associated	associate	VERB
dpc-500	262	18	with	with	ADP
dpc-500	262	19	herpes	herpe	NOUN
dpc-500	262	20	infection	infection	NOUN
dpc-500	262	21	:	:	PUNCT
dpc-500	262	22	case	case	NOUN
dpc-500	262	23	report	report	NOUN
dpc-500	262	24	and	and	CCONJ
dpc-500	262	25	review	review	NOUN
dpc-500	262	26	.	.	PUNCT
dpc-500	263	1	rev	rev	PROPN
dpc-500	263	2	inst	inst	PROPN
dpc-500	263	3	med	med	PROPN
dpc-500	263	4	trop	trop	X
dpc-500	263	5	sao	sao	PROPN
dpc-500	263	6	paulo	paulo	PROPN
dpc-500	263	7	.	.	PUNCT
dpc-500	264	1	2011;53(2):113	2011;53(2):113	NUM
dpc-500	264	2	-	-	PUNCT
dpc-500	264	3	117	117	NUM
dpc-500	264	4	.	.	NOUN
dpc-500	264	5	18	18	NUM
dpc-500	264	6	.	.	PUNCT
dpc-500	265	1	takahashi	takahashi	PROPN
dpc-500	265	2	i	i	PROPN
dpc-500	265	3	,	,	PUNCT
dpc-500	265	4	kobayashi	kobayashi	PROPN
dpc-500	265	5	tk	tk	PROPN
dpc-500	265	6	,	,	PUNCT
dpc-500	265	7	suzuki	suzuki	PROPN
dpc-500	265	8	h	h	PROPN
dpc-500	265	9	,	,	PUNCT
dpc-500	265	10	nakamura	nakamura	PROPN
dpc-500	265	11	s	s	PROPN
dpc-500	265	12	,	,	PUNCT
dpc-500	265	13	tezuka	tezuka	PROPN
dpc-500	265	14	f.	f.	PROPN
dpc-500	265	15	coexistence	coexistence	PROPN
dpc-500	265	16	of	of	ADP
dpc-500	265	17	 	 	SPACE
dpc-500	265	18	pemphigus	pemphigus	PROPN
dpc-500	265	19	 	 	SPACE
dpc-500	265	20	vulgaris	vulgaris	NOUN
dpc-500	265	21	and	and	CCONJ
dpc-500	265	22	herpes	herpe	NOUN
dpc-500	265	23	simplex	simplex	NOUN
dpc-500	265	24	virus	virus	NOUN
dpc-500	265	25	infection	infection	NOUN
dpc-500	265	26	in	in	ADP
dpc-500	265	27	oral	oral	ADJ
dpc-500	265	28	mucosa	mucosa	NOUN
dpc-500	265	29	diagnosed	diagnose	VERB
dpc-500	265	30	by	by	ADP
dpc-500	265	31	cytology	cytology	NOUN
dpc-500	265	32	,	,	PUNCT
dpc-500	265	33	immunohistochemistry	immunohistochemistry	NOUN
dpc-500	265	34	,	,	PUNCT
dpc-500	265	35	and	and	CCONJ
dpc-500	265	36	polymerase	polymerase	NOUN
dpc-500	265	37	chain	chain	NOUN
dpc-500	265	38	reaction	reaction	NOUN
dpc-500	265	39	.	.	PUNCT
dpc-500	266	1	diagn	diagn	ADJ
dpc-500	266	2	cytopathol	cytopathol	NOUN
dpc-500	266	3	.	.	PUNCT
dpc-500	267	1	1998;19(6):446	1998;19(6):446	NUM
dpc-500	267	2	-	-	SYM
dpc-500	267	3	450	450	NUM
dpc-500	267	4	.	.	NOUN
dpc-500	267	5	19	19	NUM
dpc-500	267	6	.	.	PUNCT
dpc-500	267	7	machado	machado	PROPN
dpc-500	267	8	ardsr	ardsr	PROPN
dpc-500	267	9	,	,	PUNCT
dpc-500	267	10	la	la	PROPN
dpc-500	267	11	serra	serra	PROPN
dpc-500	267	12	l	l	PROPN
dpc-500	267	13	,	,	PUNCT
dpc-500	267	14	turatti	turatti	VERB
dpc-500	267	15	a	a	PRON
dpc-500	267	16	,	,	PUNCT
dpc-500	267	17	machado	machado	PROPN
dpc-500	267	18	am	am	PROPN
dpc-500	267	19	,	,	PUNCT
dpc-500	267	20	roselino	roselino	PROPN
dpc-500	267	21	am	be	AUX
dpc-500	267	22	.	.	PUNCT
dpc-500	268	1	herpes	herpe	NOUN
dpc-500	268	2	simplex	simplex	NOUN
dpc-500	268	3	 	 	SPACE
dpc-500	268	4	virus	virus	NOUN
dpc-500	268	5	 	 	SPACE
dpc-500	268	6	1	1	NUM
dpc-500	268	7	 	 	SPACE
dpc-500	268	8	and	and	CCONJ
dpc-500	268	9	cytomegalovirus	cytomegalovirus	NOUN
dpc-500	268	10	are	be	AUX
dpc-500	268	11	associated	associate	VERB
dpc-500	268	12	with	with	ADP
dpc-500	268	13	 	 	SPACE
dpc-500	268	14	pemphigus	pemphigus	NOUN
dpc-500	268	15	 	 	SPACE
dpc-500	268	16	vulgaris	vulgaris	NOUN
dpc-500	268	17	but	but	CCONJ
dpc-500	268	18	not	not	PART
dpc-500	268	19	with	with	ADP
dpc-500	268	20	 	 	SPACE
dpc-500	268	21	pemphigus	pemphigus	PROPN
dpc-500	268	22	 	 	SPACE
dpc-500	268	23	foliaceus	foliaceus	ADJ
dpc-500	268	24	disease	disease	NOUN
dpc-500	268	25	.	.	PUNCT
dpc-500	269	1	exp	exp	NOUN
dpc-500	269	2	dermatol	dermatol	NOUN
dpc-500	269	3	.	.	PUNCT
dpc-500	270	1	2017;26(10):966	2017;26(10):966	NUM
dpc-500	270	2	-	-	SYM
dpc-500	270	3	968	968	NUM
dpc-500	270	4	.	.	PUNCT